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ABSTRACT 
This dissertation critically evaluated methodologies and devices for assessing and 
protecting the health of human populations, with particular emphasis on groundwater 
remediation and the use of wastewater-based epidemiology (WBE) to inform population 
health. A meta-analysis and assessment of laboratory-scale treatability studies for 
removing chlorinated solvents from groundwater found that sediment microcosms 
operated as continuous-flow columns are preferable to batch bottles when seeking to 
emulate with high fidelity the complex conditions prevailing in the subsurface in 
contaminated aquifers (Chapter 2). Compared to monitoring at the field-scale, use of 
column microcosms also showed (i) improved chemical speciation, and (ii) qualitative 
predictability of field parameters (Chapter 3). Monitoring of glucocorticoid hormones in 
wastewater of a university campus showed (i) elevated stress levels particularly at the 
start of the semester, (ii) on weekdays relative to weekend days (p = 0.05) (161 ± 42 μg d-
1 per person, 122 ± 54 μg d-1 per person; p ≤ 0.05), and (iii) a positive association 
between levels of stress hormones and nicotine (rs: 0.49) and caffeine (0.63) consumption 
in this student population (Chapter 4). Also, (i) alcohol consumption determined by WBE 
was in line with literature estimates for this young sub-population (11.3 ± 7.5 g d-1 per 
person vs. 10.1 ± 0.8 g d-1 per person), whereas caffeine and nicotine uses were below 
(114 ± 49 g d-1 per person, 178 ± 19 g d-1 per person; 627 ± 219 g d-1 per person, 927 ± 
243 g d-1 per person). The introduction of a novel continuous in situ sampler to WBE 
brought noted benefits relative to traditional time-integrated sampling, including (i) a 
higher sample coverage (93% vs. 3%), (ii) an ability to captured short-term analyte pulses 
(e.g., heroin, fentanyl, norbuprenorphine, and methadone), and (iii) an overall higher 
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mass capture for drugs of abuse like morphine, fentanyl, methamphetamine, 
amphetamine, and the opioid antagonist metabolite norbuprenorphine (p ≤ 0.01). 
Methods and devices developed in this work are poised to find applications in the 
remediation sector and in human health assessments. 
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CHAPTER 1 
INTRODUCTION 
Continued assessment of methodologies and devices for assessing the health of 
our natural environment and human populations are necessary to continue to innovate in 
these fields. One important discipline is soil and groundwater remediation, which began 
in earnest in the late 1970s with the establishment of the Resource Conservation and 
Recovery Act (1976) and the Comprehensive Environmental Response and Liability Act 
(1980); laws governing the cleanup of active and legacy hazardous waste sites in the 
United States (U.S.). The second is the newer discipline termed wastewater-based 
epidemiology (WBE), a sub-discipline of population of urban metabolism metrology, 
which focuses on human population health assessments using wastewater. Discussion of 
these fields are included herein.  
1.1 Treatability studies and groundwater remediation  
The methodology for hazardous waste remedial determinations includes the use of 
treatability (feasibility) studies to evaluate the performance, design and cost of potential 
remediation strategies before implementation [1]. The U.S. Environmental Protection 
Agency (EPA) offers treatability guidance documents designed to outline basic 
experimental parameters, however the specific approach taken and data required are not 
defined [2]. Bench-scale treatability studies commonly use batch bottle or continuous-
flow column designs, and contain site geologic materials, groundwater, and the proposed 
remedial technology [3]. Data obtained from treatability studies include contaminant 
removal, which is used to develop transformation kinetics [4], often in the form of rate 
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constants [5]. These variables are subsequently used to populate models [6], which 
supply cleanup time estimates, and overall remediation costs.  
1.1.1 Environmental remediation data gaps 
No studies offered information on the use occurrence of batch bottle and 
continuous-flow column treatability studies, or the proclivity to generate and report 
reaction kinetics in dual testing situations. Additionally, no study provided an in-depth 
comparison between bench-scale treatability studies and subsequent field-scale 
implementation. A critical assessment of this relationship is needed to highlight areas of 
improvement, whether related to experimental design or data generation and use. These 
factors have the potential to improve the understanding of how in situ remedial activities 
may unfold and therefore represent an opportunity to improve field-scale remediation. 
This is especially critical for complex environments, which are defined as those 
containing recalcitrant or comingled contaminants, complex hydrogeology, or requiring 
remediation times greater than 100 years.  
1.2 Wastewater-based epidemiology and population health 
Wastewater-based epidemiology (WBE) provides near real-time information 
related to health status, lifestyle, and the behaviors of populations contributing to the 
sampled sewer system [7-9]. This approach measures excretion products of human 
metabolism in wastewater to estimate consumption patterns of licit and illicit substances 
(e.g., caffeine, heroin), inadvertent chemical exposure (e.g., antimicrobials), or other 
indicators of health (e.g., genetic biomarkers) [10-13]. As the field of WBE continues to 
gain momentum as an effective and trusted tool to assess population health, there is a 
need to expand and improve upon the basic methodologies. This includes: (i) the 
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expansion of WBE into classes of endogenous compounds that are indicative of certain 
facets of human health; (ii) targeted analysis of specific demographics within a sewershed 
that may benefit from this type of assessment; and (iii) the testing of different sampling 
methods for collecting analytes of interest from the wastewater.  
1.2.1 Wastewater-based epidemiology data gaps 
To date, no wastewater-based epidemiology study has assessed glucocorticoids 
(stress hormones) in wastewater as a method to assess population-level stress. However, 
these compounds are routinely measured in urine and feces to assess stress in both human 
behavioral studies and captive and wild animal populations [14-16]. Validating this type 
of method on the population-scale would be beneficial for human health, particularly 
because chronic stress is linked to the top six leading causes of death in the US [17]. 
Currently, WBE studies most often collect wastewater samples from a wastewater 
treatment plant, because it is a centralized collection point for a community and the 
sampling infrastructure is already in place for compliance monitoring purposes. Targeted 
sampling is relatively rare due to limited access points; however, targeted analysis allows 
for isolation of specific populations that would benefit most from this assessment. One 
such demographic group is college students, which are often cited for their predilection 
for over-indulgence. To date, assessments on three campuses have only focused on 
narcotic consumption [11, 18-20], whereas none have assessed the more common licit 
compounds that are known to be used and abused, specifically alcohol, nicotine, and 
caffeine.  
As mentioned previously, WBE studies generally collect samples at the 
wastewater treatment plant, because of accessibly and ease. In almost all circumstances, 
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this involves a commercially available high-frequency discrete sampler that is designed 
to capture aliquots of wastewater based on specific time or flow parameters, and these 
aliquots then are composited over a 24-h time period [21, 22]. There are cited concerns 
that these samplers may miss pulses of target analytes [23], leading to an underestimation 
of consumption in the population; however, testing of alternative sample collection 
methods to date are extremely rare [24]. 
1.4 Primary goals and research strategy of this thesis 
 The goal of this dissertation was to critically evaluate the sampling and 
monitoring methods used to assess the health of the natural environment and human 
populations. These included bench-scale treatability studies designed to inform on 
groundwater remediation study design, and the measure of human metabolic excretion 
products in wastewater to assess human population health. Evaluation of these methods 
provided the opportunity to improve upon and expand the scope of these fields with 
respect to the spectrum of analytes and the liquid process streams subject to monitoring.  
In the assessment of treatability studies, the strategy was to perform a meta-
analysis focused on batch bottle and continuous-flow column treatability studies 
involving chlorinated solvents, with emphasis on reaction kinetic data generation and use. 
This dataset was supplemented with data from an experimental study, which involved the 
same competing treatability studies, executed for three distinct remediation strategies for 
the common groundwater and drinking water contaminant, perchloroethylene (PCE). 
Chemical speciation, reaction kinetics and mass removals were assessed and drivers 
behind variable outcomes were determined. Subsequently, a 6-month bench-scale PCE 
treatability study was performed, and results were compared to data generated from the 
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field-scale application of those amendments over a 14-month period. Comparisons were 
made in regards to chemical speciation, reaction kinetics, microbial counts, and mass 
fluxes. 
In the assessment of methodologies related to population health by wastewater-
based epidemiology, the first study moved beyond the conventional biomarkers of 
consumption commonly targeted by WBE, to monitor compounds endogenous to the 
human body, the glucocorticoid hormones, cortisol and cortisone. Daily composite 
samples were collected for seven consecutive days each month on a university campus 
during the first academic semester, including during the first week of classes and finals 
week. Statistical assessments were conducted to assess variability between months, days 
of the week, and weekends, and correlations determined between the hormones and 
biomarkers of commonly consumed psychoactive substances.  
Subsequently, in this target demographic, a WBE study was performed to monitor 
metabolites of nicotine, alcohol, and caffeine consumption contained in wastewater from 
a university campus. Published pharmacokinetic data and population estimates were used 
to determine daily per capita consumption, and these wastewater-generated consumption 
estimates were compared to self-reported targeted demographic data, and U.S. national 
average statistics. Trends were assessed statistically within and between consumption 
behaviors to assess short and long-term consumption variability.   
Finally, two competing sampler designs were selected, modified and deployed at 
a wastewater treatment plant to collect daily composite influent samples for seven 
consecutive days; this work included the deployment of a novel low-flow, near-
continuous active sampler, and a traditional sampler performing time-weighted high 
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frequency discrete sampling. Captured analytes of interest included common WBE 
indicators of the consumption of opioids, opioid antagonists, licit and illicit stimulants, 
and alcohol. Analyte mass loads captured by the two different samplers were compared to 
assess differences. A modeling exercise was performed to illustrate the relationship 
between analyte concentrations (static and dynamic events), and the resultant 
concentration signal in each type of sampler.  
1.5 Hypotheses 
Hypotheses are outline below: 
(i) batch bottle derived kinetic estimates for chlorinated solvent reduction are 
faster (higher observed rate constant) than those determined in continuous-
flow columns; 
(ii) bench-scale treatability kinetic estimates are significantly higher (α = 
0.01) than field-generated kinetic estimates; 
(iii) per capita glucocorticoids measured in university-derived wastewater are 
higher during the first week of classes and finals week (α = 0.05) over 
other sampled weeks; 
(iv) per capita estimates of alcohol, caffeine, and nicotine consumption derived 
from campus-generated wastewater will not be significantly different (α = 
0.05) from published self-reported data for the target demographic or 
national average estimates; and 
(v) mass load estimates derived from the continuous-sampler were 
significantly different (α = 0.01) than mass loads generated by the discrete 
sampler.  
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1.6 Specific aims 
Specific aims of this dissertation were to:   
(i) Determine common approaches to the use and reporting of derived kinetics in 
batch bottle and continuous-flow column treatability studies, and the drivers 
of those differences; 
(ii) Discern the relationship between remediation results of a bench-scale 
treatability study and subsequent field-scale implementation in a chlorinated 
solvent case study; 
(iii) Determine the occurrence of the glucocorticoids cortisol and cortisone in 
community wastewater and assess trends in hormone levels as a function of 
known activities; 
(iv) Measure indicators of alcohol, caffeine and nicotine consumption directly in 
wastewater and compare to per capita consumption determined by published 
self-reported data for the target demographic and U.S. national estimates; and 
(v) Measure indicators of licit and illicit drugs in wastewater with two distinct 
sampler types (near-continuous, high frequency discrete), and compare mass 
loads and estimated consumption patterns generated by each. 
 
 
 
8 
 
TRANSITION 1 
This dissertation is comprised of individual studies that critically evaluate 
methodologies and devices for environmental and population health assessments, 
including the selection and implementation of groundwater remediation strategies and 
human health monitoring using wastewater-based epidemiology.  
In groundwater remediation studies, bench-scale treatability studies are a common 
tool used to determine the efficacy of competing remediation strategies, prior to field-
scale implementation, to ensure the chosen technology will create the desired effect with 
site groundwater and sediments. Two of the most common types of studies include batch 
bottles and continuous-flow columns. Although treatability study guidelines are provided 
by government entities, individual practitioners largely define the route to completion. 
Beginning this research, there were no studies that offered information on the relative 
percentages of each type of study, the data streams generated, and how these data were 
being used, particularly kinetic data. Reaction kinetics arguably are the most important 
data stream, as degradation rates dictate contaminant removal times and with it overall 
remediation costs. Additionally, no study had assessed the similarities and/or differences 
between these types of treatability studies, and the implications for data usage 
degenerated by each.  
 In Chapter 2, a combined meta-analysis and laboratory experimental study was 
performed, focusing on batch bottles and continuous-flow columns, and their use in 
perchloroethylene (PCE) remediation. PCE is one of the most frequently encountered 
groundwater contaminants in the U.S. and individual site conditions largely drive 
treatment efficacy. The meta-analysis surveyed combined batch bottle and continuous-
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flow column treatability studies, and the data use and generation as it pertained to 
reaction kinetics. Experimentally, three PCE treatments were evaluated in both 
treatability study types, and concentrations of PCE and associated downstream 
degradates, including trichloroethene (TCE), cis-1,2-dichloroethene, trans-1,2-
dichloroethene, 1,1-dichloroethene (1,2-DCE), vinyl chloride (VC), and ethene, were 
determined by liquid chromatography tandem mass spectrometry (LC-MS/MS). 
Subsequent rate analyses and mass conversions were performed. 
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CHAPTER 2 
COMPARATIVE META-ANALYSIS AND EXPERIMENTAL KINETIC 
INVESTIGATION OF COLUMN AND BATCH BOTTLE MICROCOSM 
TREATABILITY STUDIES INFORMING IN SITU GROUNDWATER REMEDIAL 
DESIGN 
ABSTRACT 
A systematic comparison was performed between batch bottle and continuous-flow 
column microcosms (BMs and CMs, respectively) commonly used for in situ 
groundwater remedial design. Review of recent literature (2000–2014) showed a 
preference for reporting batch kinetics, even when corresponding column data were 
available. Additionally, CMs produced higher observed rate constants, exceeding those of 
BMs by a factor of 6.1 ± 1.1 standard error. In a subsequent laboratory investigation, 12 
equivalent microcosm pairs were constructed from fractured bedrock and 
perchloroethylene (PCE) impacted groundwater. First-order PCE transformation kinetics 
of CMs were 8.0 ± 4.8 times faster than BMs (rates: 1.23 ± 0.87 vs. 0.16 ± 0.05 d−1, 
respectively). Additionally, CMs transformed 16.1 ± 8.0-times more mass than BMs 
owing to continuous-feed operation. CMs are concluded to yield more reliable kinetic 
estimates because of much higher data density stemming from long-term, steady-state 
conditions. Since information from BMs and CMs is valuable and complementary, 
treatability studies should report kinetic data from both when available. This first 
systematic investigation of BMs and CMs highlights the need for a more unified 
framework for data use and reporting in treatability studies informing decision-making 
for field-scale groundwater remediation. 
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2.1 Introduction 
Despite significant remediation efforts over the last few decades by the United 
States and other developed nations, the number of hazardous waste sites remains 
considerable. Assessments conducted by the United States Environmental Protection 
Agency (U.S. EPA) concluded that 294,000 hazardous waste sites exist across the United 
States, with projected remediation costs amounting to more than $209 billion [25]. With 
some of the easiest to remediate sites now closed, a large number of challenging sites 
remain, estimated to require greater than 100 years for cleanup, and containing 
recalcitrant or comingled contaminants, typically in hydrogeologically complex 
environments [26]. In the US, the largest category of recalcitrant contaminants is 
halogenated volatile organic compounds (VOCs). This contaminant class comprises the 
highest percentage of sites on the US EPA’s National Priorities List [sites eligible for 
remedial action under the Comprehensive Environmental Response Compensation and 
Liability Act (CERCLA) or Superfund program], and the largest class of organic 
contaminants detected at Department of Defense installations [25]. Chlorinated solvents, 
which are the prime contributor to this category, are particularly challenging to remediate 
because of their pronounced recalcitrance to (bio)transformation and ability to form 
difficult to locate dense non-aqueous phase liquid (DNAPL) point sources [26]. 
The methodology for hazardous waste site characterization and remedial 
determination, known as Remediation Investigation/Feasibility Study (RI/FS), is outlined 
in CERCLA [27]. Integral to this framework is the use of treatability studies (often 
referred to as feasibility studies), intended to evaluate the performance, design and cost of 
potential remediation strategies before implementation [1]. Treatability studies require 
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site geologic materials and ground-water to be tested with the proposed remedial 
technology, most commonly at the bench-scale. Although the US EPA offers treatability 
guidance documents designed to outline basic experimental parameters, a specific 
roadmap from inception to completion is not explicitly defined [2, 28, 29]. Thus the 
approach taken and data required to satisfy treatability study goals are open for 
interpretation.  
Bench-scale treatability studies commonly use batch bottle or continuous-flow 
column designs to characterize and quantify contaminant changes in an experimental 
system as a proxy for in situ site conditions [3, 30, 31]. Batch microcosms (BMs), usually 
comprised of glass bottles with a narrow neck and orifice, are filled with geologic 
materials, site groundwater, amendments, and sealed with a gastight septum closure 
(closed systems). Batch bottle studies are the least expensive alternative in treatability 
studies and are the simplest to conduct [32-34]. Continuous-flow column microcosms 
(CMs) are commonly fabricated from glass or plastic cylinders, with sampling ports 
located at the inlet and outlet, and sometimes along the length of the column [35-37]. 
Columns are constructed with geologic material, solid amendments (optional), and 
groundwater is pumped through the column at a specified flow rate, typically in up-flow 
mode to remove trapped gases (open systems). Continuous-flow column experiments, 
although more expensive and challenging to operate, are known to be more representative 
of field conditions, by including the simulation of groundwater flow extant in the 
subsurface [38]. 
Data obtained from feasibility studies include the degree of removal (or 
sequestration) of the contaminant of interest, and are used to develop an understanding of 
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the transformation kinetics [4, 39, 40]. In studies where the contaminant is chemically or 
biologically transformed, kinetic data are often presented in the form of rate constants, 
specifically as first-order rate constants (k) and corresponding half-lives (t1/2) [5, 41, 42]. 
Often, these calculated parameters are directly compared to those of other studies with 
similar experimental designs, in an effort to further substantiate the feasibility of the 
tested technology [43-45]. First-order rate constants are often used to populate projection 
models, which are integral in determining the fate and transport characteristics of the 
contaminants of interest [6, 46-48]. A kinetic analysis is arguably the most valuable 
calculated parameter because this approach supplies the time necessary for cleanup, 
which largely dictates overall remediation costs. However, the experimental design, type 
of data extracted, calculations completed, and the manner in which data are presented is 
not stipulated, thereby rendering it subject to considerations of time, money or other 
issues.  
In this study, a meta-analysis of the scientific literature was performed to 
determine common approaches to the use and reporting of BM- and CM-derived kinetics. 
In addition, an experimental investigation was conducted to better understand 
fundamental differences in reaction kinetics derived from batch and column treatability 
studies. Experimental treatability studies were conducted using bedrock and groundwater 
impacted by perchloroethylene (PCE), one of the most frequently encountered 
recalcitrant groundwater contaminants in the US and around the world [49]. The fate of 
PCE in the environment is a function of prevailing physical, chemical and biological 
conditions at the cleanup site [50, 51], thus necessitating remedial design that is 
customized on a case-by-case basis informed by feasibility studies. Literature findings 
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and original experimental data on combined batch and column BMs and CMs treatability 
studies were completed to elucidate the benefits and limitations of each. 
2.2 Materials and methods 
2.2.1 Literature meta-analysis 
A literature review was conducted using Arizona State University’s OneSearch, 
which includes Web of Science, JSTOR, RefWorks and other sources (Appendix A: 
Table 4), to determine the number of combined batch and column chlorinated solvent 
treatability studies published in peer-reviewed sources. Search criteria included an 
aggregate of the following keywords and phrases: batch, column, dechlorination, and 
‘rate constant.’ Search results were refined by excluding the following subject terms: 
atmospheric protection/air quality control/air pollution, limnology, soil science and 
conservation, waste-water, wastewater treatment, sludge, water purification, and water 
purification methods. Publication dates included only those articles published from 2000 
to 2014. Of the total number of search results (sorted by relevance), 30% of the journal 
articles were selected randomly for evaluation. Studies captured in search results were 
excluded from analysis if they only employed analytical columns used in gas and liquid 
chromatography as opposed to microcosm columns (i.e., containing batch studies only).  
2.2.2 Experimental investigation 
2.2.2.1 Site media 
Bedrock core and groundwater for microcosm experiments were collected from 
an industrial site in Ontario, Canada. Site groundwater was amended with PCE, 
trichloroethene (TCE) and cis-1,2-dichloroethene (cDCE) to concentrations of 57, 43 and 
31 mg/L, respectively, for batch experiments and 57 mg/L PCE for columns. 
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Concentrations of these PCE, TCE, and cDCE at this particular site showed 
concentrations of 58 ± 61 mg/L, 39 ± 9 mg/L, and 17 ± 4 mg/L, respectively, in the most 
heavily impacted areas. These are similar to concentrations found at other sites 
contaminated with chlorinated solvents [52, 53]. 
2.2.3 Microcosm design 
Unless otherwise stated, microcosm treatment amendments were sourced from 
Golder Associates Ltd. (Ottawa, ON), and included common chemical and biological 
amendments to promote chlorinated solvent reduction. Treatment 1 consisted of a 
proprietary Controlled-Release Carbon Source (CRCS A). Treatment 2 included a 
commercially available CRCS B/Microscale Zero Valent Iron (mZVI) blend known as 
EHC® (Peroxychem, Philadelphia, PA). Treatment 3 consisted of nanoscale ZVI (nZVI) 
with associated palladium acetate catalyst (TCI America, Boston, MA), and an organic 
carbon source (soy protein). Further details are included in Appendix A: Table 5.  
Microcosms (Treatments 1-3) were bioaugmented with a commercial 
dechlorinating culture (KB-1®; SiREM, Guelph, ON) [54]. The chemical and biological 
treatments chosen are common amendments used for in situ groundwater remediation 
[55, 56]. Control microcosms were created in duplicate, and experimental treatments in 
triplicate, with the exception of Treatment 1 columns (duplicate). CMs were attached to a 
multi-channel ISMATEC peristaltic pump (IDEX Health and Science, Oak Harbor, WA), 
and operated with upward flow at a rate of 0.25 pore volumes per day (2.75 mL/day), or a 
4-day residence time. 
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2.2.4 Chemical analysis 
Aqueous samples were collected on a weekly to biweekly basis for analysis of 
PCE, TCE, cDCE, trans-1,2-dichloroethene (tDCE), 1,1-dichloroethene (1,1-DCE), vinyl 
chloride (VC) and ethene. Batch samples were analyzed using gas chromatography with a 
flame ionization detector (GC-FID) (Hewlett Packard 7890) (Hewlett Packard, Palo Alto, 
CA). Column samples were analyzed using headspace solid phase micro-extraction gas 
chromatography (SPME-GC-2010), with an FID and AOC-5000 auto-sampler 
(Shimadzu, Columbia, MD), using a previously published method [57]. Limits of 
detection and analyte recoveries are included in Appendix A: Table 6. 
2.2.5 Data analysis 
Rate constants were calculated for BMs using the linear regression method [33, 
58]. First-order observed rate constants (kOBS) for columns were calculated for each 
sampling period using the following equation: 
−𝑘𝑂𝐵𝑆 =  
ln(
𝐶
𝐶0
)
𝑡
      Eq. 1 
where, 𝐶 is effluent concentration, 𝐶0 is influent concentration, and t is time. The 
statistical relationship between batch and column rate constants were analyzed in 
unpaired, 2-tailed, homoscedastic Student’s t-test. 
The total contaminant mass converted to ethene 𝑀𝑇𝑜𝑡 in batch and column 
microcosms were calculated using Equation 2.  
𝑀𝑇𝑜𝑡 = (
𝐶𝑒𝑡ℎ
𝐶𝑒𝑓𝑓
) (𝐶𝑖𝑛) (
𝑡
𝜏
) (𝑉𝐺𝑊)    Eq. 2 
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where, 𝐶𝑒𝑡ℎ is total effluent molar concentration of ethene, 𝐶𝑒𝑓𝑓is effluent molar 
concentration of total (chloro)ethenes, 𝐶𝑖𝑛 is initial concentration of chloroethenes, t is the 
study duration, τ is the residence time, and 𝑉𝐺𝑊 is the groundwater volume in each 
microcosm. In columns 𝑉𝐺𝑊 may be further defined as the product of the column volume 
𝜋𝑟2ℎ and porosity ϕ, therefore Equation 2 for continuous-flow columns may be written as 
follows: 
𝑀𝑇𝑜𝑡 = (
𝐶𝑒𝑡ℎ
𝐶𝑒𝑓𝑓
) (𝐶𝑖𝑛) (
𝑡
𝜏
) (𝜋𝑟2ℎ 𝜙)      Eq. 3 
2.3 Results and discussion 
2.3.1 Literature meta-analysis 
A literature search using the criteria presented, yielded 644 publications. Analysis 
of 30% of these articles (n = 200) revealed that only 20% (n = 40) (Appendix A: Table 7) 
included a combined study of treatability using both BMs and CMs; the remainder had 
erroneous hits for analytical rather than microcosm columns and dealt with batch studies 
only. Of the resultant combined batch and column studies, only 23% (n = 9) performed a 
kinetic analysis using both datasets (Figure 1). Examination of these studies revealed that 
in 8 of the 9 studies (89%), the observed rate constants in the columns were greater than 
those observed in batch systems. On average, column kinetics were greater by a factor of 
6.1 ± 1.1 standard error than associated batch studies under similar experimental 
conditions. 
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Fig. 1 - Ratio of continuous-flow column to batch bottle rate constants (kOBS) from 
studies using both types of treatability study approaches. A ratio of unity (1) signals 
equivalent rates. In 8 of 9 referenced studies (89%), ratios were higher than 1, and 
published studies averaged a factor of 6.1 ± 1.1 standard error, indicating that columns 
consistently produced higher rate constants than comparable batch bottles [45, 59-66]. 
Experimental results show Treatments (T) were within the published range with an 
average of 7.7 ± 4.4 
 
The literature review revealed batch studies to be more common than column 
studies, with only a small fraction actually using both BM and CM approaches jointly. 
This is not surprising, as batch bottles are comparatively simpler systems with fewer 
moving parts that are easier to manage and replicate [38]. Notably, only 23% of studies 
with combined use of BMs and CMs conducted, reported kinetic analysis results for both 
experimental approaches. In other words, in 77% of the studies, available data were not 
included in the final analysis and reporting. Results show an industry preference to rely 
on kinetic analyses from batch bottles even when complimentary continuous-flow 
column results are available. Additionally, only 1 of 9 papers reported both kinetic 
datasets and discussed the differences between the calculated rate constants. To better 
understand the benefits and limitations of the two approaches, we conducted an 
experimental comparison of both systems under standardized conditions. 
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2.3.2 Experimental application 
Paired, matching BM and CM studies were conducted with equivalent 
experimental conditions for a duration of 146 days (Figure 2), and resultant 
(chloro)ethene species and associated first-order rate constants determined.  
 
Fig. 2 – Schematics and photographs of the experimental setup of batch bottle 
microcosms (A) and continuous-flow column microcosms (B). 
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2.3.2.1 VOC speciation during batch and column incubation 
 Results from the biotic control and bioaugmentation treatments in BMs and CMs 
spanned the PCE degradation spectrum from negligible to complete dechlorination, 
similar to chloroethene treatability studies reported in the literature for laboratory and 
field investigations [67-69]. Here, chloroethene mole fractions obtained in batch systems 
showed higher percentages of lighter molecular-weight PCE transformation products 
compared to the respective column series (Figure 3, Appendix A: Table 8). This pattern 
relates to differences in chloroethene compound additions and the residence time in each 
treatability system. In batch, there is a finite input of contaminant into the system at the 
start of the study, and a residence time equivalent to the study duration (~150 days). In 
the column system, chloroethenes are continuously being introduced, with a residence 
time of only 4 days. The primary chloroethene(s) at study conclusion for BMs with 
Treatment 1 were 75% VC (PCE removed by Day 34), as compared to 45/40% TCE/PCE 
in the corresponding CMs. In Treatment 2, BMs and CMs displayed ethene production at 
70% and 45%, respectively; however, PCE was removed by Day 41 in BMs, while 6% 
remained in column effluent at the study conclusion on Day 146. In Treatment 3, both 
microcosm pairs showed ~100% ethene production (PCE removed approximately by Day 
75). These findings from equivalent microcosms confirmed data from the literature, 
indicating a similar pattern of higher production of PCE/TCE degradation products (e.g., 
cDCE, VC and ethene) in batch over column microcosms [61, 66].   
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Fig. 3 - Dechlorination results in Control and Treatment microcosms operated in batch 
and continuous-flow mode. Results are shown as percent volatile organic compound 
(VOC) mole fraction throughout the study period. Arrows indicate inoculation of 
microcosms with a dechlorinating culture one month after start of incubation. Batch 
bottles with Treatment 3 were terminated after complete ethene production was achieved 
on Day 105. Monitoring of all columns commenced after a short stabilization period on 
Day 16. 
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2.3.2.2 Transformation kinetics of batch and column microcosms 
Results within analogous experimental series showed CMs to have higher 
observed rate constants (i.e., faster reaction rates) than BMs for identical dechlorination 
patterns (Figure 4). First-order rate constants of PCE transformation (removal) in 
columns were 8.0 ± 4.8 times faster than those of batch bottles, 1.23 ± 0.87 vs. 0.16 ± 
0.05 d-1, respectively. On average, CMs in Treatment 1, 2 and 3 were 3.1 ± 1.9 (0.5 vs. 
0.2 d-1), 8.1 ± 4.1 (0.9 vs. 0.1 d-1) and 11.8 ± 1.8 (2.1 vs. 0.2 d-1) times faster than 
associated BMs, respectively. This relationship was statistically significant for each 
treatment: Treatment 1 (p < 0.05), Treatments 2 and 3 (p < 0.001).  
 Box and whisker plots served to inform a detailed, VOC species-resolved 
comparison of BMs and CMs, showing the 25th, 50th (median), and 75th quartiles with 
whiskers 1.5x the interquartile (IQR) range (Figure 4). Rate constant variation within 
column data was greater, as evidenced by the larger quartiles, standard deviations, and 
the presence of both minimum and maximum outliers. These differences in data 
variability are explained by the following columns properties: (i) greater number of data 
points; (ii) multiple rates per replicate (during steady-state formation); (iii) influent 
samples collected for each sample event, and (iv) first-order integrated rate law 
containing two variables (influent and effluent). These cited differences are a function of 
the rate calculation method used: linear regression method (batch) versus application of 
first-order integrated rate law (columns), which stems from inherent differences in 
physical structure and functionality. 
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2.3.2.3 Contaminant mass converted in batch and column microcosms 
A direct comparison of the two experimental approaches revealed that the total 
mass of contaminant removed from BMs and CMs is not only dependent on the effective 
transformation activity, but also on the mass delivered to the system over the study 
duration. With a residence time equivalent to the experimental duration (here 146 days), 
each BM received a total VOC mass of 28 mg, or 11.4 mg PCE, 8.6 mg TCE and 6.2 mg 
cDCE (of 0.07; 0.07; and 0.06 millimoles (mmol), respectively). Total contaminant 
removals in batch Treatments 1 through 3 (determined by percent ethene production) 
were 6.0 ± 1.3 mg (0.21 ± 0.05 mmol), 23.6 ± 6.9 mg (0.84 ± 0.25 mmol), and 27.7 ± 
0.05 mg (0.99 ± 0.002 mmol). The average removal across all treatments for batch bottles 
was 19 ± 10 mg (0.68 ± 0.36 mmol).  
 By comparison, CMs showed an average treatment removal of 314 ± 271 mg 
(11.2 ± 9.7 mmol) as ethene, a 16-fold increase in total contaminant conversion over the 
associated batch equivalents (19 ± 10 mg). Individually, column Treatments 1, 2 and 3 
had total contaminant removals of 0 mg (no ethene production), 204 ± 100 mg (7.3 ± 3.6 
mmol), and 632 ± 85 mg (22.5 ± 3.0 mmol), respectively. This increased removal in 
columns is largely driven by the 4-day residence time. The maximum contaminant mass 
for the batch systems is the mass supplied at the outset of the experiment, whereas in the 
column system, the total mass is the mass delivered per pore volume multiplied by the 
number of pore volumes processed during the study duration. Hence, CMs over time 
receive a higher overall mass of VOCs and therefore also can transform a comparatively 
larger mass over time. In this study, the maximum VOC removal per CMs was 656 mg 
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(23.4 mmol), or 23-times higher than that of its BM analog producing the same 
experimental outcome (rate) but transforming only a total of 28 mg (1.0 mmol). 
2.3.2.4 Comparison of laboratory and meta-analysis data 
The experimental data collected here on differences in average and maximum rate 
constants of PCE transformation (7.7 and 10.6, respectively) fell soundly within the range 
of values established in the literature meta-analysis (Figure 1). Discerning the inherent 
variability between batch and column experiments within the literature cited in the meta-
analysis is challenging. Reasons for this include:  (i) one or both microcosm types did not 
have a replicate [45]; (ii) replicates are not truly replicates with variation in an additional 
parameter (e.g., dissolved oxygen, temperature) [63-65]; (iii) replicate results are not 
presented [60, 61]; (iv) replicate results are presented in multiple graphs (instead of a 
single graph with error bars) [59, 61, 62, 66]; (v) replicate results are plotted together 
without discerning which replicate is which [66]. However in two studies, greater 
variability in columns data over batch data can qualitatively be discerned [59, 66], which 
agrees with the experimental results.  
 In the literature cited in the meta-analysis, the total mass of contaminant removed 
over the study duration was not included, however relevant metrics, when available, were 
extracted to estimate the total contaminant mass introduced into or pumped through the 
two microcosm systems. This number is not indicative of mass removed, but provides a 
theoretical maximum assuming complete conversion by the selected treatment. In each 
instance where estimations were possible, results showed that CMs processed greater 
total contaminant masses than the associated BMs, agreeing with the results of the 
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present study [59, 61, 62, 66]. A 2011 study showed masses of 11 mg for batch systems 
and approximately 600 to 2300 mg for the columns (range is a function of flow rate 
variation) [61]. A 2007 study had calculated masses of 2 to 12 mg for batch as compared 
to approximately 300 to 3000 mg for columns [59]. Similarly, a 2009 study had 
calculated masses for batch and columns of 0.2 mg and 75 mg, respectively. Differences 
in total contaminant mass in the cited treatability studies ranged between 10- and 106-
fold. The present study is on the lower range of this spectrum because of the 
comparatively low flow rates [62]. 
2.3.2.5 Informational value of batch and column microcosms 
 The number of data points (n) used in kinetic calculations for microcosms varied 
from 6 to 36 for columns to from 2 to 3 for batch bottles (Figure 4). Data density for BMs 
were considerably lower than for columns because of inherent design differences, where 
the number of rate constants is equivalent to the number of bottle replicates in the series. 
This method of batch rate calculation is common and few rate constants are generated, 
typically, one rate per bottle [53-55]. In CMs, each discrete sampling point produced a 
unique rate, calculated based on the delta between influent and effluent concentration; 
therefore n was determined by the number of sampling points occurring after steady-state 
was achieved. The higher number of data points generated in columns creates what 
amounts to more reliable estimates for maximum and sustained rates thus may be 
considered a better predictor of long-term in situ kinetic activity. 
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Fig. 4 - Box plots show first-order rate constants for PCE and its associated degradates in 
batch and column microcosms. Negative rate constants signify removal of the compound 
whereas positive rate constants signify compound production. Control batch microcosms 
yielded only the two data points shown here. Note: NA - Not applicable 
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2.3.3 Conceptual comparison of batch and column microcosms 
Batch bottles and continuous-flow columns are inherently different by design and 
consequently produce not only dynamically different system conditions but also variant 
kinetic results, as shown in this study and in the literature. In BMs, the system is static 
(no flow), as compared to the flow-through design of CMs; this difference is often cited 
as the reason for differences between the two microcosms [70]. We conclude that in 
addition to differences in flow regime, the closed system/finite contaminant input of the 
batch bottle versus the open system/continuous contaminant input, drives the variability. 
Open and closed system designs produce different oxidation-reduction potentials [62, 
71], particularly a highly reduced system (over time) in BMs as the finite mass of 
electron acceptors (O2, NO2
-, VOCs) are consumed in sequential, hierarchical fashion. 
This is juxtaposed to the variable reducing conditions in columns (temporally and 
spatially), which depend on influent storage and flow rate (Figure 5). With the closed 
system of BMs, the residence time is synonymous with study duration, therefore with 
analogous amendment concentrations and dechlorination ability, columns passing 
multiple pore volumes will by default encounter and remove more contaminant mass. 
 Batch and column microcosms show variation in the ability to illustrate the phases 
of contaminant removal including: lag, acceleration, steady-state and decline (Figure 5). 
In both microcosm types, the occurrence of a lag phase is visible. In BMs, the lag phase 
presents as persistent (near)-initial contaminant concentrations after study inception, and 
in CMs it is displayed as near-identical influent and effluent concentrations. Discerning 
the acceleration and steady-state phases in BMs is challenging. Typically, the decline in 
amendment concentrations as a whole is considered the acceleration phase [72, 73]. Since 
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the ratio of parent to product compounds is constantly changing in this type of system 
[74, 75], steady-state can never be attained. In contrast, the acceleration phase in CMs 
typically shows notable variability in effluent concentrations between adjacent sampling 
events. As steady-state conditions are achieved, there is a high reproducibility in the delta 
of influent and effluent concentrations during adjacent sampling periods, which can be 
observed for extended periods of weeks or months. It is important to note that performing 
batch microcosm experiments with repeated influent injections in a semi-continuous 
fashion can create steady-state conditions [76], however, this study was interested in the 
strict closed system design. The final phase, decline (end of amendment lifetime) cannot 
usually be separated from an initial degradation sequence in BMs and requires 
subsequent chemical contaminant additions to the system. In CMs however, end of 
performance is signaled as a reappearance (break-through) of the contaminant of interest 
in column effluent.  
2.3.4 Determination of amendment dosages and durability 
The literature review showed that electron donor dosages for field studies are 
often selected based on results from batch bottle studies. This may be problematic, 
however, when considering the addition of controlled-release carbon sources (CRCS). In 
BMs, the concentration of electron donors from CRCS is a function of the release rate 
and the length of the lag phase, with the latter allowing for a potential accumulation of 
donors. In CMs in which the CRCS are packed into the column (as done in this study), 
electron donor concentrations are expected to be less variable, as they cannot accumulate 
due to the continuous flushing of the column (Figure 5). With this experimental design, 
the practitioner can observe the transformation activity resulting from the processing of 
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larger volumes of fluid, which is expected to be more similar to conditions prevailing at 
the field-scale during CRCS subsurface injections. Consequently, the effectiveness and 
durability of slow-release compounds may be best assessed through the use of 
continuous-flow columns. The differences observed in dechlorination activity between 
BMs and CMs in the Treatment 1 series (and in a limited fashion in Treatment 2) may 
have been related to the above phenomenon. Due to the delay of inoculation with the 
bioaugmentation agent by one month (necessitated by the requirement of the 
bioaugmentation agent for strictly anaerobic conditions), it is reasonable to expect that 
the available concentration of electron donors derived from the CRCSs was higher in 
batch bottles than in continuous-flow systems. 
2.3.5 Understanding data inconsistencies between batch and column microcosms 
The overall faster rates observed in CMs relative to equivalent BMs are not 
surprising. From a microbiological standpoint, continuous-flow systems typically yield 
better overall performance because they result in adaptation and attainment of steady-
state conditions that favor mass removal [61, 77]. Moreover, flow through the column 
does not allow for the accumulation of waste products of microbial metabolism, which 
could decrease biodegradation performance. Additionally, a spectrum of redox conditions 
can be established in columns, with different types of microbes co-existing and co-
transforming contaminants at the same time but in different physical locations along the 
length of the column. Therefore, columns harbor a spatially expansive diversity of 
microbial consortia, all potentially contributing to successful contaminant removal [69, 
78]. In batch bottles, the same reactions occur, but they are temporally constrained rather 
than spatially contiguous [79]. 
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Fig. 5 - Illustration of temporal and spatial oxidation-reduction zonation (A), phases of 
contaminant removal (B), and electron donor distribution (C) in batch bottles and 
continuous-flow columns. Modified from McClellan, 2013 [71]. 
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2.3.6 Study limitations 
For reasons of practicality, only 30% of the total number of published articles 
captured by search engine criteria were examined in detail; therefore, the ratio of batch to 
column degradation rates derived here may differ slightly from the comprehensive, true 
value representing all studies. However, the data are normally distributed which suggests 
that extracted values from captured results constitute a representative sample of the 
entirety of data (Appendix A: Figure 23).  The selected field location was a fractured 
bedrock site and constructing representative microcosms from such materials presents a 
challenge. Here, we adopted use of crushed bedrock cores, leaving open the possibility of 
creating reactive surfaces not representative of weathered rock in place in situ. However, 
the goal of the work was to compare rates from batch bottle and column microcosms, and 
since both were constructed with the same material, no adverse impact from this 
experimental design is expected. In laboratory experiments, as is typical for long-term 
operation of column studies, prolonged storage of groundwater was necessary. Error was 
decreased by bimonthly preparation of PCE-amended influent to achieve the desired 
cVOC concentration.  
Authors focused on a comparison of observed rate constants in this study; 
alternative approaches can be envisioned, such as normalizing transformation activity by 
parameters of known importance, e.g., surface area and or biomass. Both approaches 
potentially can be of value but also are flawed by the fact that neither parameter can be 
determined with great certainty for in situ settings in the field, to which the rates 
ultimately are applied. 
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2.3.7 Applicability of study results 
Whereas many of the aspects discussed above and captured in Table 1 should be 
broadly applicable for feasibility determinations, care must be taken when extrapolating 
the results of this work to other situations, such as different redox conditions (e.g., 
aerobic conditions) and other contaminants. For cVOC removal under anoxic conditions, 
we established that BMs tend to produce a higher percentage of lighter molecular weight 
PCE byproducts relative to CMs, and that columns tend to show faster kinetics than 
batch. Thus, if only batch bottle kinetics are available, conservative rate estimates result 
that may be lower than actually attainable rates. Total mass removal in columns is greater 
than in batch systems under equivalent starting conditions, because in columns, the 
contaminants are constantly replenished by influent flow. Since CMs can attain and 
maintain steady-state conditions, they yield a higher number of data points than BMs, 
which should apply broadly beyond VOC scenarios investigated here. The conclusion 
concerning the better utility of columns for determining the dosage and durability of 
slow-release compounds also is expected to extend to other electron donors formulations 
and contaminant scenarios. In studies examining the impact of highly reducing redox 
conditions, batch bottles are the methodology of choice because maintaining such 
conditions in flow-through columns is challenging. 
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Table 1 - Characteristics of batch bottle and continuous-flow column microcosms 
Classification Parameter Batch Bottles Columns 
General 
System Design Closed Open 
Reducing 
Conditions 
Unlimited Even 
When Initially 
Aerobic 
Limited By 
Residence Time 
When Using 
Aerobic Influent 
Stream 
Groundwater Static Flow 
Contaminant 
Input 
Finite or Pulsed 
Continuous or 
Dynamic 
Contaminant 
Transformation 
Lag Phase  
(if present) 
Visible Visible 
Acceleration 
Phase 
Visible Visible 
Steady-State 
Formation 
No Yes 
Amendment 
Lifetime 
Estimate 
Limited by Lack 
of Flow 
Reflective of In 
Situ Conditions 
Contaminant 
Transformation 
Rates 
Rate Constant 
(Relative) 
Lower Higher 
Number of Data 
Points Available 
Function of 
Number of 
Replicates and 
Re-spiking Events 
Unlimited 
Sampling 
Opportunities 
During Steady-
state 
Mass Converted Total Mass Lower than CMs Higher than BMs 
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2.4 Conclusions 
Given the differences between batch bottle and continuous-flow column studies 
established herein and summarized above, it is desirable to establish guidelines for 
treatability studies. It is imperative to evaluate the behavior of both open and closed 
system treatability studies to understand how the inherent characteristics of each system 
may affect the overall capability of the amendment to be remediated within the 
subsurface. This appears to be particularly important for controlled-release carbon 
sources, whose disparate pattern of activity in batch and column studies (poorer initial 
performance in columns), suggests reliance on batch data may overestimate in situ 
dechlorination activity if electron and carbon donors are allowed to accumulate over time 
in bottles, a scenario that does not accurately mimic flow-through, real-world conditions. 
Determining both the chemical speciation and biotransformation kinetics of both 
treatability systems are equally important not only because the systems are inherently 
different, but because resultant rate data may not be initially intuitive from degree of 
speciation (e.g., higher percentage of downstream degradates does not equate to faster 
removal rates overall). One neglected parameter, total mass removed over the study 
duration, should also be included in the analysis because proper estimations of 
amendment lifetimes are important for field-scale applications to ensure costs are 
minimized, results maximized, and remediation completed in a timely manner. 
Additionally, determinations of total mass may elucidate reasons for variability between 
batch and continuous microcosms (e.g., continuous systems likely processing more 
mass). When possible, it is also important to elucidate important variables in the field to 
ensure proper experimental design (e.g., in situ analyte concentrations), and important 
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controls post-treatability study (e.g., amendment dosages, flow rates, etc.) to determine 
implications for field-scale application. Because the quality of data extracted from 
treatability studies is the foundation for remedial design associated with thousands of 
hazardous waste sites across the country, it is necessary to begin the remedial process 
with a standardized and sound scientific approach.  
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TRANSITION 2 
Comparisons between common bench-scale treatability studies, used to inform 
decisions on full-scale field remediation activities, were explored in detail in the previous 
chapter. Critical differences were highlighted, including the inherent drivers behind those 
differences and the implications of data generation and usage. Similarly to the data gaps 
between different types of treatability studies, there also exists a deficit of information 
regarding the relationship between the results of bench-scale treatability studies and those 
generated by field-scale technology implementation. A critical assessment of this 
relationship is needed to highlight areas of improvement, whether related to experimental 
design or the generation and use of data. These factors have the potential to improve a 
practitioner’s understanding of how in situ remedial activities may unfold and, therefore, 
how to improve field-scale remediation. This is especially critical for complex 
environments, including those with recalcitrant contaminants or complex geology, which 
represent a large portion of remaining hazardous waste sites in the United States.  
In Chapter 3, a treatability study was performed in the laboratory over six months, 
for a site contaminated with PCE in the form of a dense non-aqueous phase liquid 
(DNAPL). Practitioners at the site wanted to reduce cleanup times over the currently 
deployed pump-and-treat system. Results from the treatability study were subsequently 
compared to data generated over 14 months by groundwater sampling from the field site, 
where the previously tested chemical and biological amendments were injected into the 
subsurface multiple times. Groundwater samples were analyzed for chemical species 
PCE, TCE, cDCE, tDCE, 1,1-DCE, VC and ethene by gas chromatography; additionally, 
microbial parameters including Dehalococcoides (Dhc) and the functional gene encoding 
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for the vinyl chloride reductase (vcrA) were determined by quantitative polymerase chain 
reaction assays. Subsequent comparisons of speciation, reaction kinetics, microbial 
counts, and mass fluxes also were performed. 
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CHAPTER 3 
RECONCILING DATA FROM LABORATORY FEASIBILITY AND PILOT-SCALE 
IN SITU CHEMICAL AND BIOLOGICAL REDUCTION IN FRACTURED 
BEDROCK:  LESSONS LEARNED FROM PERCHLOROETHYENE-
CONTAMINATED SITE 
ABSTRACT 
Dense non-aqueous phase liquid (DNAPL) in fractured bedrock aquifers can be 
particularly challenging to remediate. Prior to in situ field-scale remedial applications, 
bench-scale laboratory testing is completed to ensure compatibility of amendments with 
site groundwater chemistry, geology, and microbiology. This study sought to evaluate the 
relationship between data from laboratory treatability studies and pilot-scale remediation 
of perchloroethylene (PCE) using in situ chemical and biological reduction of DNAPL 
source zones, with a particular focus on fractured bedrock sites. For this North American 
study location, PCE speciation in continuous-flow laboratory columns showed 62% 
ethene production by the study conclusion (195 days). In the field, multiple field 
injections showed qualitative similarities in PCE reduction to the laboratory study, with a 
general reduction of PCE to cis-1,2-dichloroethene with observed increases in vinyl 
chloride and ethene throughout the 433 day sampling campaign. First-order degradation 
rate constants observed in the lab were 0.71 ± 0.04 d-1 for the summation of chlorinated 
volatile organic compounds (cVOCs) (n = 29), while field data showed spatial and 
temporal variability with post-injection degradation rate constants from <0.01 to 0.04 d-1 
(n = 5). In the field, Dehalococcoides (Dhc) and vinyl chloride reductase (vcrA) counts 
determined by quantitative polymerase chain reaction, were 6E+7 cells L-1 (max 2E+8 
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cells L-1) (n = 8) and 8E+7 cells L-1 (max 3E+8 cells L-1) (n = 16), respectively. 
Interpretation of the study results and literature expounding similar remediation 
feasibility activities provided more broadly applicable insights and lessons learned. In 
general, quantitative variability in lab and field results at bedrock sites can be attributed 
in part to barriers in recreating in the laboratory the (i) groundwater chemistry (e.g., field 
fluctuations in redox conditions and uneven distribution of remediation agents in situ); 
and (ii) field geology (i.e., representative bedrock columns) of the remediation site. 
Generally acceptable metrics in laboratory studies do not translate well to field-scale 
applications. Possible actions aimed at improving the informational value of laboratory 
feasibility studies include an assessment of mass flux and/or mass discharge to gauge 
source strength and remedial progress. 
3.1 Introduction 
 Data from the United States Environmental Protection Agency (U.S. EPA) show 
that approximately 300,000 hazardous waste sites currently exist in the United States 
[80]. Of these sites, many are classified as complex, requiring greater than 100 years for 
successful remediation and site closure [26]. The classification of complex is often based 
on factors such as the local (hydro)geology (e.g., fractured bedrock) or the variety and 
distribution of contaminants at the site (e.g., mixed class contaminants). One of the 
largest and most pervasive contaminant classes found at hazardous waste locations are 
halogenated volatile organic compounds. Of this class PCE and trichloroethylene (TCE) 
are two of the most common chemical species based on their ubiquitous industrial 
applications and relatively low costs [26]. Remediation of sites containing these 
compounds are often complicated by the solubility and specific gravity of these chemical 
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species that allow for DNAPL formation [81]. DNAPL generally increases the total time 
necessary to obtain site closure, and consequently is an impediment to site 
redevelopment. DNAPL serves as a continuous source of contamination for upgradient 
pristine groundwater supplies, creating a continuous downgradient dissolved plume until 
DNAPL dissolution is complete. In an effort to decrease the overall remedial timeframe, 
in situ remediation of the DNAPL source may be attempted. This directed effort typically 
involves emplacement of high concentrations of amendments into the source, to increase 
transformation and dissolution of the DNAPL [82]. As with all in situ remediation design 
considerations, extensive bench-scale laboratory testing is first completed to ensure 
feasibility of the amendments with site groundwater and geologic materials. After lab-
scale validation, small-scale pilot remediation applications are implemented as a 
secondary determination of feasibility, because of the inherent variability in some 
complex sites. Limited data are available which discuss the results of laboratory studies 
with field-scale studies. Understanding how lab and field studies correlate may improve 
the ability to understand complex sites and hasten remediation efforts at decreased costs. 
The goal of this study is to compare the results of a bench-scale continuous-flow column 
treatability study to the associated field-scale amendment applications in a PCE DNAPL-
impacted fractured bedrock site. Traditional data generation and management will be 
applied to each dataset, in an effort to critically evaluate our traditional remediation 
design and testing efforts, and provide recommendations for other similar sites. 
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3.2 Materials and methods 
3.2.1 Field site  
The study site is a former aerospace manufacturing facility located in Ontario 
Canada. Currently the property and adjacent area are commercially zoned and active. The 
entire city block is bound on three sides by an active containment system (Figure 6). 
Groundwater at the location is contaminated with chlorinated solvents, principally PCE in 
DNAPL form. In situ chemical and biological reduction were proposed for the source 
zone to shorten the time required for site remediation. This site is underlain by a shallow 
fractured Ordovician limestone bedrock aquifer of the Ottawa Formation. 
3.2.2 Treatability studies 
Bedrock cores were collected following the guidelines outlined in the American 
Society for Testing and Materials (ASTM) D2113-Standard Practice for Rock Core 
Drilling and Sampling of Rock for Site Investigation from 9.5 to 10 m depth. 
Groundwater samples were collected in compliance with Ontario Regulation 154/03, as 
amended July 1, 2011, Record of the Site Condition Part XV.1 of the Environmental 
Protection Act, R.S.O. 1990, c. E.19, for preservation of VOCs. Samples were collected 
in 4 L high-density polyethylene (HDPE) sample collection bottles and stored at 4°C.  
Bedrock samples were processed by passing the material through a steel plate 
rock crusher (Badger Crusher) and disc pulverizer (UA Disc Pulverizer) (Bico Braun 
International, Burbank, CA). Bedrock fragments were sieved with ASTM standard brass 
sieves to a desired size of 0.25 mm. Uniform grain size was necessary for reproducible 
porosities and to sustain equivalent flow rates. Site groundwater was amended to PCE 
concentrations of 57 mg/L (Fisher Chemical, Waltham, MA). Microcosm treatment 
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amendments included common chemical and biological amendments, including 
microscale zero valent iron (mZVI) (Golder and Associates, Kanata, ON) with associated 
palladium acetate catalyst (TCI America, Boston, MA), emulsified vegetable oil (i.e., 
LactOil) (JRW Remediation, Lenexa, KS), and xanthan gum (Golder and Associates, 
Kanata, ON). Zero valent iron is a common reducing agent, and when combined with 
palladium catalyst, forms a galvanizing couple that increases iron corrosion and the 
overall dechlorination rate. Emulsified vegetable oil serves as an electron donor for the 
dechlorinating culture, but also provides a medium to improve dissolution and reduction 
of DNAPL. Xanthan gum was to be included in the in situ injections to produce non-
Newtonian flow of the injection slug to improve emplacement. 
Individual flow-through glass columns have a length and inside diameter of 25 cm 
and 1.2 cm, respectively, with a total void volume of 30 mL. Columns were constructed 
in an anaerobic chamber with 90% nitrogen and 10% hydrogen and sealed with Teflon® 
caps and O-rings. Each microcosm received approximately 38 g of crushed rock with 
resultant porosities of approximately 37%. Treatment columns received 1.29 g of mZVI, 
1.3 mg of palladium acetate and were initially injected with a mixture of 4% LactOil and 
0.01% xanthan gum. Columns remained in batch mode for 40 hours post-injection before 
attachment to a multi-channel ISMATEC peristaltic pump (IDEX Health and Science, 
Oak Harbor, WA) via polyvinylidene fluoride fittings and Viton 0.89 mm tubing. 
Columns were placed in upflow mode at a rate of 0.25 pore volumes per day (2.75 mL), 
for a residence time of 4 days. Influent was stored in 2 L Tedlar® bags and newly 
prepared bimonthly. Columns were stored at 20°C and covered to avoid light exposure. 
After reducing conditions were achieved, treatment columns were inoculated with 2 mL 
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of KB-1® (SiREM, Guelph, ON) on Day 29. Columns were inoculated at the base using 
a glass gas-tight luer-lock syringe. The flow rate was reduced to 1 mL/day for 4 days, 
after which 2.75 mL/day was resumed. 
A 1 mL sample was collected from each column and injected via needle into a 2 
mL glass vial with gold aluminum magnetic crimp cap and Teflon® septum (Agilent 
Technologies, Santa Clara, CA). Samples were processed immediately post-collection. 
VOC samples were analyzed using headspace Solid Phase Micro-Extraction Gas 
Chromatography (SPME-GC-2010), with an FID and AOC-5000 auto-sampler 
(Shimadzu, Columbia, MD), using a previously published method [57]. Analytes 
included: PCE, TCE, cDCE, tDCE, 1,1-DCE, VC and ethene. 
First-order observed rate constants (kOBS) for columns were calculated for each 
sampling period using the following equation: 
−𝑘𝑂𝐵𝑆 =  
ln(
𝐶
𝐶0
)
𝑡
     Eq. 4 
where, 𝐶 is effluent concentration, 𝐶0 is influent concentration, and 𝑡 is time. Advective 
mass flux into the columns was calculated using the following equation: 
𝑀𝑎𝑠𝑠 𝐹𝑙𝑢𝑥 (𝐽) =  𝐶
𝑄
𝐴
    Eq. 5 
where, 𝐶 is the influent concentration, 𝑄 is the volumetric flow rate, and 𝐴 is the column 
area. The mass discharge is the sum mass flux per day. 
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3.2.3 Field studies  
Collected groundwater samples were sent to a commercial laboratory (SiREM , 
Guelph, ON) for analysis of (chloro)ethenes including PCE, TCE, cDCE, tDCE, 1,1-
DCE, VC, ethene, total organic carbon, bromide, as well as other available electron 
donors including iron and sulfate. Environmental molecular testing (quantitative 
polymerase chain reaction) was also performed to quantify Dehalococcoides (Dhc) and 
the vinyl chloride function gene (vcrA) (SiREM , Guelph, ON). 
First-order observed rate constants (kOBS) were calculated for each well by 
performing a linear regression analysis of the concentration data, where kOBS was 
determined by the slope of the line. Rate constants were calculated for individual 
compounds and summation of cVOCs.  
Mass flux at each well location was calculated using the following equation: 
𝑀𝑎𝑠𝑠 𝐹𝑙𝑢𝑥 (𝐽) =  𝑘𝑖𝐶    Eq. 6 
where, k is the hydraulic conductivity, i is the hydraulic gradient, and C is concentration. 
Hydraulic conductivity was calculated from previous field activities at 0.0625 m d-1. 
Hydraulic gradient was 0.18 m m-1, calculated using the average of three well 
triangulations. Mass discharge is the sum of these fluxes. 
3.3 Results  
Triplicate continuous-flow treatment columns were conducted in the laboratory 
over the course of 195 days, to determine if the selected treatment technology was 
compatible with site groundwater and geological materials. In the field, two wells were 
installed, Injection Well 5 and Injection Well 6, for pilot-scale field testing of 
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amendments (Figure 6). Wells of interest varied from 11 to 12.5 m total depth. Depth to 
groundwater was approximately 3-5 m and the flow direction was to the north. Injection 
1 occurred late October 2014 and Injection 2 occurred mid-September 2015. 
Groundwater was sampled 8 times over the duration of 433 days. 
 
Fig. 6 – PCE DNAPL study site location. Inset shows site boundary, infrastructure, and 
well spacing of monitoring (MW) and injection (IW) wells. 
 
Results show dechlorination activity in continuous-flow columns reached steady-
state at approximately 100 days. Column effluent consisted of approximately 62% 
ethene, 24% vinyl chloride, with other minor contributions of cDCE, TCE, and PCE 
(Figure 7). In the field, cDCE was the prominent cVOC in each well after the first 
injection, except Injection Well 6, whose concentrations pre- and post-injection remained 
relatively stable and principally PCE. After the second injection, all well samples were 
dominantly cDCE, however VC concentrations had increased suggesting more favorable 
dechlorination activity than the previous injection. First-order observed degradation rate 
constants in the laboratory for the summation of cVOCs were 0.71 ± 0.04 d-1 (Figure 8). 
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PCE, TCE, and cDCE showed removal rates of 2.28 ± 0.50 d-1, 1.66 ± 0.27 d-1, and 0.92 
± 0.45 d-1, respectively; Vinyl chloride displayed overall increases. Field data showed 
fluctuating concentrations for the monitoring and injection wells. First-order rate 
constants for cVOC sums ranged between <0.01 d-1 to a maximum of 0.04 d-1. PCE and 
TCE showed the most consistent behavior in the well field, generally with immediate 
declines in concentrations post-injection and rate constants ranging from 0.01 to 0.14 d-1 
for PCE, and 0.01 to 0.12 d-1 for TCE. Field data for the first field injection showed 
counts of 6E+7 cells L-1 (max 2E+8 cells L-1) and 8E+7 cells L-1 (max 3E+8 cells L-1) for 
Dhc and vcrA, respectively (Figure 9). Dhc was quantified at the start of the laboratory 
treatability study only. 
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Fig. 7 - PCE and degradates (mmoles) in sampled wells and continuous-flow columns. 
Note: Newly installed wells have only one background (BKGD) value; Laboratory data 
are the average of three treatment columns. Inset shows pattern of wells in the field; 
graph order follows this general pattern. Within approximately 200 days, laboratory 
columns produced 62% ethene, while the majority of wells were dominated by cDCE 
formation. 
Figure 2. PCE and degradate concentrations (mmoles/umoles) in 
sampled wells and continuous-flow column study. Note: New wells 
only have (1) backg ound (BKGD) value; Lab da a are average of three 
continuous-flow columns. Inset shows pattern of wells in the field; 
graph order follows this pattern.  
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Fig. 8 - First-order rate plots were generated for each monitoring and injection well and 
include individual and total cVOCs. Associated observed degradation rate constants are 
enumerated in the adjacent table. Column data include only data points considered in the 
steady-state range for each column. Data from triplicate columns are differentiated by 
symbol with n = 7, 11, 11. Note: Since residence time in the column is 4 days, observed 
rate constants (k) are plotted here for columns rather than ln(C/C0) for field data. 
Observed rate constants were generally an order of magnitude greater in column systems 
that those calculated for field data. Positive sign denotes an increase in the rate, or 
production of the compound. 
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Fig. 9 – Dehalococcoides (Dhc) and reductive dehalogenase-encoding vcrA genes in 
groundwater samples. Dhc and vcrA (cells L-1) are illustrated above and below the 0 line, 
respectively. After 215 days (denoted by black stippled line) only vcrA analyses were 
conducted. NS- Not Sampled.   
 
3.4 Discussion  
Patterns of dechlorination activity were qualitatively similar between the 
laboratory treatability and field-scale applications. Laboratory columns showed a 
prevalence of ethene production (62%) and vinyl chloride (24%). Field results showed a 
general predominance of cDCE, with increasing concentrations of vinyl chloride and 
ethene with subsequent injections. The quantitative differences in PCE speciation 
between columns and field-scale injections may be related to a variety of factors 
highlighted herein. In the laboratory study, experiments were designed to determine 
anaerobic biotic and abiotic dechlorination potentiation of the system, the desired 
remediation technology. Thus measures were taken to ensure the columns remained 
anaerobic and highly-reduced throughout the study duration (e.g., columns packed in 
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anaerobic chamber, influent water sealed in Tedlar® bags). In general, field conditions 
showed an inherent degree of subsurface heterogeneity, common to a fractured bedrock 
system, which creates challenges for producing and maintaining anaerobic conditions 
[83]. Here, field data show that the in situ subsurface environment is subject to 
perturbations that likely disrupt the anaerobic, highly-reduced conditions produced by the 
organic amendment injections. Dissolved oxygen and oxidation-reduction potential 
(ORP) fluctuated throughout the study period and cannot be completely explained by 
post-injection rebound; some of this variability may be a function of high volume 
precipitation to the shallow aquifer system (Figure 10). Precipitation data points shown 
are the total accumulated precipitation of the previous 7 days [84]. Data points 
immediately preceding the sampling event are highlighted in red and numbered 1 through 
8 corresponding to the sampling period. On day 337, a high rainfall event (48.4 mm) 
preceded the sampling period and is temporally concurrent with a substantial increase in 
ORP in the system. This result suggests that subsurface infiltration may be important to 
dechlorination capabilities at the site.   
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Fig. 10 - Precipitation (mm) at study location. Each point corresponds to the average over 
the previous 7-day period. Red data points (1-8) correspond to precipitation immediately 
pre-dating groundwater sampling. ORP (bars) and DO (diamonds) correspond to each of 
the five wells. The blue shaded region corresponds to optimal ORP conditions for 
reductive dechlorination 
 
Results of the long-term estimation of shallow groundwater recharge in this Great 
Lakes Basin by the United States Geological Survey (USGS) show local recharge on 
average ranging from 20 to 30 cm y-1 [85]. The effects of increased ORP and DO in the 
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field may translate into stalling of PCE dechlorination at cDCE. In this case, laboratory 
columns would overestimate field dechlorination activities. However, less reduced 
conditions may also result in cDCE and VC oxidation and mineralization (carbon dioxide 
formation), a marked positive benefit [86]. In the latter conditions, ethene may also be 
oxidized, thus the chemical signature of successful dechlorination may be lost, giving the 
artificial appearance of less favorable field dechlorination activity. Here, ethene 
concentrations were generally found to be two orders of magnitude lower than the 
cVOCs. Low in situ ethene concentrations (0.1 ug L-1) may be indicative of much higher 
dechlorination rates, because of the muted ethene signature due to oxidation [87]. 
Theoretically, pH (as a surrogate for carbon dioxide production) may be used to discern 
this oxidative pattern, however many other species in this system have an effect on pH 
(e.g., organic acids, zero valent iron). 
In summary, results from laboratory treatability studies should be viewed as a 
best-case scenario or upper bounds of remedial success for the specified remedial action 
for which the study has been optimized. The variability that may occur in dynamic 
subsurface conditions, such as high precipitation events, should be considered. The best 
mechanism to understand these perturbations is a thorough conceptual site model and 
subsequent modeling. Modeling these events will provide a better understanding of how 
these perturbations may affect implementation of the chosen remediation strategy, 
providing insights into the lower bounds of efficacy for the strategy.  
Beside dynamic subsurface conditions, amendment distribution will also provide 
variability between laboratory and field-scale results. With subsurface injections, 
particularly in fractured bedrock, there is the possibility that amendments will not reach 
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the desired location or emplacement will be delayed, causing less effective subsurface 
dechlorination [88]. This phenomenon is not captured in laboratory studies. In the lab, 
emphasis is placed on reproducibility in porosity and flow in the column, as to not 
introduce additional independent variables that may confound the results. As a byproduct, 
amendment-contaminant interactions are optimized, and may not always reflect field 
conditions.  
Additionally, differences in laboratory and field results may also be imparted by 
column study design. Bedrock cores frequently are crushed before packaging into 
continuous-flow columns, as done in the work described here. However, intact rock cores 
may provide more realistic in situ dechlorination rates [89], as newly created mineral 
surface of crushed bedrock may exhibit surface chemistries different from in situ bedrock 
through which fluids flow. However, microcosm size and geologic material volume often 
render the use of intact rock cores an impractical option. It is important to note that 
during in situ injection of amendments, hydraulic fracturing can occur, thereby also 
exposing newly created surfaces to groundwater and amendments [90]. In these instances 
crushed rock in laboratory studies would provide a similar environment to subsurface 
conditions.  
Due to the quantitative differences in dechlorination activity in the field as 
compared to the lab, first-order degradation constants calculated from field data were an 
order of magnitude lower than those calculated in laboratory columns. The above 
discussion of higher ORP, ethene oxidation, and amendment distributions all likely 
influence this result. However, some of the variability in the kinetic results may also be 
attributed to background data for individual wells and DNAPL presence. Although 
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background data may exist to establish a baseline concentration, at some sites baseline 
concentrations may fluctuate due to seasonal variations (e.g., precipitation) or other 
variables (e.g., groundwater extraction), which can complicate calculations. When 
determining the baseline concentration necessary for kinetic analysis, a degree of error 
will exist in any dynamic system. If enough data exists from previous years, it may be 
possible to determine seasonal variations and correct for this error. However, even if a 
baseline correction is possible, unforeseen changes in the subsurface related to in situ 
injection may occur (i.e., desorption or changes in DNAPL dissolution rates), which may 
also impart variability. At this particular location, variability is conveyed by (i) changing 
background concentrations, (ii) injection wells located within the DNAPL source zone, 
and (iii) injection wells recently placed, thus having only a single background 
concentration for each. These results suggest that although rate constants are important in 
comparisons of laboratory studies, they do not appear to be as important to understanding 
the relationship between lab and field results.  
Microbial parameters illustrated a similar result. Microbial counts quantified in 
the laboratory are often used to refine degradation kinetics, particularly in competing 
studies [61, 66]. However with microbial field data, microbial counts instead are used as 
a second line of evidence for remediation success, so as to ascertain that reactions are 
microbially-mediated rather than a byproduct of other factors such as dilution or 
volatilization [91, 92]. In continuous-flow treatment columns, Dhc were quantified in 
initial inoculations but were not subsequently sampled because conditions were known to 
be optimized for this consortium in the controlled setting. In the field, sampling was 
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conducted to confirm biological reduction was occurring, and to assess in situ activity in 
this non-ideal, real-world environment.  
It is important here to restate that two of the most important parameters in 
laboratory bioremediation treatability studies, reaction kinetics and microbial counts, are 
either much less important or used for alternative purposes when evaluating field data. In 
an effort to rectify this disparity, a more suitable parameter in evaluating field remedial 
activities is mass flux. In 2010, the Interstate Technology Regulatory Council (ITRC) 
published guidelines for using mass flux and mass discharge to evaluate a contaminated 
system, particularly when DNAPL was present, where evaluation of groundwater 
concentrations alone may fall short in characterizing the system [93]. Mass flux may be 
used to (i) better understand in situ remedial technology when variations in mass and 
complex degradation cascades exist, (ii) determine the amount of DNAPL left in a system 
(assuming source volumes known), or determine feasible removal at a site. Mass flux in 
the field was variable between wells, with an average of 92 ± 39 mmoles m-2 d-1 by the 
study conclusion (Figure 11). Mass discharge ranged between 1900 and 7000 mmoles m-2 
d-1. It is important to note that the change in slope of the monitoring well mass flux 
curves after the second injection suggests mass migration from the source to receptor 
wells, highlighting injection effectiveness. By comparison, mass flux into the continuous-
flow columns was much lower, with a constant flux of 0.084 mmoles m-2 d-1. On similar 
timescales this equates to a mass discharge into the columns of approximately 36 mmoles 
m-2 d-1 by the study conclusion (Day 433). 
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Fig. 11 - Mass flux and mass discharge through individual wells. Field data show wells 
with a mass flux of 92 ± 39 mmoles m-2 d-1 by the study conclusion and mass discharge 
ranging between 1900 and 7000 mmoles m-2 d-1. Mass flux and discharge make visible 
the increase in mass removal from the DNAPL source zone into receptor wells (MW), 
particularly visible after the second injection. Columns had a significantly lower constant 
influent mass flux of 0.08 mmoles m-2 d-1 and a mass discharge of 36 mmoles m-2 d-1 (not 
shown). 
 
Mass determinations in treatability studies are rarely discussed likely because 
mass in the system is highly controlled (constant influent concentrations), the customary 
approach involves elucidating speciation and the associated kinetics, and DNAPL 
addition is rare. Although column studies were aligned with average field contaminant 
concentrations and flow rates, the disparity in mass between the field and the lab suggests 
that the importance of this parameter should be evaluated in future studies to determine if 
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this metric should be more similar. Additionally, in situ DNAPL source zone remediation 
involves mass removal by dechlorination (e.g., ethene formation) as well as enhanced 
dissolution/desorption and subsequent downstream capture in receptor wells [94]. The 
traditional column study design only assesses the ability of the amendments to transform 
aqueous concentration of cVOCs to ethene in the presence of site bedrock and 
groundwater. Previous studies have evaluated dissolution in DNAPL amended columns; 
however, this is typically not practical in commercial treatability studies [95]. Discerning 
true inhibitory effects and competitive utilization via emplacement may provide more 
realistic depiction of field activities and thus does represent a research approach of 
potential merit. 
3.4.1 Limitations  
Data interpretation was limited to data shown since full access to site conceptual 
models, including plume mass and architecture, bedrock fracture patterns, and details on 
groundwater flow were unknown. Little historic data was available for some monitoring 
wells, which may impart error to baseline conditions used in kinetic analyses. 
Additionally, a byproduct of ZVI reduction for chloroethenes is ethane. The compound 
was not monitored in bench-scales studies so field-scale results are not included here.  
3.5 Conclusion 
Challenges arise in reconciling laboratory treatability study and field-scale 
remedial data. Qualitative comparisons between the two systems may often align, 
whereas quantitative differences become evident. Many of these differences stem from 
goals of the laboratory study (e.g., testing of a specific remediation strategy under ideal 
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conditions), and the ability to achieve those conditions in an in situ dynamic system. 
Additionally, other barriers include the inability to recreate field-identical subsurface 
conditions in the lab (e.g., subsurface flow in fractured bedrock). Interestingly, two 
common metrics important to column treatability studies, i.e., reaction kinetics and 
microbial counts, are less useful in the field, and are not employed in the same manner. 
This result suggests that moving towards alternative means of evaluating field data, 
particularly mass flux and mass discharge, may prove beneficial in future studies. Of 
particular promise are approaches that align the contaminant flux in influent of lab 
studies to the baseline fluxes extant in the field. This would ensure that results obtained in 
the laboratory are more representative of the rate and extent of in situ activities. 
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TRANSITION 3 
In previous chapters, assessments of methodologies designed to improve or 
recover the health of the natural environment were performed, which illustrated the utility 
of the obtained information for assessing the success of bench-scale treatability studies 
and limitations when translating these approaches to the field-scale. The following 
chapter shifts the focus of these studies from the natural environment to more urban 
settings and exposures incurred by human populations. Wastewater-based epidemiology 
(WBE) is a methodology used to assess population health by measuring human metabolic 
excretion products in wastewater. The majority of WBE studies have focused on 
consumption behaviors, particularly those of illicit drugs. The need exists to expand 
WBE methods to include endogenous compounds; one such group of amenable 
compounds is glucocorticoids, also known as stress hormones. Chronic stress has been 
linked to the top leading causes of death in the U.S., including heart disease, and the 
economic costs of excessive stress are estimated to figure in the billions of dollars 
annually.  
In Chapter 4, a WBE study was performed on a major U.S. university campus to 
monitor two glucocorticoid hormones, cortisol and cortisone, with the goal of assessing 
changes in stress experienced by students relative to the semester schedule and to 
educational testing. Twenty-four hour, flow-weighted daily composite samples were 
collected seven consecutive days each month, including the first week of classes and 
finals week; collected samples were analyzed by LC-MS/MS. Wastewater flow data and 
population estimates were used to determine daily per-capita glucocorticoid production, 
and statistical assessments were performed to assess variability between months, days of 
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the week, and weekends. Concurrently, biomarkers of alcohol, nicotine, and caffeine 
consumption were also monitored and correlations assessed between the associated 
behaviors and glucocorticoid production. 
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CHAPTER 4 
EXPANDING WASTEWATER-BASED EPIDEMIOLOGY BY USING 
GLUCOCORTICOID HORMONES IN SEWAGE AS INDICATORS OF 
POPULATION STRESS 
ABSTRACT 
Wastewater-based epidemiology (WBE) enables monitoring of biomarkers of human 
health in wastewater, including endogenous substances such as stress hormones. We 
tracked the concentrations of two principal glucocorticoids, cortisol and cortisone, in 
wastewater by liquid chromatography tandem mass spectrometry (LC-MS/MS), to assess 
changes in physiological markers of stress in a student population (n = 60,000) 
undergoing educational testing. Daily composite samples were collected on a major U.S. 
university campus for seven consecutive days each month during the Fall 2017 academic 
semester. Results showed reproducible weekly patterns in stress hormone excretion, with 
the highest levels occurring on Mondays (149 ± 61 µg d-1 per person), and the lowest on 
Saturdays (72 ± 18 µg d-1 per person) and Sundays (71 ± 22 µg d-1 per person). 
Weekdays were significantly different from weekend trends (p = 0.05). Results also 
showed significantly higher stress levels during the beginning of the semester (August 
and September, 161 ± 42 µg d-1 per person and 122 ± 54 µg d-1 per person) as compared 
to the remaining months (p = 0.05, 0.01). A Spearman rank order statistical analysis 
showed a positive correlation between total glucocorticoids and nicotine (rs = 0.49) and 
caffeine (rs = 0.63) consumption, but not alcohol intake. Whereas hormones have been 
analyzed in wastewater before, this study constitutes the first WBE study to assess 
population stress level via determination of glucocorticoids in community wastewater. 
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4.1 Introduction 
Wastewater-based epidemiology (WBE), a sub-discipline of population 
metabolism metrology, provides near real-time information related to health status, 
lifestyle, and the behaviors of populations contributing to the sampled sewer system [7-
9]. This approach utilizes the detection in (raw) wastewater of excretion products of 
human metabolism to estimate the consumption of chemicals of concern, including illicit 
drugs [11, 96, 97], alcoholic beverages [98, 99], tobacco [100, 101], and caffeine [12, 
102]. A recent study also monitored isoprostanes as a measure of oxidative stress [103] 
and genetic biomarkers for assessing population-wide carcinogenesis [13]. Wastewater-
based epidemiology and urban metabolism metrology also have been utilized to 
determine population exposure to various contaminants of concern, such as 
antimicrobials and preservatives found in personal care products [10, 104]. A further 
expansion of the types of analytes targeted by WBE is desirable to improve our 
understanding of community health. One potential target group are glucocorticoids, a 
class of natural steroid hormones commonly referred to as stress hormones. Cortisol is 
the major glucocorticoid driving the stress response in the human body and is 
transformed to cortisone by the enzyme 11-beta-hydroxy steroid dehydrogenase (11- ß 
HSD), to moderate the stress response in the body [105]. 
Stress has been shown to affect an individual’s mood, sense of well-being, and 
overall health. Studies to quantify the economic cost of stress in the United States have 
focused solely on workplace stress. The most recent estimate of costs associated with 
stress-related job absence and staff turnover is on the order of US$430 billion (2018-
adjusted) annually for the U.S. [106]. The American Psychological Association (APA) 
63 
 
has linked chronic stress to the top six leading causes of death in the US, including heart 
disease, cancer, lung ailments, accidents, cirrhosis of the liver, and suicide, [17] creating 
a societal burden and hardship not fully captured by economic estimates.  
Clinical monitoring of stress hormones in patients’ blood serum, urine, or saliva is 
widely practiced to diagnose diseases such as adrenal insufficiency, hypercortisolism 
(Cushing syndrome), and abnormalities in 11-ß HSD production [105, 107]. With 
personal healthcare, glucocorticoids are not measured to understand an individual’s level 
of stress due to specific stimuli, or to understand the ability of an individual to mitigate 
the negative effects of perceived stressful events. However in academic research, cortisol 
and its metabolite cortisone have been measured in different demographic groups (e.g., 
sex, age, race), to determine the type and duration of stressors, and to assess 
physiological and psychological disorders [108-110]. Monitoring stress hormones is also 
used extensively to assess stress levels in wild or captive animal populations [14, 15]. 
Human studies have established glucocorticoids detectable in urine [16], saliva [111], 
hair [112, 113], and blood [114] as biomarkers informative on acute and chronic stress. 
Glucocorticoids have previously been measured in surface waters and in 
wastewater, but not for the purpose of stress assessment of human populations. Much of 
this work focused on the detection of these hormones after introduction to natural 
environments by wastewater treatment plant effluent, and the resultant environmental 
distribution and potential impacts to ecosystems [115-118]. Additional studies have 
examined the occurrence and fate of stress hormones during conventional wastewater 
treatment. Concentrations of cortisol and cortisone in wastewater ranged from non-detect 
to 100s of ng L-1 [119-121]. Measuring cortisol and cortisone for wastewater-based 
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epidemiology purposes has not been attempted to date. Only one published study is 
related to WBE, and attempted to employ detectable concentrations of cortisol as a 
variable informing an estimation of the number of individuals represented in pooled 
community wastewater [122]. Steroid hormones in sewage as indicators of human health 
status thus currently remain an untapped informational resource. 
The goal of the present study was to (i) determine the occurrence of cortisol and 
cortisone in community wastewater, and (ii) assess trends in detectable stress hormone 
levels as a function of known activities and potential social stressors on a major 
university campus in the United States. Concurrently, a determination of additional 
biomarkers was performed to estimate population size, and assess the consumption of 
common psychoactive substances, including alcohol, nicotine, and caffeine. 
4.2 Materials and Methods 
4.2.1 Chemicals and reagents 
Native and labeled glucocorticoid standards including cortisol, cortisol-d4, 
cortisone, and cortisone-d8 were purchased from Sigma-Aldrich (Sigma-Aldrich, St. 
Louis, MO). HPLC-grade methanol, acetone, and water were from Fisher Scientific 
(Thermo Fisher Scientific, Waltham, MA), and formic acid was purchased from Fluka 
Chemical Corp (Milwaukee, WI). Stock solutions of native and isotopically-labeled 
compounds were prepared in methanol and stored in glass vials with 
polytetrafluoroethylene septa at −20 °C (or 4 °C). 
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4.2.2 Study location 
 The study was conducted from August through December 2017 at a large public 
university campus in the southwestern United States. The study location has 52,000 
enrolled students, and a total campus population of approximately 60,000.  
4.2.3 Sample collection and flow measurements 
Daily composite samples were collected for 7-consequative days, by an 
Avalanche® refrigerated sampler (Teledyne ISCO, Lincoln, NE, USA), with 9 mm inner 
diameter (ID) silicon tubing for the suction line and the pump head. Collected volumes 
ranged from 50 to 100 mL for each of the two sampling locations. Prior to each aliquot 
collection, the instrument was programed to rinse the sample lines with fresh wastewater 
and to purge that water before the actual sample collection. Samples were collected in 
acid-washed 10 L glass bottles, transferred to high-density polyethylene (HDPE) bottles 
for transport, and processed on the same day to limit degradative losses. Flow was 
monitored by ISCO LaserFlow flow meters (Teledyne ISCO, Lincoln, NE, USA), located 
within each adjacent manhole. 
4.2.4 Sample processing 
Aliquots of 200 milliliter of each sample were split into equal fractions and 
extracted separately using a DionexTM AutoTraceTM 280 Solid-Phase Extraction 
Instrument (Thermo Scientific, Waltham, MA). Prior to extraction, deuterated standards 
were added to the aliquots for a final concentration of 50 µg L-1. Wastewater was not 
filtered or centrifuged prior to processing. Samples were extracted using Hydrophilic-
Lipophilic Balance (HLB) cartridges (6 cc, 150 mg, 30 um particle size) manufactured by 
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Waters (Milford, MA). Each cartridge was conditioned with 5 mL of methanol followed 
by 5 mL of water, and then extracted with 1:1 (v/v) methanol and acetone containing 
0.5% formic acid, into a final volume of 4 mL. Aliquots of the final extract were blown-
down under a gentle stream of nitrogen at ambient temperature using a Reacti-Therm TM 
Heating and Stirring Module TS-18821 (Thermo Scientific, Waltham, MA). Samples 
were reconstituted in 1+1 (v/v) methanol and water mixture for analysis by liquid 
chromatography tandem mass spectrometry (LC-MS/MS).  
4.2.5 Sample analysis 
Organic extracts of wastewater were analyzed for glucocorticoids using a 
Shimadzu 2100 high performance liquid chromatographer (HPLC), coupled to an AB 
Sciex APE 4000 triple quadrupole mass spectrometer (Applied Biosystems, Framingham, 
MA). Analytes were separated on a Symmetry C8 column (4.6 × 150 mm, 3.5 μm particle 
size) preceded by a Symmetry VanGuard Cartridge (3.9 × 5 mm, 3.5 μm particle size) 
(Waters, Milford, MA). Methanol was used as mobile phase A, and water containing 
0.1% formic acid used as mobile phase B. The injection volume was 10 μl. Details 
regarding gradient program and mass spectrometer parameters are provided in the 
supplemental information (Appendix B: Table 9, Figure 24).  
4.2.6 Quality assurance and quality control 
Reported concentrations were determined based on a 9-point standard curve, with 
concentrations ranging from 0.1 μg L-1 to 100 μg L-1; the minimum coefficient of 
determination was r2 = 0.99. Average recoveries for analytes were determined based on 
spike-recovery experiments with four replicates. Relative recoveries, calculated with data 
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from labeled standard recoveries, were 88 ± 5% for cortisol and 94 ± 5% for cortisone.  
Absolute recoveries of labeled standards cortisol-d4, and cortisone-d8 were 69 ± 4% and 
70 ± 4%, respectively. Each extraction was performed with method blanks (DI water), 
and instrument blanks (1:1 methanol and water) to enable the detection of potential 
contamination and analyte carryover in the instrument.  
Method detection limit (MDL), limit of detection (LOD), and limit of 
quantification (LOQ), were determined using methods outline here [123-125], and are 
provided in the supplemental information (Appendix B: Table 10). Precision was 
expressed as Relative Percentage Differences (RPD) and calculated using the following 
equation: 
𝑅𝑃𝐷 (%) = 𝐴𝐵𝑆 (
𝐶𝑆1 − 𝐶𝑆2
𝐶𝑆1 + 𝐶𝑆2
2 ⁄ ) 𝑥 100    Eq. 7 
where 𝐶𝑆1 and 𝐶𝑆2 are the measured concentrations in the sample and its associated 
duplicate. RPDs ranged between 0 and 20%.  
4.2.7 Data analysis  
LC-MS/MS data were acquired with Analyst 1.5 software (Applied Biosystem, 
Foster City, CA). Concentrations were calculated using the isotope-dilution method and 
were reported as a concentration (ng L-1). Concentrations of glucocorticoids were 
reported when the analyte peak height to background signal (signal-to-noise ratio) was 
greater than 3, and the concentrations were above the MDL. Measured concentrations 
were converted to mass loads (g d-1), and mass per person (µg d-1 per person) using flow 
volume and population size data. 
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Per person consumption was determined by estimating daily population estimates 
using the average population size estimate obtained from population biomarker 
monitoring and from daily wastewater volumes using the following equation: 
𝑃𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛 =
(∑ (
𝐶𝑛 ∗ 𝑄𝑇𝑜𝑡 ∗ (
MWP
MWM
) 
𝐸𝐹𝑛 ∗ 0.00125 ∗ 14.1 ∗ 0.14
 ) + ∑ (
𝐶𝑐 ∗ 𝑄𝑇𝑜𝑡∗  (
MWP
MWM
) 
𝐸𝐹𝑐 ∗ 0.3
) +  (
𝐶𝑒 ∗ 𝑄𝑇𝑜𝑡
0.0011
) + (
𝑄𝑇𝑜𝑡
189
)) 𝑛⁄  Eq. 8 
where 𝑄𝑇𝑜𝑡 is the total volumetric flow rate, 𝐶𝑛 is the measured nicotine-related analyte 
concentration, (
MWP
MWM
) is the ratio of parent to metabolite molecular weights, 𝐸𝐹𝑛 is the 
nicotine-related excretion factor (0.09, nicotine; 0.125, cotinine; 0.365 trans-3’-
hydroxycotinine) [126], 0.00125 is the nicotine absorbance factor (1.25 mg) [126], 14.1 
is the number of cigarettes smoked by the average smoker [127], 0.14 relates to Arizona’s 
percentage of smokers at 14% [128], 𝐶𝐶 is the measured caffeine-related analyte 
concentration, 𝐸𝐹𝑐 is the caffeine-related excretion factor (0.017, caffeine; 0.046, 
paraxanthine) [102], 0.3 is the average amount of caffeine consumed (in grams per 
person) in the US [129], 𝐶𝑒 is the measured concentration of enterolactone, 0.0011 is the 
average g/day enterolactone excretion of this analyte [130], 189 is the estimated liter per 
person per day for water consumption on the mixed-used campus (approximately 50 
gallons per day), and 𝑛 is the number of population size biomarkers used in the 
assessment.  
Statistical analyses, including Mann-Whitney and Spearman non-parametric tests, 
were performed using Microsoft Excel 2010. The Benjamini-Hochberg (BH) correction 
below was performed for multiple tests to control for Type I errors.  
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𝐵𝐻 =  
𝑖
𝑚
 𝑄       Eq. 9 
where 𝑖 is the rank assigned to the p-value in the array, 𝑚 is the number of comparisons, 
and 𝑄 is the false discovery rate, 0.1.   
4.3 Results and discussion 
This study sought to measure the major human stress hormone cortisol and its 
hormonally inactive counterpart cortisone in wastewater, to assess temporal changes in 
stress levels of a university campus population as a function of semester schedule and 
educational testing. Consecutive 24-h composite samples were collected Monday through 
Sunday for each month of the semester (n = 35) including the first week of classes and 
finals week. Measured concentrations determined in campus wastewater are shown in 
Figure 12.  
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Fig. 12. Wastewater-derived glucocorticoid hormone metrics. Concentrations in 
wastewater (μg L-1) (A), daily mass loading (g d-1) (B), and hormone occurrence 
normalized to per person excretion (μg d-1 per person) (C) on a major U.S. university 
campus during the Fall semester of 2017. Error bars represent minimum and maximum 
results of duplicate samples. The value of average daily production (95 μg d-1 per person) 
of both compounds in healthy individuals [131]. 
 
In the current 5-month study (n = 35), the average cortisol concentration 140 ± 40 
ng L-1, while cortisone was 160 ± 60 ng L-1. In a Spanish study of two treatment plants, 
detectable concentrations of cortisol and cortisone averaged 203 ± 67 ng L-1 and 204 ± 82 
ng L-1 [132]. In China, a study of seven WWTPs found cortisol and cortisone at 39 ± 26 
ng L-1 and 30 ± 21 ng L-1, respectively [120], and in the Netherlands, hospital wastewater 
had measured cortisol and cortisone at 275 ± 27 ng L-1 and 381 ± 44 ng L-1, respectively 
[121]. In order to interpret these concentrations as indicators of population stress, the 
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concentrations would need to be normalized to hormone mass loading per standardized 
population size per unit time. In studies that supplied wastewater treatment plant flow and 
population data for twelve treatment plants, average cortisol and cortisone were 18.6 ± 
14.1 and 15.4 ± 12.3 µg d-1 per person, respectively [119, 120, 132, 133] (Appendix B: 
Table 11).  
In this campus study, raw cortisol and cortisone concentrations displayed a 
distinct pattern of elevated levels during the earlier portion of the week, followed by a 
general decline through the remainder of the week to terminate at minimal levels on the 
weekend. Cortisone consistently occurred at higher concentrations than cortisol; a 
correlation plot exhibited a slope of 1.15 between the two compounds, with a coefficient 
of determination (R2) value of 0.89 (Figure 13). The occurrence of cortisone to cortisol in 
urine from clinical studies, suggests a 3:1 to 2:1 ratio reported for [105]. The difference 
in the observed values likely is caused by multiple factors, including the presence of 
glucocorticoids in fecal matter and potential differences in the stability of both 
glucocorticoids during passage through the sewer pipe after excretion. In the present 
study, the severity of potential in-sewer degradation was limited because the maximum 
residence time in the sewer prior to sampling was calculated to be no greater than 2 hours 
and less than one hour on average. A study of cortisol and cortisone stability in human 
urine over 24 hours at room temperature showed no significant changes [134]. However, 
urine of healthy individuals has few microorganisms, whereas domestic wastewater 
contains very high microbial counts and is in contact with active biofilms within the 
sewer system. A stability test with untreated wastewater showed cortisol experienced a 
first-order rate loss with approximately 90% loss after 2 days at room temperature [122].  
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Fig. 13. Correlation plot of cortisol and cortisone concentrations detected in 67 raw 
wastewater samples collected on a major campus of a southwestern US university (A); 
Rate loss analysis of cortisol and cortisone in wastewater at ambient temperatures (B). 
 
With the literature lacking relevant data of cortisone stability, we determined the 
stability of each in raw wastewater (Figure 13). Results from the study showed a roughly 
zero-order rate loss for both compounds. Cortisone exhibited a faster degradation rate 
than cortisol, which is in agreement with lower ratios observed in campus wastewater. 
Whereas the occurrence of glucocorticoid hormones in the stool of mammals is well 
established, literature values of cortisol and cortisone in human feces are lacking. Animal 
studies suggest an abundance of these compounds in feces of various other species [135, 
136], including chimpanzees [135, 136], one of the genetically closest species to humans.  
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Measured concentrations of glucocorticoids were converted to mass per day 
values, using total flow data captured by flow meters at each of the two sampling 
locations (Appendix B: Table 12). In-sewer mass fluxes of glucocorticoids showed a 
nearly identical pattern to that of measured concentrations, with higher mass loads extant 
on weekdays (2.3 ± 0.5 g d-1) when compared to weekends (1.3 ± 0.3 g d-1; p = 0.01). The 
maximum value occurred on the first Monday of the first week of the semester, with a 
total glucocorticoid mass of 3.6 ± 0.1 g d-1, while the minimum occurred on the Sunday 
of December, after the completion of final exams (Figure 12). The total mass of stress 
hormones measured over the duration of the study was 69 ± 0.7 g, with the daily average 
of 2.0 ± 0.8 g d-1. 
Per person daily stress was calculated by estimating the contributing population 
on the campus for each day sampled. It is important to take this information into account 
because of the inherent variability in the campus population: almost 80% of students 
commute to campus. Additionally, as a National Collegiate Athletic Association Division 
I school, the campus population is also known to vary with sporting events, particularly 
during football season. Population was estimated from a series of chemical biomarkers 
commonly used to estimate population [122, 137-140], as well as the estimated daily per-
person water usage for mixed residential [303 liters per day (80 gallons per day)] and 
commercial use [e.g., office and school; 76 liters per day (20 gallons per day)]. 
Additionally a novel biomarker, enterolactone, was also used to estimate population. This 
compound is a product of microbial gut flora during the breakdown of lignin, and the 
intraspecies excretion variability is low making it a potentially good marker for 
population. Population estimates using this compound fell soundly within the range of the 
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other proven biomarkers of interest. Of the five measured compounds used to estimate 
population, including caffeine, paraxanthine, nicotine, cotinine, trans-3’-hydroxycotinine, 
and enterolactone, only the latter five were used to estimate population (Appendix B: 
Table 13). Caffeine was not included because it was determined that population estimates 
were consistently too high (175,000 ± 54,000 individuals), well above the campus 
maximum of 60,000 based on known student enrollment, and number of employees and 
faculty. Thus, population size was calculated as an average of six population size metrics, 
the five remaining biomarkers plus the estimate derived from observed water usage.  
Per person glucocorticoid hormone levels displayed a relatively similar overall 
pattern to that apparent in the mass data; however, the differences between weekday and 
weekend glucocorticoids levels were less pronounced when population size was 
considered in the analysis, particularly for the months of October through December 
(Figure 12). The maximum per person glucocorticoid excretion occurred on a Monday in 
September (228 ± 2 µg d-1 per person), while the excretion minimum of 50 ± 0.7 µg d-1 
per person was observed on a Friday of October. Only one day in the sampling campaign 
corresponded with a significant campus event. The Saturday in October was the 
University’s annual Homecoming, with an on-campus football game. Not surprisingly, 
this Saturday showed elevated levels of total glucocorticoids compared to the traditional 
weekly pattern. Compared to the average that we calculated from literature (cortisol, 18.6 
± 14.1 µg d-1 per person; cortisone 15.4 ± 12.3 µg d-1 per person), per-person estimates 
for total glucocorticoids in this study population were higher on all days. 
Per person levels of total glucocorticoid hormones showed elevated excretion on 
Mondays (149 ± 61 µg d-1 per person), with consecutive decreases throughout the week, 
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culminating in the lowest averages on Saturdays (72 ± 18 µg d-1 per person) and Sundays 
(71 ± 22 µg d-1 per person). Weekday stress hormones were significantly higher than 
weekends (p = 0.05), as established by a Mann-Whitney non-parametric assessment with 
Benjamini-Hochberg correlation for multiple comparisons (Figure 14, Appendix B: Table 
14). Based on a monthly comparison, stress levels were highest during the first month of 
the semester, which corresponded to the first week, and showed a monthly decline in 
average glucocorticoid levels as the semester progressed. This decline was rather 
stepwise, with higher recorded per person glucocorticoid levels during August (161 ± 42 
µg d-1 per person) and September (122 ± 54 µg d-1 per person), followed by an 
approximate 35 to 55% decrease during the remaining three months. Mann-Whitney 
statistical assessments showed measured glucocorticoids in the month of August were 
significantly different from October, November, and December (p = 0.01), while 
September was significantly different from October, November and December (p = 0.05).  
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Fig. 14. Box plot summarizing glucocorticoid occurrences detected in campus 
wastewater by day of the week (A), per month (B), and during weekdays versus 
weekends (C). Plots show the 25th, 50th (median) and 75th quartiles, minimum/maximum 
error bars, mean (diamond), and all contributing data points (circles). Colors correspond 
to day of week. Results of Mann-Whitney nonparametric statistical analyses of variability 
performed with the Benjamini-Hochberg (BH) correction for multiple tests are shown 
adjacent to the corresponding box plot. Identified significant differences are shown 
within the matrices at the 95% (p = 0.05)* and 99% (p = 0.01),** confidence level, 
respectively. 
 
The daily excretion ranges in urine (reference values) of glucocorticoids for an 
individual greater than 18 years of age, is 3.5 – 45 µg d-1 per person for cortisol, and 17 – 
129 µg d-1 per person for cortisone [105]. However, laboratory research has shown that 
these ranges vary in healthy individuals, as well as those with diagnosed conditions (e.g., 
depression) [141, 142]. Additionally, reference ranges also vary by type of quantitation 
method employed, thus alternative commercial laboratories have different 24-h urinary 
reference values [143]. A Mayo Clinic report citing an LC-MS/MS study of 24-h urine 
samples, suggested a cortisol maximum of 43 to 60 45 µg d-1 per person, and a cortisone 
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maximum of 122 to 141 45 µg d-1 per person, with both values being gender dependent 
and higher in males [144]. Cortisol surpassed the cortisol 60 45 µg d-1 per person 
threshold on Monday through Thursday (August) and Monday and Tuesday (September); 
cortisone did not breach the 141 45 µg d-1 per person threshold value. Reference ranges 
provide a coarse assessment to gauge stress levels; however, it is important to remember 
that campus per person glucocorticoid measurements are average estimates applied to the 
total contributing population. Since this average is at the very high end of the reference 
value range (regardless of source), some individuals in the population will have had much 
higher glucocorticoid levels than the average value.  
To estimate an average hormone production by healthy individuals to compare 
with measured averages in wastewater, rather than the characteristic reference range, we 
turned to the literature. A study of urinary daily cortisol and cortisone measurements in 
healthy individuals (n = 60) found average values of 23 ± 8 45 µg d-1 per person and 72 ± 
22 45 µg d-1 per person for cortisol and cortisone in urine, respectively [131]. Two 
additional studies using cortisol as a single metric, agree with the above average estimate, 
20 µg/day per person (median, interquartile range [IQR] 15, 29; n = 82) [145], and 17 
µg/day (median, IQR 14, 22; n = 19, age range 18.6 - 24.9) [146]. An average production 
estimate was calculated and applied to per person results in Figure 12 for comparison.  
Results show high levels of stress associated with this campus population during 
the workweek when the bulk of classes are offered, and during the earlier months in the 
semester. The weekday/weekend trend agreed with previous studies, where populations 
with traditional work schedules (Monday through Friday) showed higher cortisol levels 
on weekdays versus weekends [147, 148]. Intuitively, it seems reasonable that at the start 
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of the academic semester, the level of stress would be higher, followed by a progressive 
decline due to acclimation to student life. Surprisingly, no increase in glucocorticoid 
levels was observed during finals week. Studies related to academic stress have found 
increases in cortisol levels in the individual, associated with exams [149-151]; however, 
no such change in glucocorticoids was measured on the campus during finals week.  
Metabolites of nicotine, caffeine, and ethanol intake, including the summation of 
cotinine and trans-3’-hydroxycotinine, paraxanthine, and ethyl sulfate were also 
measured during this period, concomitant with stress. A Spearman rank correlation 
analysis showed strong associations between the wastewater-determined per person 
excretion rate of glucocorticoids, and the excretion of caffeine (rs = 0.63) and nicotine (rs 
= 0.49), but not of alcohol (rs = 0.03) (Table 2).  
Table 2 - Spearman nonparametric statistical analysis of variability between the sum of 
concentrations of two glucocorticoid hormones measured (cortisol and cortisone) and 
individual concentrations of alcohol and two stimulants detected in campus wastewater. 
  Parameter Ethanol Nicotine Caffeine 
Ʃ 
Glucocorticoids 
 Coefficient r
s
 0.03 0.49 0.63 
z-score 1.8 2.9 4.1 
 p value 0.86 0.002 0.00005 
 
Strength of Association  
|Coefficient r
s
 Range|  
None; Very Weak  
0 - |0.09| 
Weak  
|0.10| - |0.29| 
Moderate 
|0.30| - |0.49| 
Strong 
|0.50| - |1.00| 
 
 
These correlations are not surprising because caffeine is often used as a study aid, 
and to combat tiredness and/or low energy by university students, and faculty and staff 
[127, 152, 153]. Additionally, some studies have also showed that caffeine may increase 
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cortisol production and delay its deactivation in the body [154, 155]. Nicotine was also 
strongly correlated with measured stress. This result agrees with literature where nicotine 
consumption has been shown to serve as a coping strategy by smokers experiencing 
stress [156, 157]. However, the reasons behind why individuals smoke is complex (e.g., 
habit, addiction, stimulation), which is likely why the glucocorticoid-nicotine relationship 
is less robust than caffeine. Per person alcohol consumption showed no correlation with 
per person glucocorticoid excretion rates on campus, although alcohol consumption is 
known to increase cortisol production in the body [158]. However, alcohol consumption 
is also commonly employed as a means to relax or de-stress [159], thus it is likely that 
any kind of increase in cortisol production associated with the alcohol intake itself would 
be mitigated by the therapeutic use.   
4.3.1 Limitations 
 Sampling occurred for seven consecutive days each month and was considered 
indicative of that entire month. It is possible that the reported minima, maxima and 
average values reported here would be subject to change if the sample coverage had been 
higher than 25% (1 of 4 weeks), as chosen in this study.  
There is not a universally agreed upon analyte for the purposes of estimating 
population; different studies cite the same compounds with varying levels of success. 
This study included five of the most commonly sampled population biomarkers, and 
estimated population with previously published equations [137, 138, 160]. Equation 
parameters were determined based on the larger geographic location in which the campus 
is located. As these parameters are broad estimates, they may not exactly match the actual 
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values of this campus population. To help mitigate any biases, population estimates from 
individual compounds were averaged to obtain a final population estimate for each day.  
Unlike WBE studies that monitor consumption of compounds that are consumed 
(e.g., marijuana), this study measured compounds that are produced endogenously and 
continuously by the human body. Consequently, longer-term monitoring was necessary, 
so that baselines estimates could be established, trends assessed, and perturbations 
identified. Glucocorticoid variability occurs both as a function of the stress response, and 
also due to the natural diurnal rhythm of cortisol production in the body [107]. To 
safeguard against over- or under-estimating glucocorticoid levels, aliquots of wastewater 
were collected throughout the entire day, rather than by a single “grab” sample. This 
should be considered a study strength rather than limitation, and this strategy also is 
employed in clinical settings, where it is a common practice to composite urine or blood 
samples for a 24-hour period to obtain robust estimates of daily excretion for cortisol and 
other biomarkers of interest [161].  
4.4 Conclusions 
The data presented here identify glucocorticoid monitoring in wastewater as a 
practical and promising tool for assessing population-level stress through anonymous and 
inexpensive means. As expected, the study found a rather pronounced modulation of 
glucocorticoid hormone levels over the 5-month study period. This, and the fact that 
glucocorticoid levels vary by gender, person, and over the course of the day, renders 
them interesting for studying population well-being and unreliable for the purpose of 
measuring population size. Measuring stress hormones in hair and fluids in non-human 
species is being performed extensively to assess stress levels; however, currently the only 
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human assessments occur in academic clinical research. With the largely deleterious 
impacts of stress on human health, monitoring glucocorticoids in wastewater represents a 
practical, economical and informative means of assessing stress at the community level. 
With the successes illustrated here, other endogenous compounds commonly measured in 
clinical settings, such as aldosterone (obesity-related hypertension) may also be evaluated 
for use in assessing population health via WBE approach [7].  
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TRANSITION 4 
In the previous chapter, the utility of WBE was illustrated in an assessment of 
stress levels in a student population by way of tracking wastewater-borne glucocorticoid 
hormones, specifically cortisol and cortisone. Elevated stress levels are only one of many 
health threats in this demographic group, alcohol, nicotine and caffeine consumption are 
also included. This phenomenon is well documented in self-reported data from behavioral 
science studies, indicating higher incidences of binge drinking (> 4-5 drinks per event), 
cigarette consumption, and excess caffeine consumption (> 400 mg/day), often in energy 
drinks and co-occurring with the other behaviors. Since behavioral assessments based on 
self-reporting have well documented limitations, the WBE approach represents an 
alternative and complementary way of assessing these behaviors anonymously and at a 
low-cost, while side-stepping potential risks of data bias from self-reporting.  
In Chapter 4, a WBE study was performed on a major U.S. university campus 
during the 2017-2018 academic year, with the goal of monitoring major metabolites of 
nicotine, alcohol, and caffeine consumption, including ethyl sulfate, nicotine, cotinine, 
trans-3’-hydroxycotinine, caffeine, and paraxanthine. Twenty-four hour daily composite 
samples were collected for seven consecutive days each month, at two access points on 
the campus. Samples were analyzed by LC-MS/MS, pharmacokinetic and population 
estimates used to determine daily per capita consumption for each sampled day. 
Wastewater-generated consumption estimates were compared to self-reported targeted 
demographic data, and U.S. national statistics. Trends were assessed statistically within 
and between consumption behaviors to assess short and long-term consumption 
variability.  
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CHAPTER 5 
ALCOHOL, NICOTINE, AND CAFFEINE CONSUMPTION ON A PUBLIC U.S. 
UNIVERSITY CAMPUS DETERMINED BY WASTEWATER METROLOGY 
 
ABSTRACT 
Stimulant and depressant use in at-risk subpopulations, including college students, is a 
public health concern typically assessed intermittently only via self-reporting in surveys 
of limited sample size. We employed an alternative approach of directly measuring levels 
of three psychotropic substances (alcohol, caffeine, and nicotine) and their metabolites in 
wastewater derived from a large Southwestern U.S. university campus, during the 2017-
2018 academic year. Per-capita alcohol consumption determined from ethyl sulfate levels 
in wastewater of the ‘alcohol- and smoke-free’ campus were 11.3 ± 7.5 g d-1 per person 
or 0.8 ± 0.5 drinks d-1 per person, similar to nationwide estimates from self-reporting of 
this subpopulation aged 18 - 25 years (10.1 ± 0.8 g d-1 per person or 0.7 ± 0.06 drinks d-1 
per person).Wastewater-based rates of caffeine and nicotine consumption were 
significantly lower (p = 0.05) than nationwide estimates from self-reporting (caffeine: 
114 ± 49 vs. 178 ± 19 mg d-1 per person; nicotine: 627 ± 219 vs. 927 ± 243 µg d-1 per 
person). Positive correlations were found for consumption of alcohol and nicotine 
(Spearman rs: 0.71), nicotine and caffeine (0.59) and, more loosely associated, alcohol 
and caffeine (0.17). Alcohol and nicotine consumption were significantly higher on 
weekends over weekdays (p < 0.0001, p = 0.01), while caffeine consumption was higher 
during the week (p = 0.05). Between academic semesters, consumption patterns 
decreased for caffeine and nicotine consumption, and remained the same for alcohol. This 
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first U.S. wastewater-based epidemiology study on alcohol, caffeine and nicotine use 
among American college students demonstrated the feasibility and practicability of 
longitudinally tracking the behavior of an entire campus population of some 60,000 
students directly, repeatedly, and inexpensively, when compared to traditional surveys 
that rely on memory, limited sample size, and geospatial extrapolation of survey results 
to locales of interest. 
5.1 Introduction 
Alcohol, caffeine, and nicotine are commonly consumed psychotropic substances, 
exhibiting varying levels of addictiveness while lacking the social stigma associated with 
consumption of illicit drugs. Excess alcohol consumption is estimated to lead to 88,000 
deaths y-1 in the U.S. [162], with alcohol abuse costs (2018-adjusted) of US$289 billion 
annually [163]. Deaths related to nicotine consumption are predominately associated with 
cigarette consumption, including those from secondhand smoke, reach approximately 
480,000 deaths annually [164]. Costs from lost productivity and health impacts of 
tobacco consumption range between $317.5 and $354 B annually [165]. Comparable 
economic data on the impact of caffeine consumption are currently unavailable, however 
to date, caffeine-related deaths are estimated at 92 individuals [166]. 
Consumption of legal compounds is generally assessed by self-reporting in 
behavioral studies, medical questionnaires, through clinical identification, or 
interpretation of consumer spending data. Unfortunately, these data sources may be 
subject to biases, incomplete coverage, delays, and frequently are lacking for 
demographically and geographically distinct subpopulations and settings. Wastewater-
based epidemiology (WBE) is a complimentary approach of data gathering, whereby 
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consumption patterns are determined by measuring human biomarkers in sewage. Data 
can be collected and interpreted in near real-time and are population specific. Alcohol 
consumption is commonly assessed by the ethanol metabolite ethyl sulfate (EtS), with 
some studies including the less stable ethyl glucuronide [167, 168]. Nicotine 
consumption is commonly monitored with the parent compound as well as the two major 
metabolites, cotinine (COT) and trans-3’-hydroxycotinine (3-OH-COT) [169]. The minor 
metabolite 3-OH-COT is formed directly from COT rather than nicotine (NIC), and the 
relationship between the metabolites is an indicator of nicotine metabolism [170]. 
Caffeine consumption is assessed from caffeine, and one or more of the following 
metabolites including: paraxanthine, 7-methylxanthine, 1-methylxanthine, 1-methyluric 
acid, and/or 1,7-dimethyluric acid [160]. 
WBE has been used extensively in Europe to monitor alcohol, nicotine and 
caffeine consumption, as well as in China, Vietnam, Canada and Australia [98, 160, 169, 
171-173]. By comparison, use of WBE in the U.S. is still in its infancy, with a notable 
lack of information on baseline concentrations of parental stimulants and metabolites 
interpreted in the context of the local geographic and demographic setting and health 
challenges faced by local communities.  
An optimal demographic for WBE are institutions of higher education. Self-
reported alcohol consumption for college students collected by the Substance Abuse and 
Mental Health Services Administration (SAMHSA) in 2016 (n = 3,544) showed 57.2% 
of students consumed alcohol in the past month, with 38% reporting binge drinking (4 - 5 
drinks per event), and 10.5% reporting heavy alcohol use (binge drinking > 5 days per 
month) [174]. This study also reported that 21.1% of students consumed tobacco 
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products, predominantly cigarettes. More recently, nicotine consumption by vaporizers 
has increased, which has shown to carry less stigma than cigarette smoking and allows 
consumption in smoking-prohibited areas (e.g., smoke-free campuses, although often not 
permitted in these settings) [175]. Currently there are concerns about vaporizer use being 
a gateway to new or increased cigarette consumption. 
Caffeine is the most highly consumed of the psychotropic compounds evaluated 
in this study, with 85% of the U.S. population reporting daily consumption [176]. In the 
college student population, there is concern of overuse (> 400 mg caffeine per day FDA 
recommendation), particularly because of the increased popularity of energy drinks (75 to 
174 mg caffeine per serving) [177]. Additionally, self-reporting by college students 
showed that 25% of respondents reported consuming ≥ 3 energy drinks when mixing 
with alcohol (at a single event) [178]. Mixing caffeine with alcohol, masks the depressant 
effects of the latter, leading to increased alcohol consumption and the risk of alcohol-
attributed injury or death [179, 180].  
The goal of the present study was to (i) measure indicators of alcohol, caffeine, 
nicotine consumption directly in wastewater of an entire university campus population, 
(ii) compare per-capita consumption determined in wastewater to published self-reported 
data from the target demographic as well as U.S. national consumption averages, and (iii) 
assess consumption variability between months, days of the week, and semesters to 
identify patterns.   
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5.2 Materials and methods 
5.2.1 Chemicals and reagents 
Standards of ethyl sulfate (EtS) and sodium ethyl sulfate-d5 (EtS-d5) were 
purchased from Toronto Research Chemicals (Toronto, ON, Canada). Nicotine (NIC), 
cotinine (COT), trans-3’-hydroxycotinine (3-OH-COT), caffeine (CAF), paraxanthine 
(PAR), isotopically-labeled cotinine-d3 (COT-d3) and 
13C3-Caffeine (
13C3-CAF), were 
purchased from Sigma-Aldrich (St. Louis, MO). LC-MS (liquid chromatography-mass 
spectrometry) grade methanol, acetone, and water were purchased from Fisher Scientific 
(Thermo Fisher Scientific, Waltham, MA); formic acid was purchased from Fluka 
Chemical Corp (Milwaukee, WI). Stock solutions of native and isotopically-labeled 
compounds were prepared in methanol, except EtS and EtS-d5 which were prepared in 
water. Stock solutions were stored in glass vials with polytetrafluoroethylene septa at −20 
°C, except aqueous stock solutions which were stored at the 4°C. 
5.2.2 Study location 
 The study was conducted at an undisclosed public university (population 60,000) 
in the United States during the 2017 - 2018 academic year (August 2017 to May 2018). 
Wastewater exiting the campus was captured at two collection points (i.e., North, South), 
with relative wastewater volumes of >95%, and <5%, respectively.  
5.2.3 Sample collection and flow measurements 
 Each sample location was equipped with an Avalanche® refrigerated sampler 
(Teledyne ISCO, Lincoln, NE, USA), with 9 mm inner diameter (ID) silicon tubing on 
the pump head and suction line. Flow was monitored by an ISCO LaserFlow Flow meters 
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(Teledyne ISCO, Lincoln, NE, USA), located within each adjacent manhole. Flow-
weighted daily composite samples were collected at each sampling location for 7-
consequative days each month, with aliquot volumes ranging from 50 to 100 mL. Prior to 
each collection, the instrument was programmed to wash and purge the suction line 
before collection. Composite samples were collected in acid-washed glass bottles, 
transferred to high-density polyethylene (HDPE) sample bottles for transport and storage. 
Samples were processed same day to limit degradative losses.  
5.2.4 Sample processing 
 Two-hundred milliliter aliquots of wastewater sample (raw) were spiked with 20 
ng of COT-d3 and 
13C3-CAF, and extracted separately using a Dionex
TM AutoTraceTM 
280 Solid-Phase Extraction Instrument (Thermo Scientific, Waltham, MA) with 
Hydrophilic-Lipophilic Balance (HLB) cartridges (6 cc, 150 mg, 30 um particle size) 
manufactured be Waters (Milford, MA). Cartridges were conditioned with 5 mL of 
methanol, then 5 mL of water, and after loading, were rinsed with 5 mL of water, and 
dried with nitrogen for 10 minutes. Target analytes were extracted with 1:1 (v/v) 
methanol and acetone containing 0.5% formic acid, into a final volume of 4 mL. Finally, 
200 µL of the final extract was blown-down under a gentle stream of nitrogen at ambient 
temperature using a Reacti-Therm TM Heating and Stirring Module TS-18821 (Thermo 
Scientific, Waltham, MA), and reconstituted in 1+1 (v/v) methanol and water mixture for 
analysis. For EtS, 10 mL of raw wastewater was centrifuged at 4,000 g for 10 min 
(Eppendorf Centrifuge 5810 R, Hamburg, Germany). To 500 µL of the supernatant, 490 
µL of water and 1 ng of EtS-d5 were added. Analyses were performed by liquid 
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chromatography tandem mass spectrometry (LC-MS/MS); each sample was prepared and 
analyzed in duplicate.  
5.2.5 Sample analysis 
Wastewater extracts were analyzed using a Shimadzu 2100 high performance 
liquid chromatographer (HPLC), coupled to an AB Sciex APE 4000 triple quadrupole 
mass spectrometer (Applied Biosystems, Framingham, MA). Analytes were separated on 
a Symmetry C8 column (4.6 × 150 mm, 3.5 μm particle size) preceded by a Symmetry 
VanGuard Cartridge (3.9 × 5 mm, 3.5 μm particle size) (Waters, Milford, MA). Methanol 
was used as mobile phase A and water containing 0.1% formic acid used as mobile phase 
B (0.2% formic acid for EtS). Detailed analytical method information is provided in 
supplemental information (Appendix C: Table 15). 
5.2.6 Quality assurance/quality control 
 Reported concentrations were determined based on a 7-point (minimum) standard 
curve, with a minimum coefficient of determination was r2 = 0.99. Average recoveries for 
analytes were determined based on spike-recovery experiments. Relative recoveries 
ranged from 73% to 109%. Each extraction was performed with method blanks 
(deionized water), and instrument blanks (1:1 methanol and water) to enable the detection 
of potential contamination and analyte carryover in the instrument. Method detection 
limits (MDL) were determined using methods outline here [123], and are provided in the 
supplemental information (Appendix C: Table 16). Precision was expressed as Relative 
Percentage Differences (RPD) and calculated using the following equation: 
𝑅𝑃𝐷 (%) = 𝐴𝐵𝑆 (
𝐶𝑆1 − 𝐶𝑆2
𝐶𝑆1 + 𝐶𝑆2
2 ⁄ ) 𝑥 100    Eq. 10 
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where 𝐶𝑆1 and 𝐶𝑆2 are the measured concentrations in the sample and its associated 
duplicate. 
5.2.7 Data analysis 
LC-MS/MS data were acquired with Analyst 1.5 software (Applied Biosystem, 
Foster City, CA). Concentrations were calculated using the isotope-dilution method when 
analyte peak signal-to-noise ratio was greater than 3, and the concentrations were above 
the MDL. Per capita daily Alcohol Consumption (AC) was calculated using the following 
equation: 
𝐴𝐶 =
𝐶𝐸𝑡𝑆 ∗  𝑄𝑇𝑜𝑡 ∗ (
𝑀𝑊𝐸𝑡𝑂𝐻
𝑀𝑊𝐸𝑡𝑆
) 
𝐸𝐹𝐸𝑡𝑆 ∗ 𝑃𝑜𝑝 
      Eq. 11 
where 𝐶𝐸𝑡𝑆 is the measured ethyl sulfate concentration, 𝑄𝑇𝑜𝑡 is the total daily volumetric 
flow rate, 
𝑀𝑊𝐸𝑡𝑂𝐻
𝑀𝑊𝐸𝑡𝑆
 is the ratio of molecular weights of the parent [ethanol (EtOH)] and 
metabolite (EtS), 𝐸𝐹𝐸𝑡𝑆 is the excretion factor of ethyl sulfate (0.012%) [98, 99, 181], and 
𝑃𝑜𝑝 is the estimated population (Eq. 14). Daily Nicotine Consumption (NC) was 
calculated using the following equation: 
𝑁𝐶 =
(𝐶𝐶𝑂𝑇+𝐶3–𝑂𝐻–𝐶𝑂𝑇) ∗ 𝑄𝑇𝑜𝑡∗  𝐶𝐹𝑁𝐼𝐶 
𝑃𝑜𝑝
     Eq. 12 
where CCOT and C3–OH–COT are the measured concentrations of COT and 3-OH-COT, and 
𝐶𝐹𝑁 is the correction factor 1.35 (74% excretion, weight-basis) [101]. Daily Caffeine 
Consumption was calculated using the equation: 
𝐶𝐶 =  
𝐶𝑃𝐴𝑅 ∗ 𝑄𝑇𝑜𝑡∗  (
𝑀𝑊𝐶𝐴𝐹
𝑀𝑊𝑃𝐴𝑅
)  
𝐸𝐹𝑐 ∗ 𝑃𝑜𝑝
    Eq. 13 
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where 𝐶𝑃𝐴𝑅 is the measured paraxanthine concentration, 
𝑀𝑊𝐶𝐴𝐹
𝑀𝑊𝑃𝐴𝑅
 is the ratio of molecular 
weights of the parent (CAF) and metabolite (PAR), and 𝐸𝐹𝑃𝐴𝑅 is excretion factor of 
paraxanthine (4.6%) [102]. 
Per-person consumption was determined by estimating daily population using the 
average population size indicated by sewage-borne population biomarkers and by daily 
wastewater volumes using the following equation: 
𝑃𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛 = (
𝐶𝐻𝐼𝐴𝐴 ∗ 𝑄𝑇𝑜𝑡
𝐸𝐹𝐻𝐼𝐴𝐴
+
𝐶𝐸𝑁𝑇 ∗ 𝑄𝑇𝑜𝑡
𝐸𝐹𝐸𝑁𝑇
+
𝑄𝑇𝑜𝑡
189
) 𝑛⁄    Eq. 14 
where 𝐶𝐻𝐼𝐴𝐴 is the measured concentration of 5-Hydroxyindoleacetic acid (5-HIAA), 
𝐸𝐹𝐻𝐼𝐴𝐴 is 4.16 mg/day per capita excretion [122], 𝐶𝑒 is the measured concentration of 
enterolactone, 𝐸𝐹𝐸𝑁𝑇 1.1 is the average mg/day enterolactone excretion [130], 189 is the 
estimated liter per person per day for water consumption on the mixed-used campus 
(approximately 50 gallons per day), and 𝑛 is the number of population size biomarkers 
used in the assessment.  
Statistical assessments were performed using Mann-Whitney U-Tests for inter-
species variability. A Benjamini-Hochberg (BH) correction factor was applied with a 
false discovery rate of 0.1 to avoid false positives with replicate comparisons. Spearman 
rank-order correlations were performed to assess correlations between nicotine, caffeine, 
and alcohol consumption.  
5.3 Results and discussion 
This study sought to employ WBE to assess alcohol, caffeine, and nicotine 
consumption on a university campus to provide an alternative and comparative metric to 
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surveys from behavioral studies that targeted the college-age demographic. Daily 
composite wastewater samples were collected for seven consecutive days (Monday 
through Sunday) during each month of the semester, from August 2017 through May 
2018 (n = 70). Measured concentrations in campus wastewater from the north and south 
sample points are shown in Appendix C: Figure 25. Excretion profiles of selected 
analytes are shown in Figure 15, with half-lives ranging from 3.1 h to 16 h.  
 
 
Fig. 15. Excretion profiles of analytes of interest for alcohol, caffeine, and nicotine 
consumption. Half-lives of these compounds include 3.3 h [Ethyl Sulfate (EtS) 32 g], 4.7 
h (EtS 64 g), 4.1 h [Caffeine (CAF)], 3.1h [Paraxanthine (PAR)], 2 h [Nicotine (NIC)], 
16 h [Cotinine (COT)], and 5.5 h trans-3’-hydroxycotinine (3-OH-COT)]. EtS shows 
corresponding dose of alcohol consumed. [126, 182-184]. Excretion profiles follow zero- 
and first-order kinetics [185-187] 
 
Concentrations of EtS, PAR, COT, and 3-OH-COT were converted to daily mass 
loads using total flow data captured by flow meters at each of the two sampling locations 
(Appendix C: Table 17). Only metabolite data were used in consumption assessments due 
to suspected non-excretion inputs into wastewater (Appendix C: Figure 26). Mass loads 
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of EtS were higher on weekends (130 ± 39 g d-1) compared to weekdays (68 ± 19 g d-1, p 
< 0.00001), with maximums occurring on the day of the annual homecoming football 
game in October (Saturday, 233 ± 1.4 g d-1) and St. Patrick’s Day (Saturday, 124 ± 6.3 g 
d-1; Figure 16). An opposing trend was observed for PAR, with elevated mass loads on 
weekdays (3.4 ± 1.3 kg d-1) over weekends (1.8 ± 0.4 kg d-1, p < 0.00001). The highest 
loading occurred during the Monday of October (7.3 ± 0.004 kg d-1), but higher masses 
were also recorded during various weekdays in September, October, and February. COT 
and 3-OH-COT showed variable patterns through the academic year, with some months 
showing a decline in weekend loads (e.g., October), while others did not change between 
weekdays and weekends (e.g., January).  
Per-person consumption of alcohol, caffeine, and nicotine were estimated using 
the measured metabolite concentrations, combined with previously published 
pharmacokinetic excretion factors. Population estimates were generated using the 
biomarkers 5-HIAA (major metabolite of serotonin), ENT (byproduct of lignin 
breakdown in gut), and estimated daily per-person water usage for the campus (189 liters 
per day per person) (Appendix C: Table 18). Alcohol, nicotine, and caffeine consumption 
for the entire academic year illustrated a similar trend for all analytes, where consumption 
was elevated at the start and end of the academic year, with a mid-year trough (Figure 
16). 
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Fig. 16. Daily mass loading of ethyl sulfate (EtS) (g d-1) (A), paraxanthine (PAR) (kg d-1) 
(B), cotinine (COT) and trans-3’-hydroxycotinine (3-OH-COT) (g d-1) (C) on a major 
U.S. university campus during the 2017-2018 academic year. The corresponding bars for 
each month include Monday through Sunday mass loads. Error bars represent the 
minimum and maximum results of duplicate samples.  
 
 
Per-capita consumption of alcohol displayed a pattern similar to EtS daily mass 
loads, however, weekday/weekend differences were more prominent (p < 0.00001) 
because of the weekend decrease in campus population. Highest per-person consumption 
remained the Saturday of the university’s annual homecoming football game (41 ± 0.2 g 
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d-1), which also coincided with the Saturday immediately preceding Halloween. 
Consumption here was 1.5-times higher than any other day of the academic year and 
equated to 3 drinks per person per day. A standard drink is defined as 14 g of pure 
ethanol or more generally, 355 mL of beer (5% alcohol by volume), 148 mL of wine 
(12%), or 15 mL of distilled spirits alcohol (40%) [188]. Targeted demographic data of 
alcohol consumption from multiple studies that monitored alcohol consumption over the 
academic year showed average consumption at 10.1 ± 0.8 g d-1  per person (0.7 ± 0.1 
drinks d-1 per person) [189-191]. The annual consumption average in this study was 
similar at 11.3 ± 7.5 g d-1 per person (0.8 ± 0.5 drinks d-1 per person). For 6 of the 10 
months of monitoring, the monthly per-person average for alcohol consumption obtained 
in this study was at or below literature values. A comparison to the U.S. national average 
(19 g d-1, 1.4 drinks per day per person) [192], proved higher than the targeted 
demographic data estimated from wastewater and from survey-based data. The campus 
population only surpassed this US national average on 10 sampled days during the 
academic year, all of which occurred on a Saturday or Sunday. Statistically, the month of 
August had the highest average consumption (17.4 ± 5.2 g d-1), and was statistically 
different from November (p = 0.05), December, February and April (p = 0.01) (Figure 
17). Over the entire academic year, there was no evidence of increased alcohol 
consumption in campus wastewater as the fall (1st) and spring (2nd) semesters were not 
significantly different. These results agree with available demographic survey data [189, 
190, 193]. 
96 
 
 
Fig. 17. Box plot summarizing per capita alcohol (A), caffeine (B), and nicotine (C) 
consumption in campus wastewater during the academic year, organized by month and 
day. Plots show the 25th, 50th (median) and 75th quartiles, minimum/maximum error bars, 
mean (diamond), and all contributing data points (circles). U.S. college student average 
per capita consumption are illustrated by lines 2, 4, and 5, standard errors shown in color. 
U.S. per capita consumption is included for alcohol (1) and caffeine (3). U.S. per capita 
nicotine consumption (not shown) is 4,147 µg d-1 per person. 
 
Per-person caffeine consumption also displayed a similar pattern to daily mass 
loads, however, weekday/weekend differences were dampened when population was 
included in the analysis (p = 0.05). Monthly comparisons show elevated levels of caffeine 
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consumption in October, driven by surging weekday consumption, which were the five 
highest consumption days of the entire year (243 ± 22.4 mg d-1). Complimentary student-
specific caffeine consumption data showed an average annual consumption at 196 ± 19 
mg d-1  per person [194, 195], whereas in this study the average was lower at 114 ± 49 mg 
d-1  per person. The majority of daily campus consumption estimates were roughly 
comparable to the average amount of caffeine found in standard 150 mL home-brewed 
coffee (100 mg) [196]. The first and last months of the academic year (August, May), and 
October were found to be significantly different from December and January (p = 0.01). 
There were no statistical differences between days of the week, however the fall semester 
was significantly higher than the spring semester (p = 0.05) (Figure 17). During no point 
of the academic year did the per-person caffeine consumption average surpass the Food 
and Drug Administration (FDA) U.S. average caffeine intake estimate of 300 mg d-1  
[129] or the recommended threshold value of 400 mg caffeine d-1  [197].  
Per-capita nicotine consumption showed a more pronounced pattern of elevated 
weekend consumption than mass loads (Figure 16), with weekends being statistically 
higher (p = 0.01). The highest consumption occurred during the first month of the 
semester (970 ± 109 µg d-1 per person), which was significantly different from all other 
months except September, April, and May (p = 0.01) (Figure 18). This highest 
consumption occurred on the Saturday in August, with a per-capita estimate at 1205 ± 44 
µg d-1 per person, equivalent to 1 standard cigarette per day per person. Targeted 
demographic survey data from published sources show average nicotine consumption at 
927 ± 243 µg d-1 per person [198, 199]. In this wastewater study, nicotine consumption 
was only 627 ± 219 µg d-1 per person. The lower estimate here is in agreement with a 
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2017 campus survey study that found only 10% of students smoke, lower than the other 
published studies of campus nicotine consumption [200, 201]. The U.S. estimate of 
average per capita nicotine consumption can be expressed as approximately 3.3 cigarettes 
per day per person or 4147 µg d-1 per person [202], assuming 1.25 mg nicotine 
absorbance form a standard US cigarette [126]. Consumption patterns on the campus 
were well below this value. Comparisons between days of the week, showed no statistical 
difference, however the fall semester was significantly higher than the spring semester (p 
= 0.05), driven by August consumption. 
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Fig. 18. Correlation plots showing results of statistical comparisons of alcohol, caffeine, 
and nicotine consumption between months, days of the week, weekday/weekend, and 
semesters. Colors denote statistical significance.  
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A Spearman rank correlation analysis was performed to assess the relationship 
between these three consumption behaviors. Strong correlations were found between 
alcohol and nicotine consumption (rs = 0.71, p < 0.0001), and nicotine and caffeine 
consumption (rs = 0.59, p = 0.001), and a weak correlation between alcohol and caffeine 
(rs = 0.17). Co-occurrence of alcohol and nicotine is well documented, with studies citing 
increases in the number of cigarettes smoked by a smoker when alcohol is being 
consumed [203, 204]. Additionally a subset of the college-age population is reported to 
only consume nicotine during alcoholic beverage consumption [205]. This co-occurrence 
is largely driven by pleasure-seeking and reportedly increased the craving for each [206]. 
Similarly, the relationship between nicotine and caffeine has also been shown to co-
occur, with caffeine used to enhance the effects of the nicotine [207]. Consequently, 
nicotine consumers have been shown to have higher daily caffeine consumption than 
those who abstain [208]. In this study, only a weak correlation was observed between the 
consumption of alcohol and caffeine. However, recent literature on caffeine consumption 
in college students has specifically focused on the increasing trends of energy drink and 
alcohol consumption. Studies have found a correlation between daily energy drink intake 
and increased alcohol consumption, and reported that co-consumption increased the total 
quantity of alcohol ingested during an episode [179, 209-211]. Since this co-occurring 
behavior is a small percentage of the total caffeine consumption pattern [194], the 
correlation may not be visible in the wastewater assessment.     
5.3.1 Limitations 
The measured signal in wastewater is not only dependent on the duration and 
quantity of the consumption behavior studied, but also on the excretion half-life profiles 
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of the measured analyte and on the timing of campus attendance. The interplay between 
these variables drives the measured signal and becomes particularly important during 
weekend consumption by the non-resident population, and afternoon/evenings 
consumption of this non-resident demographic, when excretion rates are fast. Single 
excretion factors were used to back-calculate alcohol, nicotine, and caffeine consumption 
in the population, however individual demographics and behaviors will vary excretion 
rates for a specific individual. Selected excretion factors fell within accepted ranges and 
were previously used in WBE studies.  
Comparisons between wastewater data generated here and complimentary 
datasets were limited largely due to the lack of granularity in the self-reported data. Often 
data were presented as consumption ranges, which were not directly amendable to direct 
comparisons. Data dense self-reported studies (e.g., diary studies) that are best for 
comparison to WBE studies, are infrequent, as these are highly cost prohibitive. 
Wastewater sampling here occurred for seven consecutive days each month and was 
considered indicative of that entire month. Reported values may change if sample 
coverage was > 25%, particularly if winter or spring breaks were included in the analysis.  
Analyte losses during travel time in the sewer pipes were not accounted for in this 
study. Previously stability studies have shown that these compounds are relatively stable 
in wastewater [138, 212]. Here, in-pipe travel times were on average 50 min, shorter than 
most published studies. However, any degradative losses in wastewater-derived estimates 
would be systematic, and would not affect trends in the data. Additionally, there are no 
universally agreed upon analytes to assess population numbers in WBE. Many of the 
common compounds used in the field are related to nicotine and caffeine consumption, 
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which could not be included here. Therefore, fewer markers were used in this study, 
however the selected analytes showed previous success, and required fewer assumptions 
in the estimate equations.  
5.4 Conclusions 
This study is the first in the U.S. to assess alcohol, caffeine, nicotine consumption 
by WBE, on a university campus for the entire academic year and demonstrates the 
feasibility of longitudinally tracking the consumption behaviors of an entire university 
campus of a population of 60,000 students. Traditional surveys are generally much more 
limited in sample size. The published self-reported university studies cited herein for 
comparisons, surveyed approximately 1,000 people each. Larger governmental surveys 
like those conducted by the Substance Abuse and Mental Health Services Administration, 
sampled approximately 3,500 college students to determine alcohol and caffeine 
consumption patterns for the nation [174], while the Bureau of Labor Statistics consumer 
expenditure surveys sample 12,000 households per quarter [213]. Estimates of survey 
costs range from $0.50 to $4.50 per completely answered questionnaire (depending on 
dissemination method) [214]. WBE surpasses the sample size of traditional self-reported 
data collection methodologies, and at a fraction of the cost associated with those studies.  
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TRANSITION 5 
In previous chapters, steroid hormones and common licit substances were 
monitored in a student population of a major U.S. university campus, to assess population 
health and consumption patterns throughout the academic year. These studies illustrated 
the utility in these assessments for directly measuring population stress via glucocorticoid 
hormones; an interesting result was that this particularly academic population apparently 
did not indulge in overconsumption of licit drugs, reported in complementary studies of 
this age group.  
As wastewater-based epidemiology studies become increasingly more common 
for use in population health assessments, an evaluation of frequently employed WBE 
methodologies is warranted to continuously improve the robustness of data collected on 
health metrics. Wastewater sampling methodologies are one such component of the 
methodology requiring scrutiny and optimization, as errors imparted in sampling 
techniques implemented upstream will propagated through to the final estimates of per-
capita consumption. Wastewater sampling methodologies traditionally employ high 
frequency discrete samplers to collect aliquots of wastewater at intervals defined by a 
time- or flow- regime. With these sampling methods, there have been concerns regarding 
the potential to miss pulses of analytes in the sewer system.  
In Chapter 5, two different sampling strategies, a low-flow, near-continuous 
active sampler and a traditional, commercially available time-weighted discrete sampler, 
were deployed at a wastewater treatment plant. The samplers were programmed to 
collected daily composite influent samples over the course of 7 consecutive days. 
Analytes of interest measured by LC-MS/MS included the following opioids, opioid 
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antagonists, stimulants and one benzodiazepine anxiolytic (parent/ metabolite): 
morphine/ morphine-3-glucuronide, oxycodone/ noroxycodone, codeine/ norcodeine, 
heroin/ 6-acetylmorphine, fentanyl/ norfentanyl, methadone/ 2-ethylidene-1,5-dimethyl-
3,3-diphenylpyrrolidine, buprenorphine/ norbuprenorphine, methamphetamine, cocaine/ 
benzoylecgonine, 3,4-methylenedioxy-methamphetamine (MDMA), amphetamine 
(Adderall), methylphenidate (Ritalin), and alprazolam/ alpha-hydroxyalprazolam 
(Xanax). Additionally, ethyl sulfate, nicotine, cotinine, trans-3’-hydroxycotinine, 
caffeine, and paraxanthine were also monitored. Analyte mass loads were compared and 
statistically assessed for comparison of the two distinct sampler types. Consumption 
behaviors were estimated using pharmacokinetic and population data. A modeling study 
also was performed to illustrate how static and dynamic events in analyte concentrations 
are recorded differently by each type of sampler used.  
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CHAPTER 6 
IN SITU ACTIVE SAMPLING TO DETERMINE COMMUNITY EXPOSURE USING 
WASTEWATER METROLOGY 
 
ABSTRACT 
Accurately assessing community health by wastewater-based epidemiology requires the 
acquisition of representative samples and a preservation of the biomarkers contained 
therein. Traditional discrete liquid capture methods may fail to capture pulse loads of 
biomarkers in wastewater, potentially underestimating consumption. This study 
compared the capture of wastewater-borne biomarkers of licit and illicit drug 
consumption using two different devices, a traditional time-integrated liquid capture 
sampler and a low-flow, near-continuous active sampler performing in situ solid phase 
extraction. Results from modeling and field studies showed that the continuous sampler 
(i) drew samples for 93% of the total sampling duration as compared to the 3% for the 
conventional sampler that operated in 15-min intervals only; (ii) captured pulse events 
when the discrete sample did not, including for the opioids heroin and fentanyl, and the 
opioid antagonists norbuprenorphine and methadone; and (iii) consistently provided 
statistically significantly higher mass loads for morphine, heroin, fentanyl, norfentanyl, 2-
ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine [EDDP, (methadone metabolite), 
norbuprenorphine, methamphetamine, amphetamine, and caffeine (p ≤ 0.01). This study 
represents the first reported use of in situ solid phase extraction for capture of analytes of 
interest contained in sewage for health monitoring using wastewater-based epidemiology.  
106 
 
6.1 Introduction 
Domestic wastewater from centralized sewerage systems is a useful matrix to 
monitor the health, lifestyle, and behaviors of populations, including licit and illicit drug 
consumption, and inadvertent chemical exposures [98, 215-217]. Wastewater-based 
epidemiology (WBE) may be performed in parallel to traditional forms of public health 
monitoring to enrich and complement available information [169, 218, 219]. As these 
methods become increasingly integral to the analysis of public health, researchers are 
beginning to improve and standardize WBE studies [23, 220, 221]. 
The method of sample acquisition plays an important role in the 
representativeness and quality of WBE data, affecting results obtained later during 
analysis and estimation of population exposure rates. Sampling frequency is one such 
parameter under assessment. Sampling to date has generally focused on weeklong 
sampling campaigns to estimate monthly or annual consumption [13, 222]. Efforts are 
underway to determine the optimal collection frequency to accurately characterize 
exposure in a sewershed based on known analyte consumption patterns (e.g., known 
differences between weekend and weekday consumption) [223]. A recent study 
suggested 56 stratified random samples are necessary to obtain reliable results for annual 
drug consumption estimates [224]. To increase the number of days sampled, alternative 
sampling techniques have been employed, including the use of passive samplers [225, 
226]. 
Another facet of sampling that necessitates evaluation is the manner in which the 
sewage is collected for a given day. Wastewater sampling methodologies traditionally 
included single discrete (grab) samples or 24-hour composite samples [227]; the majority 
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of recent WBE studies collect daily composite samples [21, 22]. These daily composite 
samples are collected at discrete intervals based on time (time-integrated) or flow (flow-
weighted), and collected aliquots are combined into a single vessel. With these methods, 
there have been concerns regarding the potential to miss pulses of analytes flowing 
through the sewer system [23]. For compounds with rare use and short elimination half-
lives, consumption estimates may be driven largely by chance capture, resulting in an 
under- or over-estimation of substance use and exposure in the population. Although 
samplers that collect daily composite samples are capable of pumping continuously, the 
lowest flow rates possible still produce a large total volume of sample, creating 
challenges for sample storage, handling, processing, and disposal of resultant hazardous 
waste [226].  
Relatively little attention has been paid thus far to identifying and evaluating 
different sampling methodologies for collection of daily composite samples. Guo et al., 
2017 designed a device employing organic diffusive gradients in thin films (o-DGT) for 
the capture of three substances of abuse, including ketamine, methamphetamine, and 
amphetamine [24]. Deployed o-DGT samples were extracted daily and compared to 
simultaneously collected grab samples. When using passive samplers, the intent generally 
is to maximize deployment time, although short-term deployments are a viable option  
[24]. With any environment, passive samplers face challenges related to compound 
uptake rates, which are sensitive to factors such as turbulent flow, boundary layer 
development, changes in temperature, and fouling [228]. A principal challenge is to 
convert mass-per-sampler results to concentration data, a challenge typically addressed 
by employing performance reference compounds as done in polar organic chemical 
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integrative samplers [229]. The high amount of suspended particulate matter in 
wastewater poses additional challenges to the use of passive samplers. First, monitoring 
of wastewater necessitates sampler removal and cleaning to allow for continued 
efficiency [226]. Additionally, analytes of interest with an affinity for sorption to 
particulates will not be as readily captured by passive samplers, which only capture 
dissolved-phase species. 
A promising alternative solution to this predicament is the use of active samplers 
operating at low flow rates to limit the total sample volume obtained, while still capturing 
the chemistry for each time increment of interest. Active sampling devices meter water in 
a controlled manner, removing uncertainty in compound uptake rates and have the ability 
to capture the total mass of analytes regardless of whether they are truly dissolved or 
partially/completely sorbed to small, suspended particles. Low-flow active samplers offer 
a variety of designs including, submersible, in situ extraction, on- or off-board power, 
and functionality for surface water, porewater, groundwater, or ocean deployment [230-
234]. 
The goal of this study was to compare a novel low-flow, near-continuous active 
sampling device with solid phase extraction technology to a traditional 24-hour time-
weighted sampling strategy employing a traditional high frequency discrete sampler, to 
evaluate how mass loads and apparent consumption patterns changed between sampling 
methodologies. The underlying hypothesis was that near-continuous sampling at low 
flow rates may increase the overall mass of analyte recovered, due to better capture of 
short-term biomarker pulses and due to in situ extraction and preservation of labile 
biomarkers on solid phase extraction resin beds. Analytes of interest included common 
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compounds measured for WBE purposes including indicators of alcohol, caffeine, 
nicotine consumption, and various licit and illicit narcotics. 
6.2 Materials and methods 
6.2.1 Chemicals and reagents 
Standards of ethyl sulfate (EtS) and sodium ethyl sulfate-d5 (EtS-d5) were 
purchased from Toronto Research Chemicals (Toronto, ON, Canada). Nicotine (NIC), 
cotinine (COT), trans-3’-hydroxycotinine (3-OH-COT), caffeine (CAF), paraxanthine 
(PAR), isotopically-labeled cotinine-d3 (COT-d3) and 
13C3-Caffeine (
13C3-CAF), were 
purchased from Sigma-Aldrich (St. Louis, MO). Narcotics, including labeled standards, 
were purchased from Cerilliant (Sigma, Aldrich, Louis, MO) and included parent/ 
metabolite of morphine (MOR)/ morphine-3-glucuronide (M3G), oxycodone (OXY)/ 
noroxycodone (NOXY), codeine (COD)/ norcodeine (NCOD), heroin (HER)/ 6-
acetylmorphine (6-AM), fentanyl (FENT)/ norfentanyl (NFENT), methadone 
(MDONE)/2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP), buprenorphine 
(BUP)/ norbuprenorphine (NBUP), methamphetamine (METH), cocaine (COC)/ 
benzoylecgonine (BZYL), 3,4-methylenedioxy-methamphetamine (MDMA), 
amphetamine (AMP), methylphenidate (MPH), and alprazolam (ALP)/ alpha-
hydroxyalprazolam (OH-ALP). Narcotic labeled standards are listed in Appendix D: 
Table 19. LC-MS (liquid chromatography-mass spectrometry) grade methanol, acetone, 
and water were purchased from Fisher Scientific (Thermo Fisher Scientific, Waltham, 
MA); formic acid was purchased from Fluka Chemical Corp (Milwaukee, WI). Stock 
solutions of native and isotopically-labeled compounds were prepared in methanol, 
except EtS and EtS-d5 which were prepared in water. Stock solutions were stored in glass 
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vials with polytetrafluoroethylene septa at −20°C, except aqueous stock solutions which 
were stored at the 4°C. 
6.2.2 Sample location 
The study was conducted at an undisclosed wastewater treatment plant (WWTP) 
in the southwestern U.S. The facility processes approximately 57 million liters per day 
(MLD) (15 million gallons per day) of wastewater from domestic and industrial sources. 
The WWTP serves a population of approximately 125,000 people.   
6.2.3 Sample collection and handling 
Daily composite samples were collected by two sampling technologies from 
wastewater influent at the treatment plant. An ISCO 4700 refrigerated sampler (Teledyne 
ISCO, Lincoln, NE, USA), with 1.27 cm (½ in.) diameter vinyl tubing (suction line), and 
silicon tubing (pump head), was used to collect aliquots of wastewater influent at 15-
minute intervals, equating to approximately 40 min d-1 of analyte capture. Instrument 
lines were purged and rinsed with wastewater prior to sample collection. Aliquots were 
collected in a 10-L LDPE bottle, and transferred to high-density polyethylene (HDPE) 
sample bottles (on ice) for transport to the laboratory. Samples were processed on the 
same day to limit degradative losses. Concurrently, daily composite samples were 
collected by a sampler designed and fabricated at the Biodesign Center for Environmental 
Health Engineering at Arizona State University [230, 233]. The sampler consists of a 
positive displacement pump, which meters liquid through an inert fluid train, to replicate 
solid phase extraction (SPE) cartridges. Daily composite samples were collected from 
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approximately 7:30 am to 7:30 am Monday through Sunday during the Month of April 
2018.  
6.2.4 Sample processing 
Wastewater collected by the high-frequency discrete sampler was separated into 
duplicate two-hundred milliliter aliquots and spiked with 20 ng of labeled standard. 
Wastewater was extracted using Hydrophilic-Lipophilic Balance (HLB) cartridges (6 cc, 
150 mg, 30 um particle size) manufactured by Waters (Milford, MA) on a DionexTM 
AutoTraceTM 280 Solid-Phase Extraction Instrument (Thermo Scientific, Waltham, MA). 
Cartridges were first conditioned with 5 mL of methanol, then 5 mL of water before 
sample loading, then rinsed with 5 mL of water, and dried with nitrogen for 10 minutes. 
Analytes were extracted with 1:1 (v/v) methanol and acetone containing 0.5% formic 
acid, into a final volume of 4 mL. Finally, 200 µL of the final extract was evaporated 
under nitrogen at ambient temperatures using a Reacti-Therm TM Heating and Stirring 
Module TS-18821 (Thermo Scientific, Waltham, MA). Samples were reconstituted in 
1+1 (v/v) methanol and water mixture for analysis of caffeine- and nicotine-related 
compounds, and 100% water for narcotics. For EtS, 10 mL of raw wastewater was 
centrifuged at 4,000 g for 10 min (Eppendorf Centrifuge 5810 R, Hamburg, Germany). 
Supernatant (500 µL) was collected and mixed with 490 µL of water and 10 µL of 100 
µL mL-1 of EtS-d5. 
The near-continuous sampler extracted wastewater in situ throughout the 24-h 
time period when the instrument was deployed, at an average flow rate of 160 µL min-1. 
Prior to deployment, 20 ng of labeled standard were spiked into ~200 mL of deionized 
water and loaded onto SPE cartridges; the conditioning steps were the same as outlined 
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above, however the cartridges were not dried. Cartridges were exchanged daily on the in 
the instrument. Loaded cartridge were capped and upon return to the lab, the remaining 
wastewater volume was vacuum-pulled through the cartridge using a VisiprepTM Solid 
Phase Extraction (SPE) Vacuum Manifold [Sigma-Aldrich (St. Louis, MO)], followed by 
5 mL of liquid chromatography grade water. The cartridges were then dried for 
approximately 10 minutes under vacuum. Cartridge extraction and sample preparation 
were the same as outlined above for nicotine- and caffeine- related compounds, and for 
narcotics. The processed wastewater from each SPE cartridge was captured and later used 
to quantify EtS in the same manner as outlined above for the raw wastewater samples. All 
analyses were performed by liquid chromatography tandem mass spectrometry (LC-
MS/MS).  
6.2.5 Sample analysis 
Wastewater extracts were analyzed using a Shimadzu 2100 high performance 
liquid chromatographer (HPLC), coupled to an AB Sciex APE 4000 triple quadrupole 
mass spectrometer (Applied Biosystems, Framingham, MA). CAF, PAR, NIC, COT, 3-
OH-COT, and EtS were separated on a Symmetry C8 column (4.6 × 150 mm, 3.5 μm 
particle size) preceded by a Symmetry VanGuard Cartridge (3.9 × 5 mm, 3.5 μm particle 
size) (Waters, Milford, MA). For narcotics, a Symmetry C18 column (4.6 × 75 mm, 3.5 
μm particle size) preceded by a Symmetry VanGuard Cartridge (Waters, Milford, MA), 
was used. Methanol was used as mobile phase A for all methods, and water containing 
0.2% formic acid used as mobile phase B for EtS and narcotics; 0.1% formic acid was 
used for remaining compounds. Detailed analytical method information has been 
published previously [11].  
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6.2.6 Quality assurance and quality control 
 Concentrations of biomarkers were determined using a 7-point (minimum) 
standard curve, and a coefficient of determination of ≥ 0.99. Each extraction was 
performed with method blanks (deionized water), and instrument blanks (1:1 methanol 
and water) to enable the detection of potential contamination and analyte carryover in the 
instrument. Method detection limits (MDL) were determined according to national 
protocols [123]. MDLs and analyte recoveries are shown in Appendix D: Table 20. 
Precision was expressed as Relative Percentage Differences (RPD) and calculated using 
the following equation: 
𝑅𝑃𝐷 (%) = 𝐴𝐵𝑆 (
𝐶𝑆1 − 𝐶𝑆2
𝐶𝑆1 + 𝐶𝑆2
2 ⁄ ) 𝑥 100    Eq. 15 
where 𝐶𝑆1 and 𝐶𝑆2 are the measured concentrations in the sample and its associated 
duplicate.  
5.2.7 Data analysis 
LC-MS/MS data were acquired with Analyst 1.5 software (Applied Biosystem, Foster 
City, CA). Concentrations were calculated using the isotope-dilution method when 
analyte peak signal-to-noise ratio was greater than 3, and the concentrations were above 
the MDL. Per-capita daily consumption was calculated using the following equation: 
𝐶𝑜𝑛𝑠𝑢𝑚𝑝𝑡𝑖𝑜𝑛 =
𝐶𝑜𝑛𝑐 𝑥  57 𝑀𝐿𝐷 𝑥 (
𝑀𝑊𝑃𝑎𝑟𝑒𝑛𝑡
𝑀𝑊𝑀𝑒𝑡𝑎𝑏𝑜𝑙𝑖𝑡𝑒
) 
𝐸𝐹 𝑥 125,000
     Eq. 16 
where 𝐶𝑜𝑛𝑐 is the measured concentration of the analyte of interest, 57 𝑀𝐿𝐷 is the total 
daily volumetric flow rate, 
𝑀𝑊𝑃𝑎𝑟𝑒𝑛𝑡
𝑀𝑊𝑀𝑒𝑡𝑎𝑏𝑜𝑙𝑖𝑡𝑒
 is the ratio of molecular weights of the parent and 
metabolite (used where applicable), 𝐸𝐹 is the excretion factor of the analyte [11] 
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(Appendix D: Table 21), and 125,000 is the population served by the WWTP. Statistical 
analyses, including Student’s t-test, were performed using Microsoft Excel 2010. 
6.3 Results and discussion 
 A modified near-continuous In Situ Sampler (C-IS2) was outfitted with a glass 
syringe pump assembly, fluid train consisting of polytetrafluoroethylene (PTFE) intake 
lines and an influent manifold, combinations of PTFE and nylon fitting connections, 
styrene-acrylonitrile resin/silicon check values to control flow direction, and Viton® 
tubing for solid phase extraction (SPE) effluent capture (Figure 19).  
 
Fig. 19. In Situ Sampler (IS2) schematic and images. 
 
The instrument’s water intake was modified to include a commercially available 
stainless steel strainer, which served to protect the influent line from clogging by large 
suspended solids. Wastewater moved through the instrument as followed: intake, influent 
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manifold, glass syringes of pump, internal standard-loaded SPE cartridges. SPE 
cartridges were inverted in the instrument to help prevent clogging in the resin by 
allowing suspended solids to settle away from sorbent frits. For evaluation purposes, 
effluent was recovered from each cartridge to determine pump efficacy, and for the 
analysis of EtS, which is not amendable to SPE capture with the chosen cartridge type. 
The pump flow rate was 160 µL min-1, translating to approximately 93% sample 
coverage for the day (Figure 20).Wastewater volumes processed per day per operating 
channel are shown in Appendix D: Figure 27. On average, the C-IS2 pumped 191 ± 24 
mL for the 7-day sampling period (n = 14). The pump program was stopped and restarted 
during daily SPE collection, and the influent line purged from the influent manifold. The 
commercially available high frequency sampler was programed to collected sample 
aliquots every 15 minutes (~ 30 second collection time), equating to approximately 3% 
coverage of the sampling period (Figure 20). This sampler is in common use at WWTPs 
for compliance sampling purposes, and when set in time-integrated sampling mode, it is 
commonly programed to sample at 15-min. intervals, a strategy that was implemented 
and evaluated here.  
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Fig. 20. Modeled concentrations of target analytes in wastewater. Blue intervals denote 
when sampler is collecting wastewater and the % captured during a 1-hour timeframe in 
the discrete (A) and continuous (B) samplers. Constant and variable concentrations in 
wastewater (C) and in the corresponding inferred concentration estimates returned by the 
two respective samplers for a given analyte mass flow (D).  
 
The concentrations and subsequent masses recorded by the discrete and continuous 
(C-IS2) samplers vary depending on whether the analyte concentration is constant or 
occurs as a pulse event. Figure 20 models three types of distinct inputs scenarios, 
including a constant analyte input, and two pulse events occurring at varying times 
throughout the hypothetical sampling period. The constant input in wastewater (1.25 ppb) 
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produced identical concentrations in both the discrete and continuous samplers, reporting 
the conditions in wastewater with high fidelity. However, for pulse events, the timing, 
and duration of sample acquisition have a large impact on the data quality of the 
estimated concentrations recorded by the two samplers. In the event of pulse inputs into 
wastewater, the C-IS2 has a greater likelihood of capturing the event because the 
instrument is collecting wastewater for approximately 93% of the monitoring period. 
Whereas the C-IS2 data are anticipated to be robust, this device cannot inform on the 
duration of a pulse and the peak concentrations during the event (Figure 20). The 1.5 ppb 
spike in concentration from t = 20 to t = 25 minutes was captured by the C-IS2; however, 
the average concentration recorded by the sampler was 0.13 ppb. A similar result was 
seen with the 1.20 ppb pulse scenario that produced a corresponding C-IS2 concentration 
of 0.1 ppb.  
With pulse events in the discrete sampler, the likelihood of capture is lower, as only 
~3% of the wastewater during the sampling period is captured. If the sampler does not 
capture the pulse in those 100 seconds of pumping, non-detect values will result, as was 
the case with the 1.5 ppb pulsed input. And, if fortuitously captured as shown with the 
1.20 ppb pulse, the recorded concentration estimate will represent only 25% of the actual 
average concentration, decreased by the other three 15-minute interval collections that 
occurred during that sampled hour (e.g., 1.2 ppb in wastewater, 0.3 ppb in the sampler). 
During a field study at a full-scale wastewater treatment plant, under conditions 
where the actual concentration profiles of analytes in sewage were unknown, the C-IS2 
and discrete samplers indeed returned different average concentration estimates, as 
shown in Appendix D: Figure 28, Figure 29. Twenty-six of the analytes were consistently 
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detected and quantifiable in each duplicate daily composite sample collected by each 
sampler. Notable exceptions included the analytes morphine-3-glucuronide, heroin, 
norcodeine, alprazolam, and alpha-alprazolam. Morphine-3-glucuronide was only 
detected in four samples, including in duplicates collected by the discrete sampler and in 
those collected by the C-IS2 on Thursday. Similarly, heroin had non-detects (ND) for all 
days except for the duplicate C-IS2 samples collected on Monday. Norcodeine, 
alprazolam, and alpha-alprazolam were generally detected except in select duplicate 
samples in the C-IS2 samples near the end of the week/weekend (Appendix D: Figure 
28). 
Concentrations were converted to daily mass loads using provided flow data by the 
WWTP. Of the 26 analytes showing consistent detection, the average daily mass loads of 
9 of the analytes (36%) were significantly higher (p < 0.01) in the C-IS2 (Figure 21, 
Table 3). These included morphine, 6-acetylmorphine, fentanyl, norfentanyl, 2-
ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP), norbuprenorphine, 
methamphetamine, amphetamine (Adderall), and caffeine. Only one compound, the 
metabolite of alprazolam, recorded higher masses in the discrete sampler over the C-IS2 
(p < 0.001). The low mass load of this compound in the C-IS2 were driven by its 
susceptibility to degradation. Instances of increased masses captured by the C-IS2 were 
apparent throughout the duration of the study. Most noteworthy included (i) a +100% in 
fentanyl on Tuesday concurrently with a (ii) +55% in the opioid antagonist metabolite 
norbuprenorphine on the same day, and a 218% increase in methadone on Thursday 
(Figure 21).  
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Fig. 21. Mass loading comparisons between a discrete and near-continuous in situ 
extraction sampler. Inset shows daily mass load comparisons for specific compounds 
including fentanyl (FENT), norbuprenorphine (NBUP), and methadone (MDONE). 
Boxed portions denote divergences between samplers suggesting captured events by the 
C-IS2. 
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Table 3 - Average daily mass loads and standard deviations (SD) for the discrete and 
continuous samplers, including associated p values where applicable (p ≤ 0.01). Shaded 
values delineated the sampler with the higher mass loading. In all but a single case, the 
continuous sampler provided higher mass loads.  
Analyte 
Discrete Continuous 
p value 
mg/day (SD) 
Morphine 13 (0.5) 19 (1.7) <0.0001 
Oxycodone  5.7 (0.5) 6.0 (0.8) -- 
Noroxycodone 7.4 (0.18) 8.0 (0.5) -- 
Codeine 14 (0.6) 16 (2.5) -- 
Norcodeine 0.40 (0.02) 0.42 (0.17) -- 
6-acetylmorphine 0.95 (0.23) 1.9 (0.56) 0.005 
Fentanyl 0.01 (0.003) 0.02 (0.004) 0.001 
Norfentanyl  0.55 (0.01) 1.5 (0.65) 0.01 
Methadone 0.27 (0.07) 0.35 (0.03) -- 
2-ethylidene-1,5-dimethyl-
3,3-diphenylpyrrolidine 
(EDDP) 
1.8 (0.24) 2.5 (0.42) 0.01 
Buprenorphine 1.6 (0.08) 1.9 (0.48) -- 
Norbuprenorphine 1.8 (0.29) 2.5 (0.42) 0.005 
Methamphetamine 124 (8.0) 171 (10.5) <0.0001 
Cocaine 7.0 (1.4) 8.8 (1.6) -- 
Benzoylecgonine  15 (1.9) 17 (1.9) -- 
3,4-methylenedioxy-
methamphetamine 
(MDMA) 
1.5 (1.1) 2.0 (1.3) -- 
Amphetamine 33 (1,.1) 50 (5.4) 0.001 
Methylphenidate  0.19 (0.11) 0.26 (0.14) -- 
Alprazolam  0.78 (0.02) 0.95 (0.3) -- 
Alpha-alprazolam 0.23 (0.03) 0.03 (0.01) <0.0001 
Ethyl sulfate 614 (137) 741 (153) -- 
Nicotine 40 (5.6) 44 (7.8) -- 
Cotinine 39 (2.6) 45 (7.2) -- 
trans-3’-hydroxcotinine 19 (2.4) 30 (15) -- 
Caffeine 2982 (127) 3482 (240) 0.001 
Paraxanthine 473 (32) 624 (248) -- 
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Per-capita consumption of caffeine, nicotine, alcohol, and various licit and illicit 
narcotics was estimated using mass loads, combined with previous excretion rates, and 
population estimates provided by the WWTP. For per-capita consumption, the metabolite 
for each parent compound was used to estimate consumption. However, parent 
compounds were used for methamphetamine, 3,4-methylenedioxy-methamphetamine 
(MDMA), amphetamine (Adderall), methylphenidate (Ritalin) (no metabolites included 
in this study), morphine (>99% non-detect in metabolite), and codeine (selected non-
detected in metabolite). Additionally, internal standard normalization was included in this 
calculation to control for compound losses. Average per-capita consumption estimates 
provided by the C-IS2 were higher than the per-capita estimates generated by the discrete 
sampler. Mass percent difference between the two samples ranged from 3% to as high as 
100%. Note that the disparity in alprazolam between the two samplers was corrected 
when taking into account the internal standards, which corrected for losses in the C-IS2 
while deployed in the field. The degradation vulnerability of this compound agrees with 
results from other studies [235-238]. 
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Fig. 22. Per-capita consumption rates of licit and illicit drugs of interest generated from 
mass loadings with the 15 min time-integrated sampler and the near- continuous in situ 
sampler (with and without internal standards being considered). Alcohol consumption is 
shown in units of g/day per person. 
 
Results from the modeling and the field deployment show that continuous 
samplers offer the opportunity to capture analytes that are missed with less frequent 
sample collection. This was seen in the detections of heroin that were recorded as non-
detects in the discrete sampler, and the singular events that increased the mass disparities 
between the two samplers on selected days (e.g., fentanyl, methadone). Additionally, 
with certain compounds, the continuous sampler captured more of the target compound, 
suggesting that the occurrence of events outside the 15-min interval, 30-s sample duration 
of the discrete sampler were enough to drive the overall concentration in the C-IS2 
higher. In addition, the design of the C-IS2 also offers the option of less material transfer 
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to the laboratory (SPE cartridges only), and a shortened sample processing time than the 
liquid wastewater samplers if no additional SPE effluent analyses are necessary. Different 
SPE cartridges may be placed in tandem if all analytes are not amendable to capture by a 
single commercially available cartridge. Also, with the addition of internal standard to the 
cartridges prior to deployment, as was done here, in situ extraction by the sampler is able 
to quantify abiotic losses occurring in the field. Continuous samplers offer a viable 
alternative to conventional sampling methodologies in WBE studies.  
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CHAPTER 7 
RESEARCH IMPLICATIONS AND RECOMMENDATIONS 
 This work has shown that the critical assessment of standard methodologies can 
highlight opportunities to improve the health of the natural environment and human 
populations. As highlighted in this dissertation, this can include assessments in well-
defined fields such as environmental remediation, or those that are relatively new and 
adaptive as is the case with wastewater-based epidemiology. Assessments of this type can 
highlight inconsistencies or weakness in the methodology or create new opportunities to 
expand the field.  
7.1 Groundwater remediation assessments 
 In Chapter 2, the differences between common bench-scale treatability studies 
were explored, first in a literature meta-analysis, with an emphasis on reaction kinetics in 
chlorinated solvent remediation, and second through experimental studies, which 
included three treatments technologies for in situ remediation of perchloroethylene. 
Results showed that there was a preference for reporting batch kinetic data, even when 
available continuous-flow column data were available, and that columns produced higher 
observed rate constants (faster rates) than batch bottles within comparable systems, by a 
factor of 6.1 ± 1.1. Experimentally, the same trend was found, with columns generating 
higher rate constants that were 8.0 ± 4.8 times faster than batch (1.23 ± 0.87 d-1 vs. 0.16 ± 
0.05 d-1). Additionally, kinetic data density in columns was also found to be higher than 
associated batch bottles, where column rates are a function of the number of samples 
collected after steady-state is achieved, while the number of batch bottle rates are 
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equivalent to the number of replicates. Progressing outside the traditional assessment of 
chemical speciation and kinetic analysis, a mass transformation assessment was included 
in this study, which found that columns were transforming 16.8 ± 8 times more mass than 
batch bottles of traditional design, and also had the potential to predict amendment 
longevity if column systems are conducted until rebound of the contaminant. The rate 
disparities between these bench-scale studies suggest that varying estimates of total 
cleanup time and associated costs vary significantly depending on which kinetic 
estimates are used in subsequent modeling of remediation at the site. Batch kinetics may 
underestimate in situ remediation, therefore overestimated time and costs, and potentially 
affecting downstream decision-making at the site. Additionally, increased kinetic data 
density with columns suggests these estimates are more relatable and indicative of both 
maximum and sustained rates in the system. This is not to say that continuous-flow 
columns are the superior option to groundwater remediation studies. Batch bottles in 
these cases may serve as a more conservative estimate for remediation in the system, and 
in the case fractured bedrock, the remediation occurring in vertical fractures may be more 
accurately assessed by a batch bottle system. In general, this study highlighted the need 
for a more unified framework for data use and reporting, to produce more representative 
outcomes at the field-scale.   
 Next steps in this research should focus on modeling kinetic data generated by 
batch and column treatability studies, to understand how differences in reaction kinetics 
translate into modeled cleanup times and costs. Additionally, one of the amendment 
technologies tested here, the controlled-release carbon source (CRCS), displayed very 
different patterns of contaminant speciation in each of the two treatability study types 
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(enhanced removal in the batch system). In batch bottles, release of electron donor is 
largely a function of the release rate of the materials, whereas in the column, donor 
availability is largely controlled by the flow rate of the system, which continually pushes 
the donor out of the column. Studying the differences of the CRCS in these variable 
conditions is important for understanding field-scale remediation activities using these 
materials. 
In Chapter 3, a bench-scale continuous-flow column treatability study was 
performed and results compared to those of field-scale remedial activities, in which the 
test amendments were applied in the field as a method for source zone reduction of a 
DNAPL PCE plume. Results in the lab were qualitatively similar to those in the field, 
meaning that PCE reduction followed the similar trend towards formation of less 
chlorinated species, however bench-scale studies performed better. First-order 
degradation rates generated from column data were 0.71 ± 0.04 d-1, while field rates were 
variable at <0.01 to 0.04 d-1. Variably was largely driven by the challenges to creating 
fractured bedrock DNAPL remediation in the lab. Field conditions are spatial and 
temporal heterogeneous, the system is effectively open to outside perturbations, and there 
is no guarantee subsurface injections will reach DNAPL locations. Additionally, there is 
inherent variability in DNAPL dissolution, which drives downgradient measured 
concentrations. In lessons learned, valued quantitative parameters in bench-scale studies 
including chemical speciation, reaction kinetics, microbial numbers and gene copies do 
not all translate well into field-scale assessments. Compound speciation is the most useful 
of the three, microbial parameters are used only as secondary indicators of remediation to 
supplement chemical data, and kinetic estimates are insignificant. This suggests 
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alternative means of analyses are needed. Mass flux and mass discharge are two 
parameters that are more commonly being used in field-scale assessments, but have no 
counterpart in the lab. These analyses greatly improved the ability to interpret remedial 
successes at the site, as changes in DNAPL dissolution were collected in downgradient 
receptor wells, and showed changing slopes in flux diagrams. Assessments of mass flux 
into columns were two-orders of magnitude lower than those recorded in the field, 
suggesting maybe there is value to more closely aligning the flux between lab- and field-
scale studies. It is important to note that in DNAPL source zone reduction studies, 
DNAPL is not included in the bench-scale assessment, either as an injected slug into the 
column or in the steady-stream of influent. No published studies could be found that 
tested either of these methods of DNAPL removal, and conversations with commercial 
laboratories have suggested this is too laborious and lacks reproducibility. However, 
there is merit is testing the feasibility of this type of treatability study in an effort to 
improve the understanding of source zone reduction in the lab.  
7.2 Human population assessments 
In Chapter 4, traditional wastewater-based epidemiology study methodologies 
were expanded to include the endogenous steroid hormones cortisol and cortisone, to 
assess human population stress on a university campus. The compounds were 
consistently detected, and followed a reproducible weekly trend of elevated 
concentrations during the week, correlating with class schedules, and lower measured 
concentrations during the weekend. The highest levels of per person total glucocorticoids 
occurred on Mondays (149 ± 62 μg d-1 per person) and lowest on Saturdays and Sundays 
(72 ± 18 μg d-1 per person and 71 ± 22 μg d-1 per person), and weekends were 
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significantly different than weekdays (p = 0.05). Higher stress levels were recorded 
during the first two months of the semester in August during the first week of school (161 
± 42 μg d-1 per person), and September (122 ± 54 μg d-1 per person), which were 
significantly different from the remaining months (p = 0.05, 0.01). Stress hormones were 
positively correlated with nicotine (rs = 0.49) and caffeine (rs = 0.63) consumption but not 
alcohol intake. This study showed promise in measuring glucocorticoids in wastewater as 
a metric of population stress, and has long-reaching implications for using WBE to assess 
stress in cities. Stress is known to degrade quality of life, and is linked to the six major 
causes of death in the U.S., so directly measuring primary physiological markers of stress 
in wastewater would allow for the identification of events and conditions putting 
populations at risk. For example, universities are notorious for representing high-stress 
environments, so consistent tracking the population would elucidate deviations from the 
baseline, such that high-stress situations could be identified and interventions 
implemented if necessary. Additionally, stress is often correlated with increases of 
substance abuse, so further studies into the relationship of concurrence with stressors is 
desirable. This study focused on a specific target population, and it is necessary to assess 
other non-student populations, and to scale up to treatment plant sampling, which 
generally has much longer travel times and travel distances than those in the current 
study. This is particularly important because cortisone and cortisol are relatively unstable, 
excreted at the µg/L concentrations and measured in WWTPs at ng/L [105, 120]. If 
degradation is an issue, tracking of the major metabolites tetrahydrocortisol and 
tetrahydrocoritsone, may add confidence and robustness to the data stream, as both 
compounds are excreted at mg/L concentrations in urine [239]. Additionally, other 
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compounds that occur during the stress response may also be options for fine-tuning the 
stress assessment, including: epinephrine and norepinephrine [240, 241].    
In Chapter 5, WBE analysis was conducted to assess patterns of alcohol, caffeine 
and nicotine consumption in a target demographic (college students), and compared this 
to self-reported estimates generated from behavioral science peer-reviewed publications, 
as well as U.S. national statistics on consumption. Per capita wastewater-derived 
estimates for alcohol consumption were 11.3 ± 7.5 g d-1 per person (0.8 ± 0.5 drinks d- 
per person), similar to estimates obtained from literature 10.1 ± 0.8 g d-1 per person (0.7± 
0.006 drinks d- per person). Caffeine and nicotine consumption were lower than the 
literature estimates, 114 ± 49 g d-1 per person vs. 178±19 g d-1 per person (caffeine), and 
627 ± 219 g d-1 per person and 927 ± 243 g d-1 per person (nicotine). Strong correlations 
were found between alcohol and nicotine (rs = 0.71), and nicotine and caffeine (rs = 0.59), 
and weak with alcohol and caffeine (rs = 0.17). In general, alcohol and nicotine 
consumption were higher on weekends than weekdays (p <0.0001, p = 0.01), and caffeine 
higher during the week (p = 0.05). Between semesters, alcohol consumption remained 
stable and caffeine and nicotine decreased. In this study, sampling occurred directly from 
the subsurface pipe infrastructure allowing for the isolation of a subpopulation for 
assessment, which was repeatedly and inexpensively monitoring for an entire academic 
year. Reported surveys often cite this target demographic as prone to abuse of these 
substances, however this alternative method of assessment showed this is not true for this 
specific university.  This method of targeted sampling would greatly benefit subset 
locations containing at-risk populations, including schools, assisted living/retirement 
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communities, and socioeconomically disadvantaged neighborhoods. This is particularly 
true in the current climate of opioid abuse.  
In the college-age demographic, caffeine consumption from energy drinks is a 
particular concern because: (i) caffeine concentrations in those beverages are high, 
increasing the likelihood of overconsumption; and (ii) energy drink consumption is often 
co-occurring with alcohol consumption. In the latter instance, the stimulant effects of 
caffeine mask the depressive effects of alcohol, leading to overconsumption of the latter. 
Future studies should try to elucidate consumption of energy drinks over other caffeine-
containing products. This could be accomplished by monitoring common additives in this 
drinks, including compounds such as guarana, taurine, and ginseng, which themselves are 
natural stimulants and add to the health burden of the population [242]. Similarly, with 
the rise in e-cigarettes, there is a concern that these devices will increase nicotine 
consumption among youth, and will serve as a gateway to cigarette consumption. 
Tracking compounds in the nicotine liquids used by the e-cigarettes, would elucidate how 
these devices impact smoking patterns in this demographic.  
In Chapter 5, a near-continuous in situ sampler was used to collected wastewater 
influent from a WWTP to assess compounds common to WBE, and to compare the 
associated mass loads to a traditional time-integrated sampler. Modeled data showed that 
the percentage of sample covered from each of the two samples varied, with 3% coverage 
by the 15-minute interval sampler, and 93% for the near-continuous sampler. Mass load 
results showed that the near-continuous sampler captured analytes when the discrete 
sampler did not (heroin), and captured pulse events that were not apparent in the discrete 
sampler (e.g., fentanyl, norbuprenorphine, and methadone). Additionally, the near-
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continuous sampler consistently captured higher masses than the discrete sampler for the 
opioids morphine, 6-acetylmorphine (heroine metabolite), fentanyl, norfentanyl, the 
opioid antagonist norbuprenorphine, and the stimulants methamphetamine, amphetamine, 
and caffeine (p ≤ 0.01). These results suggest that continuous capture may be an 
alternative sampling methodology to the current high frequency discrete sample design, 
and has the potential to improve our understanding of consumption estimates generated 
by WBE. More work is needed to fully explore this relationship. WBE practitioners tout 
flow-weighted samplers at the gold standard in sample collection. Similar to the time-
averaged sampler this study, flow-weighted collection occurs at a brief interval after a 
certain volume of wastewater has moved through the system, which translates into high-
flow periods being more heavily represented in the composite sample. Comparing the 
near-continuous sampler to the flow-weighted sampler will likely provide different 
results that the time-interval sampler. In terms of in situ sampler improvements, future 
instrument iterations should include: (i) integration of more sophisticated valve 
technology to allow for back-flushing; (ii) a mechanism to record channel flow so 
effluent need not be captured; (iii) incorporation of flow meter for near-continuous, flow-
weighted studies. There is also a need to study abiotic degradation on SPE cartridges, and 
alternative mechanisms for internal standard addition. 
This critical assessment of methodologies and devices provided here has shown 
that assessments of this type can highlight inconsistencies or weakness in the 
methodology, providing space for a discussion of avenues to improvement, and also can 
highlight previously unseen opportunities for advancement of the field.    
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APPENDIX A 
SUPPLEMENTAL MATERIAL FOR CHAPTER 2 
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Field Collection 
Bedrock cores were collected following the guidelines outlined in the American Society 
for Testing and Materials (ASTM) D2113-Standard Practice for Rock Core Drilling and 
Sampling of Rock for Site Investigation. Rock cores were Ordovician limestone of the 
Ottawa formation collected from 9.5 to 10 m depth. Groundwater samples were collected 
in compliance with Ontario Regulation 154/03, as amended July 1, 2011, Record of the 
Site Condition Part XV.1 of the Environmental Protection Act, R.S.O. 1990, c. E.19, for 
preservation of volatile organic compounds (VOCs). Samples were collected in four L 
high-density polyethylene (HDPE) sample collection bottles and stored at 4°C.  
Media Preparation 
Site bedrock was prepared for BM construction by crushing with a construction grade 
hammer and steel plate. Bedrock fragments were further processed for CMs by passing 
the material through a steel plate rock crusher (Badger Crusher) and disc pulverizer (UA 
Disc Pulverizer) (Bico Braun International, Burbank, CA). Bedrock fragments were 
sieved with ASTM standard brass sieves to a desired size of 0.25 mm. Uniform grain size 
was necessary to sustain equivalent flow rates in continuous-flow columns.  
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Table 4 – Databases used in treatability study literature review.  
Relevant Databases 
American Geophysical Union National Academy of Sciences 
ASCE Library  National Technical Information Service 
ASTM Standards and Engineering 
Digital Library (SEDL)  ProQuest  
Dissertations & Theses @ Arizona State 
University ProQuest Dissertations & Theses Global 
Earth and Environmental Science PubMed  
EDP Sciences  SAGE Premier 
Environment Complete  Science Direct 
GeoScienceWorld  Scientific American Archive Online 
Google Scholar  SciFinder  
JSTOR Health & General Science 
Collection Scitation Publications 
JSTOR Life Sciences Collection SpringerLink 
Knovel Web of Science 
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Table 5 - Batch bottle and continuous-flow column construction details.  
Control/Treatment Batch Bottle Microcosms 
Treatment/ 
Control 
No. 
Crushed 
Bedrock 
(g) 
Ground-
water 
(mL) 
Proprietary 
(g) 
nZVI 
(g) 
Pd 
(mg) 
Org. 
Carbon 
Source 
(mL) 
EHC® 
(g)  
KB-
1® 
Biotic 
Control 
2 60 200 NA NA NA NA NA NA 
Treatment 1 3 60 200 2.3 NA NA NA NA 
Day 
29 
Treatment 2 3 60 170 NA 2.3 20 30 NA 
Day 
29 
Treatment 3 3 60 200 NA NA NA NA 1.2 
Day 
29 
Control/Treatment Batch Bottle Microcosms 
Treatment/ 
Control 
No. 
Crushed 
Bedrock 
(g) 
Ground-
water 
(mL/Day) 
Proprietary 
(g) 
nZVI 
(g) 
Pd 
(mg) 
Org. 
Carbon 
Source 
(mL) 
EHC® 
(g)  
KB-
1® 
Biotic 
Control 
2 38 3 NA NA NA NA NA NA 
Treatment 1 2 37 3 1.21 NA NA NA NA 
Day 
30 
Treatment 2 3 37 3 NA 1.21 12 11.6 NA 
Day 
30 
Treatment 3 3 37 3 NA NA NA NA 0.75 
Day 
30 
Notes: NA- Not Applicable, Pd – palladium acetate, nZVI – nanoscale zero valent iron 
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Table 6 - Limits of detection and recoveries (n = 3) for target analytes.  
Analyte 
Batch Bottles Continuous-Flow Columns 
LOD (µg/L) LOD (µg/L) Recovery % 
PCE 10 5 105 ± 4  
TCE 10 1.3 95 ± 5 
cDCE 10 2 104 ± 3  
tDCE 10 2 97 ± 2 
1,1-DCE 10 2.9 101 ± 3  
VC 10 2.5 90 ± 5  
Ethene 10 6 88 ± 7  
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Table 7 - Selected journal articles from treatability study literature review.  
J.H. Choi, Y.H. Kim, S.J. Choi, Reductive dechlorination and biodegradation of 
2,4,6-trichlorophenol using sequential permeable reactive barriers: Laboratory studies, 
Chemosphere 67 (2007) 1151-1557. 
E.I. Garcia-Pena, P. Zarate-Sequra, P. Guerra-Blanco, T. Poznyak, I. Chairez, 
Enhanced Phenol and Chlorinated Phenols Removal by Combining Ozonation and 
Biodegradation, Water Air Soil Poll. 223 (2012) 2047-4064. 
P.J. Haest, J. Philips, D. Springael, E. Smolders, The reactive transport of 
trichloroethene is influences by residence time and microbial numbers, J. Contam. 
Hydrol. 119 (2011) 89-98. 
Y.P. Katsenovich, F.R. Miralles-Wilhelm, Evaluation of nanoscale zerovalent iron 
particles for trichloroethene degradation in clayey soils, Sci. Total Environ. 407 (2009) 
4986–4993. 
T. Lee, C.H. Benson, G.R. Eykholt, Waste green sands as reactive media for 
groundwater contaminated with trichloroethylene (TCE), J. Hazard. Mater. 109 (2004) 
25-36. 
Z. Li, Y. Inoue, S. Yang, N. Yoshida, A. Katayama, Mass balance and kinetic 
analysis of anaerobic microbial dechlorination of pentachlorophenol in a continuous 
flow column, J. Biosci. Bioeng. 110 (2010) 326-332. 
K. Mackenzie, J. Battke, R. Koehler, F.D. Kopinke, Catalytic effects of activated 
carbon on hydrolysis reactions of chlorinated compounds Part 2. 1,1,2,2,-
Tetrachloroethane, Appl. Catal. B. 59 (2005) 171–179. 
T.T. Tsai, C.M. Kao, T.Y. Yeh, S.H. Liang, H.Y. Chien, Application of surfactant 
enhanced permanganate oxidation and biodegradation of trichloroethylene in 
groundwater, J. Hazard. Mater. 161 (2009) 111-119. 
C.E. Schaefer, C.W. Condee, S. Vainbery, R.J. Steffan, Bioaugmentation for 
chlorinated ethenes using Dehalococcoides sp.: Comparison between batch and column 
experiments, Chemosphere 75 (2009) 141-148. 
G.V. Lowry, M. Reinhard, Pd-Catalyzed TCE Dechlorination in Groundwater: 
Solute Effects, Biological Control, and Oxidative Catalyst Regeneration. Environ. Sci. 
Technol. 34 (2000) 3217-3223. 
B. Yim, H. Okuno, Y. Negata, Y. Maeda, Sonochemical degradation of chlorinated 
hydrocarbons using batch and continuous flow system, J. Hazard. Mater. (2001) 253-
263. 
C.M. Kao, S.C. Chen, M.C. Su, Laboratory column studies for evaluating a barrier 
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system for providing oxygen and substrate for TCE biodegradation, Chemosphere 44 
(2001) 925-934. 
J.E. Szecsody, J.S. Fruchter, M.D. Williams, V.D. Williams, V.R. Vermeul, D. 
Sklarew, In situ chemical reduction of aquifer sediments: enhancement of reactive iron 
phases and TCE dechlorination, Environ. Sci. Technol. 38 (2004) 4656-4663.   
S. Chen, S. Wu, Feasibility of using metals to remediate water containing TCE, 
Chemosphere 43 (2001) 1023-1028. 
G.F. Slater, B. Sherwood Lollar, R. Allen King, S. O’Hannesin, Isotopic 
fractionation during reductive dechlorination of trichloroethene by zero-valent iron: 
influence of surface treatment, Chemosphere 49 (2002) 587-596. 
C.K.J. Yeh, H.M. Wu, T.C. Chen, Chemical oxidation of chlorinated non-aqueous 
phase liquid by hydrogen peroxide in nation sand systems. J Hazard. Mater. (2003) 29-
51. 
C.M. Kao, S.C. Chen, J.Y. Wang, Y.L. Chen, S.Z. Lee, Remediation of PCE-
contaminated aquifer by an in situ two layer biobarrier: laboratory batch and column 
studies, Water Res. 37 (2003) 27-38. 
G.R. Kassenga, J.H. Pardue, S. Blair, T. Ferraro, Treatment of chlorinated volatile 
organic compounds in upflow wetland mesocosms, Ecol. Eng. 19 (2003) 305-323. 
B.K. Taşeli, C.F. Gökçay, H. Taşeli, Upflow column reactor design for 
dechlorination of chlorinated pulping wastes by Penicillium camemberti, J. Environ. 
Manage. 72 (2004) 175-179. 
B.K. Taşeli, C.F. Gökçay, Degradation of chlorinated compounds by Penicillium 
camemberti in batch and up-flow column reactors, Process Biochem. 40 (2005) 917-
923. 
J. Dries, L. Bastiaens, D. Springael, S.N. Agathos, L. Diels, Combined removal of 
chlorinated ethenes and heavy metals by zerovalent iron in batch and continuous flow 
column systems. Environ. Sci. Technol. 39 (2005) 8460-8465. 
L.A. Hellerich, N.P. Nikolaidis, Sorption studies of mixed chromium and chlorinated 
ethenes at the field and laboratory scales, J. Environ. Manage. 75 (2005) 77-88. 
R.A. Brennan, R.A. Sanford, C.J. Werth. Biodegradation of Tetrachloroethene by 
Chitin Fermentation Products in a Continuous Flow Column System, J. Eng-ASCE 132 
(2006) 664-673. 
R.A. Brennan, R.A. Sanford, C.J. Werth, Chitin and corncobs as electron donor 
sources for the reductive dechlorination of tetrachloroethene, Water Res. 40(11) (2006) 
2125–2134. 
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T.S. Kwon, J.S. Yang, K. Baek, J.Y. Lee, J.W. Yang, Silicone emulsion-enhanced 
recovery of chlorinated solvents: Batch and column studies, J. Hazard. Mater. B136 
(2006) 610-617. 
F. He, D. Zhao, J.Liu, C.B. Roberts, Stabilization of Fe−Pd Nanoparticles with 
Sodium Carboxymethyl Cellulose for Enhanced Transport and Dechlorination of 
Trichloroethylene in Soil and Groundwater, Ind. Eng. Chem. Res. 46(1) (2007) 29–34. 
Petersen MA, Sale TC, Reardon KF. Electrolytic trichloroethene degradation using 
mixed metal oxide coated titanium mesh electrodes. Chemosphere 67 (2007) 1573-
1581. 
L.H Chen, C.C. Huang, H.L. Lien, Bimetallic iron–aluminum particles for 
dechlorination of carbon tetrachloride Chemosphere 73 (2008) 692–697. 
M.F. Azizian, S. Behrens, A. Sabalowsky, M.E. Dolan, A.M. Spormann, L. 
Semprini, Continuous-flow column study of reductive dehalogenation of PCE upon 
bioaugmentation with Evanite enrichment culture, J. Contam. Hydrol. 100 (2008) 11-
21. 
Y. Seol, I. Javandel, Citric acid-modified Renton’s reactions for the oxidation of 
chlorinated ethylenes in soil solution systems, Chemosphere 72 (2008) 537-542. 
Z. Li, H. Hanlie, Combination of surfactant solubilization with permanganate 
oxidation for DNAPL remediation, Water Res. 42 (2008) 605-614. 
K. Choi, W. Lee, Reductive dechlorination of carbon tetrachloride in acidic soil 
manipulated with iron(II) and bisulfide ion, J. Hazard. Mater. 172 (2009) 623-630. 
M. Lee, R. Cord-Fuwisch, M. Manefield, A process for the purification of 
organochlorine contaminated activated carbon: Sequential solvent purging and 
reductive dechlorination, Water Res. 44 (2010) 1580-1590. 
M.F. Azizian, I.P.G. Marshall, S. Behrens, A.M. Spormann, L. Semprini, 
Comparison of lactate, formate, and propionate as hydrogen donors for the reductive 
dehalogenation of trichloroethene in a continuous-flow column, J. Contam. Hydrol. 
113 (2010) 77-97. 
V. Nagpala, A.D. Bokarea, R.C. Chikateb, C.V. Rodec, K.M. Paknikara, Reductive 
dechlorination of γ-hexachlorocyclohexane using Fe–Pd bimetallic nanoparticles, J. of 
Hazard. Mater. 175 (2010) 680-687. 
X. Xu, H. Lin, L. Zhu, Y. Yang, J. Feng, Enhanced biodegradation of 2-
chloronitrobenzene using a coupled zero-valent iron column and sequencing batch 
reactor system. J. Chem. Technol. Biot. 86 (2010) 993-1000. 
M.C. Shin, J.S. Yang, G.Y. Park, K. Baek, Influence of mixed-surfactant on 
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reductive dechlorination of trichloroethylene by zero-valent iron, Korean J. Chem. Eng. 
28(4) (2011) 1047-1053. 
A.J. Salter-Blanc, E.J. Suchomel, J.H. Fortuna, J.T. Nurmi, C. Walker, T. Krug, S. 
O’Hara, N. Ruiz, T. Morley, P.G. Tratnyek, Evaluation of zerovalent zinc for treatment 
of 1,2,3-trichloropropane-contamianted groundwater: laboratory and field assessment. 
Groundwater Monit. R. 32(4) (2012) 42-52. 
Z. Öztürk, B. Tansel, Y. Katsenovich, M. Sukop, S. Laha, Highly organic natural 
media as permeable reactive barriers: TCE partitioning and anaerobic degradation 
profile in eucalyptus mulch and compost, Chemosphere 89 (2012) 665-671. 
S. H. Liang, K.F. Chen, C.S. Wu, Y.H. Lin, C.M. Kao, Development of KMnO4-
releasing composites for in situ chemical oxidation of TCE contaminated groundwater, 
Water Res. 54 (2014) 149-158. 
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Table 8 - Concentrations for batch bottle and continuous-flow microcosms (steady-state 
only).  
Microcosm Analyte Concentrations (mg/L) 
BM Control A 
PCE 
57, 24, 9, 37, BDL 
BM Control B 57, 49, 16, 2.7, BDL 
BM Control A 
TCE 
43, 61, 17, BDL 
BM Control B 43, 71, 58, BDL 
BM Control A 
cDCE 
31, 45, 110, 130, 130, 120 
BM Control B 31, 43, 56, 78, 120, 120 
BM Control A 
VC 
0.36, 0.34, 0.35, 0.34, 0.41 
BM Control B 0.40, 0.94, 0.35, 0.37, 2.5 
CM Control A 
PCE 
46, 47, 46, 47, 46, 47, 47, 46, 48, 50 
CM Control B 45, 46, 44, 47, 45, 47, 48, 47, 48, 49 
CM Control A 
TCE 
3.0, 0.9, 1,1. 1.5, 1.7, 1.0, 1.0, 0.8, 0.8 
CM Control B 3.2, 1.7, 1.8, 1.7, 2.2, 1.6, 1.5, 1.4, 1.2, 1.2 
CM Control A 
cDCE 
5.0, 5.8, 6.5, 4.8, 5.9, 5.3, 4.7, 5.1, 4.6, 4.0 
CM Control B 4.2, 4.6, 5.0, 4.9, 4.7, 4.6, 4.8, 5.4, 4.2, 3.3 
BM Treatment 1A 
PCE 
57, 25, 3.2, BDL 
BM Treatment 1B 57, 34, 3.1, BDL 
BM Treatment 1C 57, 31, 0.84, BDL 
BM Treatment 1A 
TCE 
43, 42, 17, BDL 
BM Treatment 1B 43, 44, 18, BDL 
BM Treatment 1C 43, 45, 17, BDL 
BM Treatment 1A 
cDCE 
31, 39, 40, 76, 80, 70, 44, 31, 18 
BM Treatment 1B 31, 39, 40, 72, 78, 64, 35, 16, 4 
BM Treatment 1C 31, 39, 46, 76, 75, 64, 30, 10, 1.4 
BM Treatment 1A VC 0.44, 0.37, 0.39, 1.2, 9.7, 27, 38, 40 
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BM Treatment 1B 0.36, 0.29, 0.27, 1.2, 14, 27, 45, 35 
BM Treatment 1C 0.34, 0.27, 0.29, 1.4, 14, 30, 48, 42 
BM Treatment 1A 
Ethene 
BDL, 0.56, 1.7, 4.5 
BM Treatment 1B BDL, 0.16, 0.81, 2.5, 5.6 
BM Treatment 1C 
 
BDL, 0.24, 0.89, 2.7, 5.8 
CM Treatment 1A 
PCE 
2.7, 0.7, 1.0 
CM Treatment 1B 17, 10, 11 
CM Treatment 1A 
TCE 
31, 31, 32 
CM Treatment 1B 23, 29, 30 
CM Treatment 1A 
cDCE 
9, 10, 9 
CM Treatment 1B 6, 6, 5 
BM Treatment 2A 
PCE 
57, 35, 0.41, 0.12, 0.17, BDL 
BM Treatment 2B 57, 29, 0.13, BDL 
BM Treatment 2C 57, 34, 0.1, 0.17, 0.14, BDL 
BM Treatment 2A 
TCE 
43, 45, 69, 22, BDL 
BM Treatment 2B 43, 48, 80, 78, 71, 22, BDL 
BM Treatment 2C 43, 46, 26, BDL 
BM Treatment 2A 
cDCE 
31, 40, 57, 97, 97, 110, 71, 9.1, 1.7 
BM Treatment 2B 31, 43, 48, 54, 53, 90, 66, 13, BDL 
BM Treatment 2C 31, 40, 85, 110,110,  80, 8.1, BDL 
BM Treatment 2A 
VC 
0.3, 0.27, 0.31, 0.7, 4,4, 24, 36, 14 
BM Treatment 2B 0.42, 0.39, 0.43, 0.47, 1.2, 25, 37, 0.37 
BM Treatment 2C 0.3, 0.26, 0.35, 1.2, 21, 16, BDL 
BM Treatment 2A 
Ethene 
BDL, 1.1, 6.3, 8.6 
BM Treatment 2B BDL, 0.14, 0.17, 0.7, 4.3, 13 
BM Treatment 2C BDL, 1.1, 9.1, 13, 14 
CM Treatment 2A PCE 0.1, 0.5, 0.3, BDL, BDL, 5.1, 0.7, BDL, 0.2 
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CM Treatment 2B 6.0, 5.3, 4.9, 3.0, 5.5, 7.3, 6.2, 4.7, 6.5  
CM Treatment 2C 4.7, 3.8, 3.6, 4.9, 3.9, 0.2, 3.9, 4.5, 8.7 
CM Treatment 2A 
cDCE 
11, 17, 16, 17, 16, 12, 15, 9.0, 4.5 
CM Treatment 2B 11, 13, 12, 15, 13, 13, 12, 12, 9.4, 7.6 
CM Treatment 2C 12, 13, 12, 15, 13, 16, 11, 8.0, 4.7 
CM Treatment 2A VC 6.3, 3.1, 3.0, 2.5, 4.5, 2.8, 6.0, 8.2, 9.7 
CM Treatment 2B 
 
1.7, 1.2, 1.3, 0.9, 2.1, 2.3, 3.5, 3.4, 3.8 
CM Treatment 2C 2.1, 1.5, 1.6, 0.9, 2.4, 4.6, 3.4, 4.4, 4.4 
CM Treatment 2A 
Ethene 
3.4, 2.9, 3.5, 3.5, 2.8, 3.7, 2.3, 3.1, 3.7 
CM Treatment 2B 4.5, 4.2, 4.5, 4.2, 3.9, 3.5, 3.4, 4.3, 4.3 
CM Treatment 2C 4.2, 4.4, 4.5, 4.1, 3.7, 2.7, 3.8, 4.2, 4.4 
BM Treatment 3A 
PCE 
57, 29, 0.39, BDL 
BM Treatment 3B 57, 33, BDL 
BM Treatment 3C 57, 38, 0.15, 0.17, BDL 
BM Treatment 3A 
TCE 
43, 43, 12, BDL 
BM Treatment 3B 43, 43, 18, BDL 
BM Treatment 3C 43, 43, 14, 2.6, BDL 
BM Treatment 3A cDCE 31, 37, 72, 83, 81, 22, BDL 
BM Treatment 3B   31, 37, 67, 89, 80, 13, BDL 
BM Treatment 3C   31, 36, 67, 78, 75, 2.5, BDL 
BM Treatment 3A VC 0.43, 0.62, 0.65, 4.7, 28, BDL 
BM Treatment 3B   0.32, 0.58, 0.64, 6.5, 25, BDL 
BM Treatment 3C   0.28, 0.49, 0.61, 4.6, 9.7, BDL 
BM Treatment 3A Ethene 0.11, 0.42, 0.35, 0.41, 6.6, 13, 13 
BM Treatment 3B   BDL, 0.42, 0.35, 0.44, 6.6, 9.6, 10 
BM Treatment 3C   BDL, 0.33, 0.49, 0.49, 10, 7.8, 9 
CM Treatment 3A VC 0.14, 0.01, 0.01, 0.02, 0.08, BDL, BDL, BDL, 0.03, 
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BDL, BDL 
CM Treatment 3B 
0.02, 0.01, 0.02, 0.04, 0.02, BDL, 0.02, 0.02, BDL, 
0.01, 0.03 
CM Treatment 3C 
0.05, 0.03, 0.33, 0.50, 0.23, 0.07, 1.9, 1.6, 0.18, 0.04, 
0.11 
CM Treatment 3A 
Ethene 
9.58, 9.58, 9.63, 9.63, 9.63, 9.60, 9.64, 9.64, 9.64, 
9.63, 9.64, 9.64 
CM Treatment 3B 
9.62, 9.62, 9.62, 9.62, 9.59, 9.62, 9.62, 9.62, 9.62, 
9.62, 9.61, 9.61 
CM Treatment 3C 
9.60, 9.61, 9.47, 9.94, 9.51. 9.59, 8.75, 8.90, 9.54, 
9.61, 9.58 
Note: BM – Batch Microcom, CM – Column Microcoms, BDL- Below Detection Limits. A/B/C denotes 
replicate. Analytes with non-dectects during the entire study period in batch or during steady-state in 
columns were not included here. Once removal was achieved in batch, additional BDLs for subsequent 
sampling periods were not included.   
 
 
 
Fig. 23. Normal probability plot of column observed rate constants normalized to batch 
observed rate constants from combined studies captured in meta-analysis. Coefficient of 
determination of 0.91 illustrates normal data distribution, thus data extracted from 
captured results likely are representative of true values. 
  
R² = 0.91
0
5
10
15
0 5 10
k
O
B
S
C
o
lu
m
n
/ 
k
O
B
S
B
a
tc
h
Theoretical
168 
 
APPENDIX B 
SUPPLEMENTAL MATERIAL FOR CHAPTER 4 
 
  
169 
 
Table 9 – Glucocorticoid mass spectrometry parameters. 
Compound Q1 Q3 DP EP CE CXP 
Cortisone 361 163/91 91/91 12/6 35/93 16/6 
Cortisol 363 121/91 81/81 6/10 47/93 10/6 
Cortisol-d4 367.2 121/96.9 81/81 10/10 37/55 10/16 
Cortisone- d8 369.3 169/337 71/71 10/10 37/19 8/18 
Notes: 
Q1 = precursor ion, Q3 = product ions, DP = declustering potential, EP = entrance 
potential, CE = collision energy, CPX = collision cell exit potential 
 
 
Table 10 – Glucocorticoid analytical method parameters.  
Analyte 
Absolute 
Recovery (%) 
Relative 
Recovery (%) 
MDL 
(ng/L) 
LOD 
(ng/L) 
LOQ 
(ng/L) 
Cortisol 66 ± 4 88 ± 5 78 84 281 
Cortisone 65 ± 3 94 ± 5 60 65 217 
Cortisol- d4 69 ± 4 NA ND ND ND 
Cortisone- d8 70 ± 4 NA ND  ND ND  
Notes: 
NA = not applicable, ND = not determined, MDL = method detection limit 
LOD = limit of detection, LOQ = limit of quantitation 
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Table 11 - Calculated total mass load, and per person cortisol and cortisone in selected 
studies. Estimated total mass load based on average urinary excretion of cortisol (23 μg d-
1) and cortisone (72 μg d-1) [131]. 
Reference Compound 
Measured 
Concentration 
(ng/L) 
Total 
Flow (L) 
Population 
g/day 
(actual) 
μg/day 
person 
Herrerro 
et al., 
2012 
Cortisol 
190 3.00E+07 140000 5.7 40.7 
136 3.00E+07 140000 4.1 29.1 
270 1.60E+07 107000 4.3 40.4 
136 1.60E+07 107000 2.2 20.3 
Cortisone 
285 1.60E+07 107000 4.6 42.6 
122 1.60E+07 107000 2.0 18.2 
135 3.00E+07 140000 4.1 28.9 
122 3.00E+07 140000 3.7 26.1 
Liu et al., 
2011  
Cortisol 
28.8 2.00E+08 425,000 5.8 13.6 
12.7 7.00E+07 230,000 0.9 3.9 
Cortisone 
45.8 2.00E+08 425,001 9.2 21.6 
14.5 7.00E+07 230,001 1.0 4.4 
Liu et al., 
2012 
Cortisol 
9.67 7.44E+07 425,000 0.7 1.7 
123 9.60E+07 380,000 11.8 31.1 
Cortisone 
4.58 7.44E+07 425,000 0.3 0.8 
48.2 9.60E+07 380,000 4.6 12.2 
Chang et 
al., 2007 
Cortisol 
15 6.00E+07 400,000 0.9 2.3 
85 4.00E+07 100,000 3.4 33.9 
57 7.92E+08 2,400,000 45.3 18.9 
14 2.00E+08 480,000 2.9 6.0 
41 4.74E+08 814,000 19.3 23.7 
26 1.50E+07 180,000 0.4 2.2 
37 6.00E+08 1,925,000 21.9 11.4 
Cortisone 
10 6.00E+07 400,000 0.6 1.6 
70 4.00E+07 100,000 2.8 28.1 
38 7.92E+08 2,400,000 29.9 12.4 
14 2.00E+08 480,000 2.7 5.7 
31 4.74E+08 814,000 14.7 18.1 
25 1.50E+07 180,000 0.4 2.0 
26 6.00E+08 1,925,000 15.8 8.2 
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Table 12 - Daily wastewater flow (L d-1) from North and South campus sampling 
locations.  
Month Day 
North Campus 
(L/day) 
South Campus 
(L/day) 
Aug 
Mon 6,090,685 193,260 
Tue 5,896,581 184,272 
Wed 6,061,116 182,472 
Thu 6,121,856 271,625 
Fri 5,951,132 191,359 
Sat 5,586,937 125,876 
Sun 5,759,957 112,247 
Sept 
Mon 7,325,565 283,586 
Tue 7,325,565 312,928 
Wed 7,734,011 252,644 
Thu 7,261,903 253,164 
Fri 6,738,106 292,729 
Sat 6,203,102 119,123 
Sun 6,290,142 128,017 
Oct 
Mon 6,736,704 235,242 
Tue 6,586,472 251,998 
Wed 6,659,124 230,506 
Thu 6,650,750 271,294 
Fri 6,025,289 198,753 
Sat 5,833,181 101,395 
Sun 5,674,872 99,660 
Nov 
Mon 6,215,578 299,279 
Tue 5,961,781 251,830 
Wed 6,065,051 242,515 
Thu 5,928,467 256,215 
Fri 5,624,905 237,873 
Sat 5,132,319 114,527 
Sun 5,221,398 105,766 
Dec 
Mon 6,019,810 225,177 
Tue 5,993,890 210,178 
Wed 5,845,066 190,682 
Thu 5,743,360 198,269 
Fri 5,070,626 181,962 
Sat 4,349,397 75,931 
Sun 4,226,058 55,365 
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Table 13 - Calculated campus population with biomarkers caffeine (CAF), paraxanthine 
(PAR), nicotine (NIC), cotinine (COT), trans-3’-hydroxycotinine (3-OH-COT), 
enterolactone (ENT) and total wastewater flow normalized to 50 gallons per day (GPD) 
per person estimates. 
Month Day CAF PAR 
Water    
(50 
GPD) 
NIC COT 
3-OH-
COT 
ENT 
Aug 
Mon 224,027 9,530 33,196 17,362 15,258 6,090 15,072 
Tue 228,976 10,011 32,123 17,432 16,461 6,350 15,560 
Wed 187,350 9,483 32,983 16,399 16,384 6,679 17,594 
Thu 213,555 11,861 33,774 17,463 16,925 7,890 17,957 
Fri 168,500 7,397 32,448 16,924 18,311 6,620 14,498 
Sat 108,101 6,992 30,179 16,589 17,672 7,317 10,266 
Sun 104,247 5,412 31,021 16,556 15,933 5,787 9,394 
Sept 
Mon 133,409 7,785 27,896 17,152 16,105 3,054 27,024 
Tue 192,306 11,205 28,051 24,121 19,822 4,067 38,149 
Wed 269,874 14,390 42,190 30,417 23,844 4,368 41,705 
Thu 247,227 18,086 39,699 27,924 23,641 4,479 39,320 
Fri 230,048 14,509 37,141 30,875 26,943 5,858 35,471 
Sat 137,108 9,328 33,398 27,537 24,714 4,907 19,267 
Sun 123,955 6,249 33,905 29,706 25,670 4,067 22,035 
Oct 
Mon 229,660 24,215 34,416 39,202 33,686 4,709 33,295 
Tue 213,814 23,117 32,824 36,054 33,094 4,534 30,027 
Wed 201,184 19,304 33,320 34,099 30,134 3,899 20,023 
Thu 161,503 15,036 32,671 29,209 28,049 3,362 17,981 
Fri 143,473 12,450 30,971 29,820 26,086 2,956 14,616 
Sat 95,730 7,415 27,717 30,167 27,286 3,008 15,037 
Sun 87,544 5,747 28,141 34,831 26,199 2,821 12,848 
Nov 
Mon 220,251 9,696 34,416 44,986 20,657 4,221 34,519 
Tue 202,984 9,813 32,824 56,819 20,100 3,829 30,219 
Wed 284,918 10,127 33,320 90,773 24,135 4,618 50,147 
Thu 190,453 9,652 32,671 40,767 20,472 3,914 38,835 
Fri 179,767 9,509 30,971 36,588 23,062 4,683 34,264 
Sat 114,334 6,169 27,717 35,824 18,790 3,555 22,804 
Sun 107,780 5,206 28,141 34,257 17,920 3,119 20,900 
Dec 
Mon 204,909 10,227 32,990 49,140 21,669 4,609 62,525 
Tue 219,397 10,257 32,774 65,001 23,821 4,923 48,458 
Wed 169,936 7,753 31,885 43,496 20,145 3,836 29,013 
Thu 185,438 8,191 31,387 46,736 25,407 4,980 31,510 
Fri 139,744 5,245 27,747 50,992 19,546 3,014 21,676 
Sat 120,106 3,380 23,377 36,346 17,955 2,798 14,817 
Sun 75,275 3,245 22,617 32,277 15,333 2,985 12,871 
Notes: 
       
 
GPD = gallons per day 
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Table 14 - Statistical comparisons between days, months, and weekdays/weekends. 
Mann-Whitney U values, associated Z-score and p-values showed in table. P-values 
ranked for each set of comparisons and combined with number of comparisons (m) and 
false discovery rate (FDR) of 0.1 to establish Benjamini-Hochberg correction. BH 
corrections not completed for weekday versus weekend because only a single 
comparison. 
Pair 
1 
Pair 
2 
Mann-
Whitney 
U 
Z-
score 
 p-
value 
 p-
value 
rank 
BH 
Mon Tues 6 1.36 0.175 8 0.038 
Mon Wed 3 1.98 0.047 1 0.005 
Mon Thu 6 1.36 0.175 8 0.038 
Mon Fri 3 1.98 0.047 1 0.005 
Mon Sat 3 1.98 0.047 1 0.005 
Mon Sun 3 1.98 0.047 1 0.005 
Tues Wed 9 0.73 0.465 15 0.071 
Tues Thu 7 1.15 0.251 13 0.062 
Tues Fri 5 1.57 0.117 7 0.033 
Tues Sat 4 1.78 0.076 6 0.029 
Tues Sun 3 1.98 0.047 1 0.005 
Wed Thu 11 0.31 0.754 18 0.086 
Wed Fri 9 0.73 0.465 15 0.071 
Wed Sat 7 1.15 0.251 13 0.062 
Wed Sun 6 1.36 0.175 8 0.038 
Thu Fri 9 0.73 0.465 15 0.071 
Thu Sat 6 1.36 0.175 8 0.038 
Thu Sun 6 1.36 0.175 8 0.038 
Fri Sat 13 -0.10 0.917 21 0.100 
Fri Sun 11 0.31 0.754 18 0.086 
Sat Sun 11 0.31 0.754 18 0.086 
Aug Sep 12 1.60 0.110 7 0.070 
Aug Oct 0 3.13 0.002 1 0.010 
Aug Nov 0 3.13 0.002 1 0.010 
Aug Dec 0 3.13 0.002 1 0.010 
Sep Oct 8 2.11 0.035 5 0.050 
Sep Nov 8 2.11 0.035 5 0.050 
Sep Dec 6 2.36 0.018 4 0.040 
Oct Nov 27 -0.32 0.750 9 0.090 
Oct Dec 23 0.19 0.848 10 0.100 
Nov Dec 17 0.96 0.338 8 0.080 
Day End 63 2.59 0.010 NA NA 
Notes 
      
BH = Benjamini-Hochberg correction 
  
NA = Not Applicable  
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Fig. 24. Liquid chromatography gradient program.  
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Table 15 - Measured analyte transitions and method detection limits (MDLs) for alcohol, 
caffeine, and nicotine compounds.  
Compound Q1 Q3 MDL 
Ethyl Sulfate 124.773 96.8/79.8 73 
Caffeine 195.195 137.9/42.2 12 
Paraxanthine 181.032 124.0/162.9 24 
Nicotine 162.996 84.1/79.8 21 
Cotinine 177.113 79.6/98.0 2 
trans-3’-hydroxycotinine 193.122 79.9/133.8 6 
Ethyl Sulfate-d5 129.713 98.0/79.9 ND 
13C3-Caffeine 198.179 139.8/112.0 ND 
Cotininie-d3 180.000 79.8/101.0 ND 
Notes: ND = not determined 
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Table 16 - Daily wastewater flow (L d-1) from North and South Campus sampling 
locations, Fall 2017 – Spring 2017.  
 
Month Day 
North 
Campus 
(L/d) 
South 
Campus  
(L/day) 
Aug 
Mon 6,090,685 193,260 
Tue 5,896,581 184,272 
Wed 6,061,116 182,472 
Thu 6,121,856 271,625 
Fri 5,951,132 191,359 
Sat 5,586,937 125,876 
Sun 5,759,957 112,247 
Sept 
Mon 7,325,565 283,586 
Tue 7,325,565 312,928 
Wed 7,734,011 252,644 
Thu 7,261,903 253,164 
Fri 6,738,106 292,729 
Sat 6,203,102 119,123 
Sun 6,290,142 128,017 
Oct 
Mon 6,736,704 235,242 
Tue 6,586,472 251,998 
Wed 6,659,124 230,506 
Thu 6,650,750 271,294 
Fri 6,025,289 198,753 
Sat 5,833,181 101,395 
Sun 5,674,872 99,660 
Nov 
Mon 6,215,578 299,279 
Tue 5,961,781 251,830 
Wed 6,065,051 242,515 
Thu 5,928,467 256,215 
Fri 5,624,905 237,873 
Sat 5,132,319 114,527 
Sun 5,221,398 105,766 
Dec 
Mon 6,019,810 225,177 
Tue 5,993,890 210,178 
Wed 5,845,066 190,682 
Thu 5,743,360 198,269 
Fri 5,070,626 181,962 
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Sat 4,349,397 75,931 
Sun 4,226,058 55,365 
Jan 
Mon 6,036,375 243,782 
Tue 6,010,379 248,313 
Wed 5,961,489 226,156 
Thu 6,052,731 236,367 
Fri 5,758,942 192,831 
Sat 5,267,119 109,662 
Sun 5,397,830 105,985 
Feb 
Mon 6,391,610 232,124 
Tue 6,211,325 286,484 
Wed 6,352,415 241,714 
Thu 6,052,006 298,174 
Fri 5,819,215 270,251 
Sat 5,351,702 184,081 
Sun 5,518,886 166,734 
Mar 
Mon 6,330,403 249,771 
Tue 6,456,077 277,580 
Wed 6,361,471 212,558 
Thu 6,330,250 235,590 
Fri 5,920,964 171,663 
Sat 5,457,231 74,934 
Sun 5,471,597 73,968 
Apr 
Mon 6,309,493 213,524 
Tue 6,515,371 220,865 
Wed 6,299,732 215,553 
Thu 6,302,010 204,520 
Fri 6,065,704 144,171 
Sat 6,011,489 82,040 
Sun 5,860,513 82,589 
May 
Mon 6,243,979 149,102 
Tue 6,154,980 157,589 
Wed 5,948,889 125,754 
Thu 6,132,745 142,308 
Fri 5,854,486 85,647 
Sat 5,303,718 14,008 
Sun 4,778,672 12,310 
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Table 17 - Estimated campus population from biomarkers Fall 2017- Spring 2018.  
Month Day ENT 5-HIAA 
Water 
(50 
GPD) 
Avg. 
Aug 
Mon 15,072 7,536 33,196 18,601 
Tue 15,560 7,780 32,123 18,488 
Wed 17,594 8,797 32,983 19,791 
Thu 17,957 8,979 33,774 20,237 
Fri 14,498 7,249 32,448 18,065 
Sat 10,266 5,133 30,179 15,193 
Sun 9,394 4,697 31,021 15,037 
Sept 
Mon 27,024 13,512 27,896 22,811 
Tue 38,149 19,074 28,051 28,425 
Wed 41,705 20,853 42,190 34,916 
Thu 39,320 19,660 39,699 32,893 
Fri 35,471 17,735 37,141 30,116 
Sat 19,267 9,634 33,398 20,766 
Sun 22,035 11,017 33,905 22,319 
Oct 
Mon 33,295 16,262 34,416 27,991 
Tue 30,027 16,975 32,824 26,609 
Wed 20,023 12,785 33,320 22,043 
Thu 17,981 10,658 32,671 20,437 
Fri 14,616 7,373 30,971 17,653 
Sat 15,037 9,204 27,717 17,320 
Sun 12,848 7,453 28,141 16,148 
Nov 
Mon 34,519 14,496 34,416 27,810 
Tue 30,219 14,522 32,824 25,855 
Wed 50,147 26,905 33,320 36,791 
Thu 38,835 15,078 32,671 28,861 
Fri 34,264 11,365 30,971 25,533 
Sat 22,804 8,645 27,717 19,722 
Sun 20,900 8,461 28,141 19,167 
Dec 
Mon 62,525 24,059 32,990 39,858 
Tue 48,458 23,029 32,774 34,754 
Wed 29,013 19,436 31,885 26,778 
Thu 31,510 18,890 31,387 27,262 
Fri 21,676 14,764 27,747 21,396 
Sat 14,817 11,404 23,377 16,533 
Sun 12,871 10,674 22,617 15,387 
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Jan 
Mon 45,513 15,171 33,176 31,287 
Tue 41,082 13,694 33,062 29,279 
Wed 53,700 17,900 32,687 34,762 
Thu 52,674 17,558 33,223 34,485 
Fri 47,797 15,932 31,441 31,723 
Sat 31,491 10,497 28,403 23,464 
Sun 34,429 11,476 29,075 24,993 
Feb 
Mon 55,388 17,560 34,991 35,980 
Tue 145,723 26,721 34,325 68,923 
Wed 66,113 19,610 34,834 40,186 
Thu 65,410 17,703 33,546 38,886 
Fri 53,641 12,638 32,168 32,816 
Sat 43,480 6,747 29,243 26,490 
Sun 39,228 5,040 30,035 24,768 
Mar 
Mon 50,959 11,870 34,761 32,530 
Tue 40,119 14,773 35,571 30,154 
Wed 34,986 11,610 34,728 27,108 
Thu 25,561 12,377 34,685 24,208 
Fri 33,998 9,041 32,185 25,075 
Sat 38,043 14,288 29,224 27,185 
Sun 25,421 8,144 29,295 20,953 
Apr 
Mon 45,202 37,033 34,761 38,999 
Tue 39,898 35,593 35,571 37,021 
Wed 36,278 31,141 34,728 34,049 
Thu 30,830 31,584 34,685 32,366 
Fri 1,941 1,215 32,185 11,780 
Sat 18,136 22,576 29,224 23,312 
Sun 16,957 21,984 29,295 22,746 
May 
Mon 37,637 19,752 33,772 30,387 
Tue 40,470 20,416 33,347 31,411 
Wed 21,102 12,873 32,090 22,022 
Thu 14,438 11,204 33,149 19,597 
Fri 13,336 8,027 31,379 17,581 
Sat 9,400 6,155 28,092 14,549 
Sun 8,601 5,089 25,309 13,000 
Notes: GPD = gallons per day 
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Table 18 – Published survey data of alcohol, caffeine, and nicotine consumption 
estimates in college students.  
  
Per Capita 
Consumption (SD) 
Citation 
Alcohol  
(g d-1 per capita) 
11.3 (7.5) This Study 
10.5 (8.1) Hoeppner et al., 2009 
9.0 (10.9) Tremblay et al., 2009 
10.9 (29.9) Patrick & Lee, 2009 
Caffeine  
(mg d-1 per capita) 
114 (49) This Study 
159 Mahoney et al., 2018 
196 Norton et al., 2011 
Nicotine  
(mg d-1 per capita) 
0.63 (0.22) This Study 
1361, 944, 618, 859 Seo et al., 2011 
853.5 (486) Caldeira et al., 2012 
927 (243) Caldeira et al., 2012 
Notes: SD = Standard deviation 
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Fig. 25. Concentrations (ug L-1) of EtS, caffeine (CAF), paraxanthine (PAR), nicotine 
(NIC), cotinine (COT), trans-3’-hydroxycotinine (3-OH-COT) in wastewater at the north 
(A-C) and south (D-F) sample locations, on a university campus.  
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Fig. 26. Correlation plot of caffeine (CAF), paraxanthine (PAR) (A), trans-3’-
hydroxycotinine (3-OH-COT), cotinine (COT) (B), nicotine (NIC), COT (C) and NIC, 3-
OH-COT (D) in wastewater on a university campus.  
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Table 19 – List of narcotic labeled standards. 
Narcotic  Labeled Standard 
Morphine morphine-d6 
Morphine-3-Glucuronide morphine-3-glucuronide-d3  
Oxycodone oxycodone-d3 
Noroxycodone noroxycodone-d3  
Codeine codeine-d6 
Norcodeine norcodeine-d3  
Heroin heroin-d9  
6-Acetylmorphine 6-acetylmorphine-d3   
Fentanyl fentanyl-d5 
Norfentanyl nofentanyl-d5 
Methadone methadone-d3 
2-ethylidene-1,5-dimethyl-3,3-
diphenylpyrrolidine-d3  
2-ethylidene-1,5-dimethyl-3,3-
diphenylpyrrolidine-d3  
Buprenorphine buprenorphine-d4  
Norbuprenorphine norbuprenorphine-d3  
3,4-methylenedioxy-
methamphetamine  
3,4-methylenedioxy-
methamphetamine-d5  
Cocaine cocaine-d3  
Benzoylecgonine benzoylecgonine-d8  
Amphetamine amphetamine-d6  
Methylphenidate methylphenidate-d9  
Alprazolam alprazolam-d5  
α-hydroxyalprazolam α-hydroxyalprazolam-d5  
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Table 20 – Licit and illicit compound method detection limits and recoveries.  
Analyte 
Method 
Detection 
Limit (ng/L) 
Average 
Recovery 
(%) 
Ethyl Sulfate 73 104 
Caffeine 12 89 
Paraxanthine 24 86 
Nicotine 21 91 
Cotinine 2 102 
trans-3’-hydroxycotinine 6 84 
Morphine 0.9 91 
Morphine-3-Glucuronide 0.2 121 
Codeine 1.4 99 
Norcodeine 0.8 128 
Oxycodone 0.2 104 
Noroxycodone 0.3 110 
Heroin 0.3 139 
6-Acetylmorphine 0.3 116 
Fentanyl 0.3 124 
Norfentanyl 0.2 112 
Methadone 1.4 125 
2-ethylidene-1,5-dimethyl-3,3-
diphenylpyrrolidine (EDDP) 
1.7 109 
Buprenorphine 140 99 
Norbuprenorphine 120 138 
Methamphetamine 71 88 
3,4-Methylenedioxy-methamphetmaine 
(MDMA) 
0.5 126 
Amphetamine 0.9 135 
Methylphenidate 0.3 83 
Cocaine 0.6 141 
Benzoylecgonine 0.7 161 
Alprazolam 0.5 98 
alpha-hydroxyalprazolam 0.2 144 
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Table 21 – Licit and illicit compound excretion values. 
Indicator 
Excretion Rate 
(%) 
Source 
Morphine 10 [243] 
Noroxycodone 22.1 [244] 
Codeine 30 [245] 
6-Acetylmorphine 1.3 [246] 
Norfentanyl 91.08 [247] 
EDDP 27.5 [245] 
Norbuprenorphine 15.3 [248] 
Methamphetamine 43 [249] 
Benzoylecgonine 39.1 [221] 
MDMA 22.5 [250] 
Amphetamine 36.3 [250] 
Methylphenidate 1.5 [251] 
alpha-hydroxyalprazolam 15 [252] 
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Fig. 27. Flow rates generated by in situ sampler. Error bars represent minimum/ 
maximum of duplicate samples. 
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Fig. 28. Analyte concentrations measured by the discrete auto-sampler. 
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Fig. 29. Analyte concentrations measured by the continuous auto-sampler. 
 
